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In today’s public health world, the term “neglected disease” conjures up obscure tropical 
illnesses of little relevance to contemporary practice in the United States. Yet, when one 
considers the actual meaning of the words, the time may be right to add hypertension to this list. 
Despite the magnitude of hypertension-associated morbidity and mortality and the $73 billion in 
annual costs to the health care system, hypertension prevention and control is only one of a 
number of programs competing for a total of only $54 million (2009) in CDC’s entire Heart 
Disease and Stroke Prevention portfolio. 
The lack of attention to hypertension goes against the objective facts. Hypertension is one 
of the leading causes of death in the United States. In 2005, high blood pressure was responsible 
for about one in six deaths of U.S. adults and was the single largest risk factor for cardiovascular 
mortality accounting for about 45 percent of all cardiovascular deaths. Based on data from the 
Centers for Disease Control and Prevention (CDC) and the National Heart, Lung, and Blood 
Institute (NHLBI) from 1995 to 2005, the death rate from high blood pressure increased by 25 
percent and the actual number of deaths rose by 56 percent (AHA, 2009a).  
Hypertension, defined for adults as a systolic pressure of 140 mm Hg or greater or a 
diastolic pressure of 90 mm Hg or higher, is highly prevalent (Chobanian et al., 2003). 
Approximately 73 million Americans or nearly one in three U.S. adults has hypertension (AHA, 
2009b; Fields et al., 2004). An additional 59 million have prehypertension, which is defined as 
blood pressure ranging from 120-139 mm Hg systolic and/or 80-89 mm Hg diastolic (Chobanian 
et al., 2003). 
The risk of developing hypertension increases with age and in older age groups it is more 
common than not. Based on data from the Framingham study, the lifetime risk of hypertension is 
estimated to be 90 percent for people with normal blood pressure at age 55 or 65 who live to be 
age 80 to 85, respectively (Cutler et al., 2007; Vasan et al., 2002).  
Hypertension is costly to the healthcare system. It is the most common primary diagnosis 
in America (Chobanian et al., 2003), and it contributes to the costs of cardiovascular disease 
(coronary heart disease, myocardial infarction) and stroke. The American Heart Association 
(AHA) recently reported the direct and indirect costs of high blood pressure as a primary 
diagnosis as $73.4 billion for 2009 (Lloyd-Jones et al., 2009). With respect to the cost of treating 
hypertension, an analysis by DeVol and Bedroussian (2007) estimated that the total expenditure 
for the population reporting hypertension as a condition in the Medical Expenditure Panel 
Survey (MEPS) was $32.5 billion in 2003 (DeVol and Bedroussian, 2007). Another study 
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estimated the total incremental annual direct expenditures for treating hypertension (the excess 
expenditure of treating patients with hypertension compared to patients without hypertension) to 
be about $54 billion in 2001 (Balu and Thomas, 2006).  
Much is known about the health consequences and costs associated with hypertension 
(Chapters 1 and 2). Robust clinical and public health research efforts have developed safe and 
cost-effective nonpharmacological and pharmacological interventions (Chapters 4 and 5) to 
prevent, treat, and control hypertension. Nonetheless, millions of Americans continue to develop, 
live with, and die from hypertension because we are failing to translate our public health and 
clinical knowledge into effective prevention, treatment and control programs. In the committee’s 
view this current state is one of neglect; as defined by Webster’s, “giving insufficient attention to 
something that merits attention.” The recommendations offered in this report outline a 
population-based policy and systems change approach to addressing hypertension that can be 
applied at the federal, state, and local level. It is time to give full attention and take concerted 
actions to prevent and control hypertension. 
THE CHARGE TO THE COMMITTEE 
The CDC Division for Heart Disease and Stroke Prevention (DHDSP) provides national 
leadership to reduce the burden of disease, disability, and death from heart disease and stroke. 
DHDSP is co-lead, along with the NHLBI, for the Healthy People 2010 objectives related to 
heart disease and stroke including four objectives specific to hypertension (Table S-1).  
TABLE S-1 Healthy People 2010 Focus Area 12: Heart and Stoke, Blood Pressure Objectives 
Focus Area Blood Pressure Objective 
12-9. Reduce the proportion of adults with high blood pressure. 
12-10. Increase the proportion of adults with high blood pressure whose blood pressure is under control.  
12-11. Increase the proportion of adults with high blood pressure who are taking action (for example, losing 
weight, increasing physical activity, or reducing sodium intake) to help control their blood pressure. 
12-12. Increase the proportion of adults who have had their blood pressure measured within the preceding 2 
years and can state whether their blood pressure was normal or high. 
SOURCE: CDC, 2002. 
Findings from the Healthy People 2010 Midcourse Review (CDC, 2002) indicated that 
the nation was moving away from making progress in the target objectives as reflected by 
increases in the prevalence of high blood pressure among adults and among children and 
adolescents. This moving away from Healthy People 2010 goals provided an increased emphasis 
for a DHDSP programmatic focus on hypertension.  
The DHDSP has developed a strategic plan to reduce and control hypertension that 
recognizes the urgent need to implement known effective practices and to develop new ones. The 
plan identifies a number of action areas and goals for the prevention and control of hypertension. 
The CDC requested assistance and guidance from the Institute of Medicine (IOM) to determine a 
small set of high-priority areas in which public health can focus its efforts to accelerate progress 
in hypertension reduction and control. Specifically, the CDC requested that the IOM convene an 
expert committee to review available public health strategies for reducing and controlling 
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hypertension in the U.S. population, including both science-based and practice-based knowledge. 
In conducting its work, the committee was asked to consider the following questions: 
1. Identify the particular role of CDC’s DHDSP in addressing the highest-priority areas. 
2. Identify the role of state health departments in advancing progress in the priority action 
areas. 
3. Identify the role of other public health partners. 
4. What visible impacts can be expected if DHDSP focuses its efforts in these priority 
areas?  
5. What indicators should be monitored to assess the progress of DHDSP, state health 
departments, and partners in implementing the committee’s recommendations? 
6. What are the potential positive and negative impacts on health disparities that could 
result if the committee’s recommendations are implemented? 
7. What indicators should be monitored related to health disparities to ensure the intended 
impact of the DHDSP priority action areas identified? 
The committee was not expected to conduct a new, detailed review of peer-reviewed 
literature on hypertension because such literature reviews, meta-analyses, and syntheses already 
exist and have been used to inform existing guidelines and recommendations. 
FINDINGS AND RECOMMENDATIONS 
The CDC, through the Division of Heart Disease and Stroke Prevention, has leveraged its 
broader cardiovascular disease prevention and control programmatic efforts to address 
hypertension primarily through its state heart disease and stoke prevention programs. Many of 
these efforts are described in Chapter 3 and throughout other chapters. Objectively however, 
there are several significant problems with the current status and direction of hypertension 
prevention and control activities: 
• Hypertension is only one component of a larger cardiovascular disease prevention 
program that as a consequence, has more of a medical care rather than a population-based 
prevention focus based on system change. 
• The CDC’s cardiovascular disease program in general, and the hypertension program in 
particular, are dramatically under funded relative to the preventable burden of disease and 
the strategy and action plan that has been developed.  
In light of the current situation, short-term programmatic priorities must be tempered by 
the economic reality that the absolute amount of prevention resources available to CDC are 
limited and thus cost effectiveness and absolute costs must be considered. Compared with 
interventions directed towards individuals, population-based interventions and interventions 
directed at system improvements and efficiencies are more likely to be more practical and 
realistic in the current resource-constrained environment. The committee believes that the reality 
of limited resources for hypertension prevention requires that DHDSP shift the weight of its 
focus to approaches that cater to the strength of the public health system – population-based and 
systems approaches rather than health care-based approaches.  
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To that end, the committee has recommended a number of high priority strategies to 
prevent and control hypertension to the CDC and DHDSP. The recommendations embody a 
population-based approach grounded in the principles of measurement, system change, and 
accountability and bridge public health and clinical care. In brief, the recommendations seek to:  
• Shift the balance of the Division’s hypertension priorities from individual-based 
strategies to population-based strategies to:  
• strengthen collaboration among CDC units (and their partners) to ensure that 
hypertension is included as a dimension of other population-based activities around 
healthy lifestyle improvement, particularly greater consumption of potassium rich 
fruits and vegetables, increased physical activity, and weight management 
• strengthen CDC’s leadership in monitoring and reducing sodium intake in the 
American diet to meet current dietary guidelines 
• improve the surveillance and reporting of hypertension to better characterize general 
trends and trends among subgroups of the population 
• Promote policy and system change approaches to: 
• Improve the quality of care provided to individuals by assuring that individuals who 
should be in treatment are in treatment and receive care that is consistent with 
current treatment guidelines 
 Increase the importance of treating systolic hypertension, especially among the 
elderly 
• Remove economic barriers to effective antihypertensive medications  
• Provide community-based support for individuals with hypertension through 
community health workers who are trained in dietary and physical activity 
counseling. 
The population-based policy and systems approach recommended is not limited to the 
CDC and DHDSP but also extends and applies to state and local health departments and to other 
partners. The high priority recommendations directed to DHDSP are discussed in Chapters 4 and 
5 have been translated for action by state and local health jurisdictions in Chapter 6. Successfully 
implementing a population-based approach policy and systems approach at all levels will depend 
on the resources available and systems of accountability to ensure that resources are 
appropriately aligned and outcomes are achieved; those recommendations are also found in 
Chapter 6. For ease of presentation in this summary, the recommendations for the DHDSP and 
their most important partners, state and local health jurisdictions, have been integrated in this 
summary but are discussed separately in relevant chapters.  
Population-based strategies  
Hypertension is highly preventable and manageable through lifestyle interventions. Given 
the co-occurrence or association with poor diet, physical inactivity, and obesity, which appear to 
be on the increase, lifestyle modifications are of even greater importance. Government public 
health agencies are the only organizations with the mandate to provide population-wide services, 
and the CDC and state and local public health agencies are more experienced and skilled in 
population-based interventions than in interventions that provide health care directly to 
individuals. Through leadership and convening strategies, government public health agencies can 
galvanize political commitment, develop policy, prioritize funding, and coordinate programs 
(Baker and Porter, 2005). 
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A stronger focus on primary prevention of hypertension is consistent with DHDSP’s 
responsibility as co-lead of Healthy People 2010’s focus area on heart disease and stroke and in 
achieving progress in reducing the proportion of adults with high blood pressure. The committee 
acknowledges that within the CDC, the DHDSP is not the focal point for addressing dietary 
imbalances, physical inactivity, and other determinants to prevent the development of risk factors 
and progression of high blood pressure. It also acknowledges that the focus of DHDSP activities 
is primarily adults, not children. The committee is also aware that the DHDSP, through the 
Cardiovascular Health Collaboration of the National Center for Chronic Disease Prevention and 
Health Promotion, collaborates with units across CDC. The committee believes, however, that 
this collaboration can be strengthened and extended to leverage the efforts and resources of those 
programs to ensure proper attention to the prevention of hypertension and the reduction of 
hypertension risk factors.  
Based on the review of the literature there is strong evidence linking overweight and 
obesity, high sodium intake, low potassium intake, unhealthy diet, and decreased physical 
activity to hypertension. These risk factors contribute substantially to the burden of hypertension 
in the United States, further; the prevalence of many of these risk factors is increasing. The 
observational and randomized clinical trial literature on interventions to reduce overweight and 
obesity, decrease sodium intake, support eating a healthy diet, increase potassium intake and 
increase physical activity also indicate that these risk factors are modifiable and that they can 
help reduce blood pressure levels. The committee concludes in light of : (1) the high prevalence 
of these risk factors that contribute significantly to the development of high blood pressure, (2) 
existing interventions to reduce these risk factors, and (3) the potential to reduce the burden of 
hypertension if the interventions are implemented, that actions to reduce these risk factors merit 
a high priority. The committee recommendations follow; the number appearing before the 
recommendation refers to the chapter and number of the recommendation in that chapter.  
4.1 The committee recommends that the Division of Heart Disease and Stroke 
Prevention integrate hypertension prevention and control in programmatic efforts 
to effect system, environmental, and policy changes through collaboration with 
other CDC units and their external partners, to ensure that population-based 
lifestyle or behavior change interventions where delivered, are delivered in a 
coordinated manner that includes a focus on the prevention of hypertension. High 
priority programmatic activities to collaborate on include interventions for:  
• reducing overweight and obesity 
• promoting the consumption of a healthy diet that includes a higher intake 
of fruits, vegetables, whole gains, and unsaturated fats and reduced 
amounts of overall calories, sugar, sugary beverages, refined starches, and 
saturated and trans fats (for example, a diet that is consistent with the 
OmniHeart diet)  
• increasing potassium rich fruits and vegetables in the diet  
• increasing physical activity 
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4.2 The committee recommends that population-based interventions to improve 
physical activity and food environments (typically the focus of other CDC units) 
should include an evaluation of their feasibility and effectiveness, and their specific 
impact on hypertension prevalence and control.  
4.3 To create a better balance between primary and secondary prevention of 
hypertension the committee recommends that the Division of Heart Disease and 
Stroke Prevention leverage its ability to shape state activities, through its grant 
making and cooperative agreements, to encourage state activities to shift toward 
population-based prevention of hypertension.  
The committee views a population-based policy and systems approach to prevent and 
control hypertension at the state and local level to be consistent with the broad mandates of state 
and local public health jurisdictions.  
6.1 The committee recommends that state and local public health jurisdictions give 
priority to population-wide approaches over individual-based approaches to 
prevent and control hypertension. 
6.2 The committee recommends that state and local public health jurisdictions 
integrate hypertension prevention and control in programmatic efforts to effect 
system, environmental, and policy changes that will support healthy eating, active 
living, and obesity prevention. Existing and new programmatic efforts should be 
assessed to ensure they are aligned with populations most likely to be affected by 
hypertension such as older populations which are often not the target of these 
programs.  
Based upon 2004 statistics using calculated intakes of sodium, 87 percent of US adults 
consumed what the CDC considers excess sodium (>100 mmol of sodium ≅ >2,400 mg sodium 
≅ >6,000 mg of salt [sodium chloride]) (NCHS, 2008). Further, the American Heart Association 
recommends that African Americans and persons who are middle aged or older or who have 
hypertension should consume less than 1,500 mg of sodium daily. Calculated sodium intake may 
not be accurate because the large majority of sodium in the US food supply is added in 
processing and manufacturing of foods, and a large and increasing amount is used in the fast 
food industry. The amounts added can vary widely by brand and with time, making calculations 
difficult, and the smaller amounts added at home can also be challenging to quantify. 
Unfortunately, 24-hour urinary sodium excretion, which provides the best measure of sodium 
intake, has never been assessed in a nationally representative sample of the U.S. population, so 
that the true distribution of intakes in the United States is not known.  
The committee finds the evidence base to support policies to reduce dietary sodium as a 
means to shift the population distribution of blood pressure levels in the population convincing. 
The newly reported analysis of the substantial health benefits (reduced number of individuals 
with hypertension) and the equally substantial health care cost savings and QALYs saved by 
reducing sodium intake to the recommended 2,300 mg per day and lower, provide resounding 
support to place a high priority on policies to reduce sodium intake (Palar and Sturm, 2009).  
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The committee is aware of the Congressional directive to CDC to engage in activities to 
reduce sodium intake and the DHDSP’s role in these activities. The DHDSP’s sponsorship of an 
IOM study to identify a range of interventions to reduce dietary sodium intake is an important 
step. The committee believes that the DHDSP is well positioned to take greater leadership in this 
area through it role as co-leader of Healthy People 2010 Focus Area 12: Heart Disease and 
Stoke, Co-Leader of the National Forum for Heart Disease and Stroke, and as the sponsor of 
grants to state health departments and other entities.  
4.4 The committee recommends that The Division of Heart Disease and Stroke 
Prevention take active leadership in convening other partners in the federal, state, 
local government, and industry to advocate for and implement strategies to reduce 
sodium in the American diet to meet dietary guidelines, which are currently less 
than 2.3 grams (100mmol)/day and 1.5 grams (100mmol)/day for blacks, middle-
aged and older adults, and individuals with hypertension. 
The committee recognizes other work in progress by the IOM Committee on Strategies to 
Reduce Sodium Intake therefore it did not develop specific recommendations for specific 
intervention strategies.  
Of all of the modifiable risk factors for hypertension, an inadequate consumption of 
potassium based on the current Dietary Reference Intakes (DRI) criteria (IOM, 2004) is among 
the most prevalent. In a recent report from the CDC (NCHS, 2008), approximately 2 percent of 
U.S. adults met the current guidelines for dietary potassium intake (≥4.7 grams per day or 4,700 
mg), but insufficient potassium intake is most prevalent in Blacks and Hispanics, among whom 
the proportion consuming an adequate amount of potassium was close to 0 percent. Of note, the 
primary basis of the Dietary Reference Intake (DRI) of 4.7 grams per day for potassium is its 
beneficial effect on blood pressure (IOM, 2004).  
4.5 The committee recommends that the Division of Heart Disease and Stroke 
Prevention specifically consider as a strategy, advocating for the greater use of 
potassium/sodium chloride combinations as a means of simultaneously reducing 
sodium intake and increasing potassium intake. 
State and local health jurisdictions can also play a strong role in formulating policies and 
other activities to reduce sodium in the diet. Across the country, 26 state and local public health 
agencies and 17 professional associations and organizations have coalesced to work toward the 
goal of reducing salt intake through the National Salt Reduction Initiative (The City of New 
York, 2009). 
6.3 The committee recommends that all state and local public health jurisdictions 
immediately begin to consider developing a portfolio of dietary sodium reduction 
strategies that make the most sense for early action in their jurisdiction. 
Surveillance 
Data collection is fundamental to addressing any public health problem. Data are critical 
for determining the burden of hypertension, characterizing the patterns among subgroups of the 
population, assessing changes in the problem over time, and evaluating the success of 
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interventions. Repeated independent cross-sectional surveys in the same populations over time 
can provide important information about secular trends in blood pressure. In the general U.S. 
population, government surveys (NHES I [National Health Examination Survey]; NHANES I, II, 
and III [National Health and Nutrition Examination Survey]; HHANES [Hispanic Health and 
Nutrition Examination Survey]) may provide the best data to examine secular trends in 
hypertension. However, there are marked, not easily explainable changes in the temporal trends 
for hypertension based on NHANES data. In particular, there was a dramatic reduction in age-
adjusted hypertension prevalence between NHANES II (1976-1980) from 31.8 to 25 in 
NHANES III (1991-1994). At the same time, there have been significant modifications in the 
protocol for blood pressure measurement, sample sizes, and other factors that may increase the 
potential for measurement error (Burt et al., 1995). As a consequence, there is ongoing 
uncertainty about the validity and therefore usefulness of long-term temporal data for U.S. trends 
in hypertension.  
Effective monitoring and surveillance systems need to be in place to monitor progress in 
reducing the prevalence of hypertension and increasing the awareness, treatment, and control of 
hypertension. Given the challenges posed by the changing methodologies used to collect blood 
pressure measurements, the committee believes that efforts to strengthen hypertension 
surveillance and monitoring are critical.  
2.1 The committee recommends that the Division for Heart Disease and Stroke 
Prevention 
• Identify methods to better use (analyze and report) existing data on the 
monitoring and surveillance of hypertension over time.  
• Develop norms for data collection, analysis, and reporting of future 
surveillance of blood pressure levels and hypertension. 
In developing better data collection methods and analyses, the DHDSP should 
increase and improve analysis and reporting of understudied populations 
including: children, racial and ethnic minorities, the elderly, and socioeconomic 
groups. 
Access to and use of hypertension measures at the state and local health jurisdictions 
(SLHJs) level has proven especially difficult. The primary national data source for population 
estimates of hypertension – National Health and Nutrition Examination Survey (NHANES)– is 
not designed to produce accurate state or local estimates. This shortcoming is a major one, as 
there is likely substantial variation across regions not only in prevalence but in the proportions of 
the hypertensive population not diagnosed, diagnosed but not under treatment, and under 
treatment but not controlled. Some state and localities have begun to develop local level HANES 
to better monitor hypertension. 
6.4 The committee recommends that state and local public health jurisdictions 
assess their capacity to develop local HANES as a means to obtain local estimates 
of the prevalence, awareness, treatment and control of hypertension. Further, if a 
program to reduce hypertension is a national goal, funding should be made 
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available to assure that localities have relevant data that will assist them in 
addressing hypertension in their communities.  
The committee recognizes that local financial constraints may not allow many SLHJs to 
move forward in this regard in the short-term; thus, SLHJs may want to actively seek other 
reliable and available population-based data sets as a way to monitor local hypertension trends. 
Accurate information on sodium intake or the content of sodium in specific foods that 
presently contribute importantly to sodium intake is necessary for monitoring its reduction. 
These data are not currently available in a systematic or timely fashion. The lack of data presents 
a significant gap that will hamper efforts to evaluate the progress made in reducing sodium 
intake in the American population. 
4.6 The committee recommends that the Division of Heart Disease and Stroke 
Prevention and other CDC units, explore methods to develop and implement data 
gathering strategies that will allow for a more accurate assessment and tracking of 
specific foods that are important contributors to dietary sodium intake by the 
American people.  
4.7 The committee recommends that the Division of Heart Disease and Stroke 
Prevention and other CDC units, explore methods to develop and implement data 
gathering strategies that will allow for a more accurate assessment and the 
tracking of population-level dietary sodium and potassium intake including the 
monitoring of 24-hour urinary sodium and potassium excretion.  
System Change Strategies Directed at Individuals with Hypertension 
Although patient nonadherence to treatment is one reason for lack of hypertension 
control, the lack of physician adherence to Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure guidelines (JNC) contributes to the lack of 
awareness, lack of pharmacologic and non-pharmacologic treatment, and lack of hypertension 
control in the United States (Chiong, 2008; Pavlik et al., 1997). Studies show that despite the 
JNC recommendation to screen and to start treatment if systolic blood pressure is >140 mm Hg 
or diastolic blood pressure is >90 mm Hg, physicians are not providing treatment consistent with 
the guidelines. In particular, physicians are less aggressive in treating elevated blood pressure in 
older patients and less aggressive in treating isolated systolic hypertension (Berlowitz et al., 
1998; Chiong, 2008; Hyman et al., 2000; Izzo et al., 2000; Lloyd-Jones et al., 2002). In fact, the 
largest attributable fraction for lack of awareness and lack of control of hypertension is being 
aged 65 or older and having isolated hypertension. According to Hyman and Pavlik, 
“Undiagnosed hypertension and treated but uncontrolled hypertension occurs largely under the 
watchful eye of the health care system” (Hyman and Pavlik, 2001). While the reasons for 
physician nonadherence to JNC guidelines are unclear, lack of physician awareness and 
physician beliefs about the practicality and benefit of treatment may contribute.  
The goal of improving the education and training of health care providers in the 
prevention of cardiovascular disease is central to DHDSP activities. Numerous questions remain 
regarding whether the lack of adherence is related to a lack of physician agreement with the new 
treatment guidelines, physician lack of knowledge regarding the guidelines, inertia based on 
treating at the previous guideline of 160 mmHg/95 mmHg, or other barriers. 
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5.1 The committee recommends that the Division of Heart Disease and Stroke 
Prevention give high priority to conducting research to better understand the 
reasons behind poor physician adherence to current JNC guidelines. Once these 
factors are better understood, strategies should be developed to increase the 
likelihood that primary providers will screen for and treat hypertension 
appropriately, especially in elderly patients.  
5.2 The committee recommends that Division of Heart Disease and Stroke 
Prevention work with the Joint Commission and the healthcare quality community 
to improve provider performance on measures focused on assessing adherence to 
guidelines for screening for hypertension, the development of a hypertension 
disease management plan that is consistent with JNC guidelines, and achievement 
of blood pressure control.  
6.5 The committee recommends that state and local health jurisdictions serve as 
conveners of health care system representatives, physician groups, purchasers of 
health care services, quality improvement organizations, and employers (and 
others) to develop a plan to engage, and leverage skills and resources for 
improving the medical treatment of hypertension. 
Controlling for health status, financial burden has been shown to be significantly greater 
for persons with chronic conditions such as hypertension (Rogowski et al., 1997). Many studies, 
using a variety of methodologies, have documented a relationship between patient cost and 
poorer adherence to treatment and poorer control of hypertension (Fihn and Wicher, 1988). Out-
of-pocket cost of medication has been identified in the literature as a significant barrier to patient 
adherence to hypertension treatment. It is estimated that for every 10 percent increase in cost-
sharing, overall prescription drug spending decreases by 2-6 percent (Kilgore and Goldman, 
2008). The impact of out-of-pocket costs is greatest for those with low income, those with 
chronic illnesses, and those taking multiple drugs (Austvoll-Dahlgren et al., 2008). Reducing 
out-of-pocket costs increases medication adherence. Goldman compared the impact of reducing 
out-of-pocket costs with other interventions designed to improve patient adherence to chronic 
medications and noted that even the most successful interventions designed to increase patient 
adherence to medication did not result in larger improvements in adherence than cost strategies 
and generally relied on complicated, labor-intensive regimens (Goldman et al., 2007). The 
committee finds the evidence convincing that reducing costs of antihypertensive medication is an 
important and efficient way to increase medication adherence.  
5.3 The committee recommends that the Division of Heart Disease and Stroke 
Prevention should encourage the Centers for Medicare and Medicaid Services to 
recommend the elimination or reduction of deductibles for antihypertensive 
medications among plans participating under Medicare Part D, and work with 
state Medicaid programs and encourage them to eliminate deductibles and 
copayments for antihypertensive medications. The committee also recommends 
that the DHDSP work with the pharmaceutical industry and its trade 
organizations to standardize and simplify applications for patient assistance 
programs that provide reduced-cost or free antihypertensive medications for low-
income or uninsured individuals.  
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6.6 State and local health jurisdictions should work with business coalitions and 
purchasing coalitions to remove economic barriers to effective antihypertensive 
medications for individuals who have difficulty accessing them.  
The committee notes that the Division is also well positioned to educate the private sector 
that eliminating or reducing the costs of antihypertensive medications is an important and 
efficient way to increase medication adherence. Through collaborations with partners, the 
Division provides support and guidance to the employer community on hypertension and 
cardiovascular disease prevention and control. The private sector is already experimenting with 
reducing copayments associated with drugs commonly prescribed for diabetes, asthma, and 
hypertension (Pitney Bowes, Marriott, and others). The results of the studies showing the impact 
of cost-sharing and the reporting of improved outcomes from these company’s experiences 
should be shared broadly with the business community through trade associations and purchasing 
coalitions.  
5.4 The committee recommends that the Division of Heart Disease and Stroke 
Prevention collaborate with leaders in the business community to educate them 
about the impact of reduced costs on antihypertensive medication adherence and 
work with them to encourage employers to leverage their healthcare purchasing 
power to advocate for reduced deductibles and copayments for antihypertensive 
medications in their health insurance benefits packages. 
The use of community health workers to support the care of individuals with 
hypertension has been identified as a promising strategy. Community health workers have 
contributed to higher medication adherence among individuals with hypertension and have been 
shown to play an important role in linking and navigating diverse communities to the health care 
system. Some of the roles and the successes achieved appear to be similar to those of nurses who 
have provided educational interventions aimed at hypertension control, and suggest an efficient 
strategy for bringing about enhanced treatment and sustained blood pressure control for targeted 
racially or ethnically diverse, high-risk populations. While trained laypeople cannot perform in 
the same capacity as professional nurses and health educators, with appropriate training and 
supervision they can successfully contribute to the care of community members with 
hypertension (Bosworth et al., 2005).  
Community health workers may also play an important role in linking diverse 
communities to the health care system for care (HRSA, 2007). The IOM committee that 
produced the report Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare 
found that “community health workers offer promise as a community-based resource to increase 
racial and ethnic minorities’ access to healthcare and to serve as a liaison between healthcare 
providers and the communities they serve.” Based on this finding, the committee recommended 
supporting the use of community health workers. “Programs to support the use of community 
health workers (e.g., as health care navigators), especially among medically underserved and 
racial and ethnic minority populations, should be expanded, evaluated, and replicated” (IOM, 
2002, p. 195). 
5.5 The committee recommends that the Division of Heart Disease and Stroke 
Prevention work with state partners to leverage opportunities to ensure that 
existing community health worker programs include a focus on the prevention and 
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control of hypertension. In the absence of such programs, the Division should work 
with state partners to develop programs of community health workers who would 
be deployed in high risk communities to help support healthy living strategies that 
include a focus on hypertension.  
6.7 State and local health jurisdictions should promote and work with Community 
Health Worker initiatives to ensure that prevention and control of hypertension is 
included in the array of services they provide and are appropriately linked to 
primary care services. 
In an era of declining resources and conflicting priorities for public health, taking on any 
new challenges needs careful consideration. But given the disease and economic burden 
associated with hypertension, and in the current climate of health care reform and increasing 
attention to prevention, there is great public health opportunity and no better time to rise to the 
challenge.  
6.8 The committee recommends that the Congress give priority to assuring 
adequate resources for implementing a broad suite of population-based policy and 
system approaches at the federal, state and local levels that have the greatest 
promise to prevent, treat, and control hypertension.  
Attendant to current funding and potential future funding for hypertension prevention, 
treatment and control, systems need to be in place to track and measure current and new 
programs activities at the federal, state, and local level. Such a system would help ensure that 
resources are appropriately aligned and outcomes are achieved. 
6.9 The committee recommends that Division of Heart Disease and Stroke 
Prevention develop resource accountability systems to track and measure all 
current and new State programs for the prevention, treatment and control of 
hypertension that would allow for resources to be assessed for alignment with the 
population-based policy and systems strategy and for measuring the outcomes 
achieved. 
The committee acknowledges that the recommendations proffered, if adopted, would 
result in a significant programmatic change for the DHDSP. To effectively support the change 
and maintain a population-based focus, new expertise and guidance may be required beyond that 
which may be available through the DHDSP’s partnership with the National Forum for Heart 
Disease and Stroke Prevention.  
6.10 The committee recommends that the Division of Heart Disease and Stroke 
Prevention identify and work with experts grounded in population-based 
approaches to provide guidance and assistance in designing and executing 
hypertension prevention and control efforts that focus on population-based policy 
and system change. These experts could augment an existing advisory body or be 
drawn from an existing body with this expertise. 
The committee believes that attention to the high priority areas it has identified would 
ultimately lead to a reduction in the prevalence of hypertension, improve the quality of care 
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provided to individuals with hypertension, reduce health disparities, and ultimately reduce 
mortality and morbidity due to heart disease and stroke.  
In the short term, one visible impact would be strong federal, state, and local public 
health agency leadership that gives priority to reducing the prevalence of hypertension through 
population-based approaches integrated throughout agency activities, particularly those that 
target hypertension risk factors by reducing obesity, promoting health diets, increasing physical 
activity and reducing sodium intake.  
Active engagement and efforts by federal, state, and local jurisdiction to reduce sodium 
consumption, an area not typically addressed by parts of the governmental public health system, 
is an area where federal and SLHJ could exert a unique leadership role. Efforts to improve the 
surveillance and monitoring systems that track hypertension trends would result in improved 
estimates of hypertension prevalence, awareness, and treatment and control for the population as 
a whole and subgroups of the population at the national and state and local level. Similarly, with 
improved data collection, public health officials would be able to monitor their progress in 
reducing dietary sodium consumption and the sodium content in food. Strategies designed to 
address the factors contributing to poor physician adherence to JNC treatment guidelines would 
result in improved blood pressure control, especially isolated systolic hypertension among the 
elderly. The visible impacts of removing economic barriers to effective antihypertensive 
medications and employing the use of community health workers to provide community-based 
support for individuals with hypertension would be improved access to treatment, particularly for 
vulnerable populations. 
The committee observes that hypertension may provide an opportunity unparalleled in 
public health chronic disease prevention for program evaluation through outcome measurement. 
In this context, it provides a single, reliable outcome measure that can be linked to intervention 
process measures to rapidly inform program interventions.  
The committee offers a number of short-term and intermediate outcomes and potential 
process and outcome indicators to assess progress in the high-priority areas in Table S-2. 
Decreased mortality and morbidity from heart disease and stroke are understood as the ultimate 
long-term indicators, as such, they are not included in the table due to space consideration. The 
table is divided into broad sections (e.g., Population-based Recommendations to CDC’s Division 
of Heart Disease and Stroke Prevention (DHDSP) and State and Local Jurisdictions (SLHJ), 
System Approaches Targeting Individuals with Hypertension Directed to CDC and State and 
Local Health Jurisdictions, and others. Outcomes and indicators found in adjacent columns do 
not tract directly across but correspond to the group of recommendations.  
Hypertension as a Sentinel Indicator for Health Disparities 
Hypertension is a disease for which there are major inequities across racial groups and 
economic groups—along the entire spectrum from risk factors to delivery of medical care. 
Interventions directed toward general population groups historically do not correct these 
inequities and can even worsen them. Care must be taken to assure that any portfolio of 
interventions implemented will minimize existing inequities in prevention, detection, treatment 
and control of hypertension. 
Hypertension is a condition strongly influenced by underlying individual and community 
risk factors related to healthy eating and active living – risk factors driven by race and class in 
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most communities today. As such, it is a potential sentinel indicator for assessing and testing 
broader approaches to reduce health disparities. The prevalence of hypertension may provide a 
relative quick and objective measure of programs directed at these risk factors as well as 
underlying social determinants of health. Hypertension while treatable requires ongoing access to 
primary care for maximum effectiveness. As such, it is also a potentially very good marker for 
lack of access to or continuity of health care in a community. SLHJs should consider 
hypertension as a sentinel measure for evaluation of the effectiveness of a range of disparity-
reducing activities, including importantly, place-based strategies tackling conditions through 
community policy interventions. 
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In today’s public health world, the term “neglected disease” conjures up obscure tropical 
illnesses of little relevance to contemporary practice in the United States. Yet, when one 
considers the actual meaning of the words, the time may be right to add hypertension to this list. 
Hypertension, or high blood pressure, describes the condition in which systemic arterial blood 
pressure remains elevated over time. High blood pressure is caused primarily by an increase in 
the resistance to the flow of blood through arteries and an increase in cardiac output, which is a 
function of the heart rate and stroke volume. Hypertension is dangerous because it forces the 
heart to work harder and can contribute to atherosclerosis and hardening of the large arteries 
causing cardiovascular disease. These factors can also lead to subsequent blockage and 
weakening of the walls of the smaller cerebral arteries causing them to rupture and result in 
stroke. The lack of attention to hypertension is difficult to understand. Hypertension is one of the 
leading causes of death in the United States. A recent study (Danaei et al., 2009) listed it at 
number two, just behind tobacco. Based on data from the Centers for Disease Control and 
Prevention (CDC) and the National Heart, Lung, and Blood Institute (NHLBI) from 1995 to 
2005, the death rate from high blood pressure increased by 25.2 percent and the actual number of 
deaths rose by 56.4 percent (Lloyd-Jones et al., 2009). In 2005, high blood pressure was 
responsible for about one in six deaths of U.S. adults. Further, high blood pressure is the single 
largest risk factor for cardiovascular mortality accounting for about 45 percent of all 
cardiovascular deaths. High blood pressure was the leading cause of death among women, 
accounting for 19 percent of all female deaths, and the second leading cause of death among men 
(second to smoking) (AHA, 2009). Hypertension is estimated to contribute to 35 percent of 
myocardial infarctions and strokes and 49 percent of episodes of heart failure (AHRQ, 2007).  
Hypertension is diagnosed by a simple test. Using a sphygmomanometer, blood pressure 
is typically measured at two points: at peak pressure when the heart is most contracted (this point 
is referred to as systolic blood pressure) and then when the heart is most relaxed (diastolic 
pressure). High blood pressure for adults is defined as a systolic pressure of 140 mm Hg or 
greater or a diastolic pressure of 90 mm Hg or greater. Using this definition, hypertension is 
highly prevalent; nearly one in three U.S. adults has hypertension (Fields et al., 2004; Lloyd-
Jones et al., 2009). The risk of developing hypertension increases with age. In older age groups it 
is more common than not; based on data from the Framingham study, the lifetime risk of 
hypertension is estimated to be 90 percent for people with normal blood pressure at age 55 or 65 
who live to be age 80-85, respectively (Cutler et al., 2007; Vasan et al., 2002). Approximately 73 
million Americans have high blood pressure, and an additional 59 million have prehypertension, 
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which is defined as blood pressure ranging from 120-139 mm Hg systolic and/or 80-89 mm Hg 
diastolic. Prehypertension is a new classification introduced by the Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (Chobanian et al., 2003)1 because of the increasing amount of data associating 
cardiovascular complications with what had previously been considered normal blood pressure 
readings. Figure 1-1 shows the increased risk of heart disease death, and Figure 1-2 shows the 
increased risk of stroke death, associated with prehypertension and hypertension by decade of 
life. Starting at a systolic blood pressure of 115 mmHg, every 20 mmHg increase in systolic 
blood pressure is associated with a doubling in the risk of death for both heart disease death and 
stroke death. 
 
FIGURE 1-1. Increased risk of death from heart disease associated with blood pressure by decade of life. SOURCE: 
NHLBI, 2004.  
 
FIGURE 1-2. Increased risk of death from stroke associated with blood pressure by decade of life. SOURCE: 
NHLBI, 2004. 
Hypertension is highly treatable, and a range of medications—some relatively 
inexpensive—are available. In the late 1950s and early 1960s, oral diuretics were primarily used 
                                                 
1 The NHLBI administers the National High Blood Pressure Education Program Coordinating Committee, a 
coalition of 39 major professional, public, and voluntary organizations and 7 federal agencies. An important function 
of the committee is to issue guidelines and advisories designed to increase awareness, prevention, treatment, and 
control of hypertension.  Reports from this body are referred to by their number: in this case, the Seventh Report of 
The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure  
(Chobanian et al., 2003). 
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to treat hypertension. Since then, additional medications including calcium channel blockers and 
beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor 
antagonists can be found among the antihypertensive therapies available to physicians for 
managing high blood pressure. Studies comparing the effectiveness of antihypertensive therapies 
suggest that generally low-dose diuretics, which also tend to be lowest in cost,2 are the most 
effective first line of treatment for preventing mortality and morbidity from cardiovascular 
disease (ALLHAT, 2002; Psaty et al., 2002). 
More importantly, hypertension is highly preventable through a decrease in obesity, 
increase in physically activity, and improved diet (particularly through reduced sodium and 
increases in fruit and vegetable consumption). Moreover, since poor diet, physical inactivity, and 
obesity appear to be on the increase, reductions in these risk factors takes on even greater 
importance. 
Finally, hypertension is costly to the healthcare system. It is the most common primary 
diagnosis in America (Chobanian et al., 2003), and it contributes to the costs of cardiovascular 
disease (coronary heart disease, myocardial infarction) and stroke. The methodologies used to 
estimate the costs associated with hypertension vary; one estimate reports the total economic 
burden of coronary heart disease and stroke as $120.6 billion and $48.9 billion, respectively, in 
2002 (Cutler et al., 2007). The American Heart Association (AHA), recently reported the direct 
and indirect costs specifically of high blood pressure as a primary diagnosis as $73.4 billion for 
2009 (Lloyd-Jones et al., 2009). With respect to the cost of treating hypertension, an analysis by 
DeVol and Bedroussian (2007) estimated that the total expenditure for the population reporting 
hypertension as a condition in the Medical Expenditure Panel Survey (MEPS) was $32.5 billion 
in 2003. Another study estimated the total incremental annual direct expenditures for treating 
hypertension (the excess expenditure of treating patients with hypertension compared to patients 
without hypertension) to be about $54 billion in 2001 (Balu and Thomas, 2006). More 
specifically, it is estimated that a 10 percent decrease in annual healthcare visits for hypertension 
would save $480 million each year in healthcare costs (NHLBI, 2004b).  
CDC Efforts to Reduce and Control Hypertension 
The CDC is the lead federal agency responsible for promoting health and quality of life 
by preventing and controlling disease, injury, and disability. The CDC Division for Heart 
Disease and Stroke Prevention (DHDSP) provides national leadership to reduce the burden of 
disease, disability, and death from heart disease and stroke. DHDSP has six programmatic 
priority areas: (1) control high blood pressure, (2) control high cholesterol, (3) improve 
emergency response, (4) improve quality of care, (5) increase awareness of the signs and 
symptoms of heart attack and stroke and of the need to call 911, and (6) eliminate health 
disparities related to heart disease and stroke. The DHDSP carries out its programmatic 
responsibilities with a budget of $54 million for fiscal year 2009. 
                                                 
2 A review of data from the Medical Expenditure Panel survey (MEPS) analyzing trends in the pharmaceutical 
treatment of hypertension from 1977 to 2003 found that in 2003, diuretics were the most inexpensive 
antihypertensive drugs, with an average per user expenditure of $92 compared to calcium channel blockers with an 
average per user expenditure of $421 (Miller and Zodet, 2006)). 
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DHDSP is co-lead, along with the NHLBI, for the Healthy People 2010 Focus Area 12 
objectives related to heart disease and stroke including four objectives specific to hypertension 
(Table 1-1).  
TABLE 1-1 Healthy People 2010 Focus Area 12: Heart Disease and Stroke, Blood Pressure Objectives 
Focus Area Blood Pressure Objective 
12-9. Reduce the proportion of adults with high blood pressure. 
12-10. Increase the proportion of adults with high blood pressure whose blood pressure is under control.  
12-11. Increase the proportion of adults with high blood pressure who are taking action (for example, losing 
weight, increasing physical activity, or reducing sodium intake) to help control their blood pressure. 
12-12. Increase the proportion of adults who have had their blood pressure measured within the preceding 2 
years and can state whether their blood pressure was normal or high. 
SOURCE: CDC, 2002. 
Findings from the Healthy People 2010 Midcourse Review (CDC, 2002) indicated that 
the nation was moving away from making progress in the target objectives as reflected by 
increases in the prevalence of high blood pressure among adults and among children and 
adolescents. This moving away from Healthy People 2010 goals provided an increased emphasis 
for a DHDSP programmatic focus on hypertension.  
The DHDSP has developed a strategic plan to reduce and control hypertension that 
recognizes the urgent need to implement a number of effective practices and to develop new 
public health practices. The plan identifies a number of action areas and goals for the prevention 
and control of hypertension from which the most important priorities must be selected. These 
priorities must also take into consideration state health departments and other critical partners. 
The CDC requested assistance and guidance from the Institute of Medicine (IOM) to determine a 
small set of high-priority areas in which public health can focus its efforts to accelerate progress 
in hypertension reduction and control. Specifically, the CDC requested that the IOM convene an 
expert committee to review available public health strategies for reducing and controlling 
hypertension in the U.S. population, including both science-based and practice-based knowledge. 
In conducting its work, the committee was asked to consider the following questions: 
What are the highest-priority action areas on which CDC's Division for Heart Disease 
and Stroke Prevention and other partners should focus near-term efforts in hypertension?  
1. Identify the particular role of CDC's DHDSP in addressing the highest-priority areas. 
2. Identify the role of state health departments in advancing progress in the priority action 
areas. 
3. Identify the role of other public health partners. 
4. What visible impacts can be expected if DHDSP focuses its efforts in these priority 
areas?  
5. What indicators should be monitored to assess the progress of DHDSP, state health 
departments, and partners in implementing the committee’s recommendations? 
6. What are the potential positive and negative impacts on health disparities that could 
result if the committee’s recommendations are implemented? 
7. What indicators should be monitored related to health disparities to ensure the intended 
impact of the DHDSP priority action areas identified? 
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The committee was not expected to conduct a new, detailed review of peer-reviewed 
literature on hypertension because such literature reviews, meta-analyses, and syntheses already 
exist and have been used to inform existing guidelines and recommendations. 
The report is organized into six chapters, including this introduction which discusses the 
study process and the committee’s approach to questions it was asked to address. Chapter 2 
provides a discussion of the public health importance of hypertension and an overview of 
hypertension trends in the United States. Chapter 3 provides an overview of the CDC’s Division 
of Heart Disease and Stroke Prevention and background information on its budget and activities. 
Chapters 4 and 5 provide the committee’s response to the task of identifying a small set of 
priority areas for the DHDSP in which public health can focus its efforts to accelerate progress in 
hypertension reduction and control. Specifically, Chapter 4 addresses priority areas for 
interventions that are directed at population-based risk factors that are known to increase the risk 
of hypertension in the general population. Chapter 5 addresses priority areas for interventions 
directed at individuals with hypertension. The recommendations in Chapters 4 and 5 are 
specifically directed to the DHDSP. The committee recognizes that the DHDSP cannot work in 
isolation to implement the population-based policy and system change approach to prevent and 
control hypertension, thus, it notes when partnerships with other partners are appropriate (for 
example the business community, healthcare quality community, and the Centers for Medicare 
and Medicaid Services). The committee, however, views state and local health jurisdictions to be 
critical DHDSP partners. In Chapter 6, the Committee specifically recommends the action steps 
state and local health jurisdictions can take to implement the priority actions (response to 
question 2). Chapter 6 also provides the potential short-term and intermediate outcomes and 
potential indicators to be monitored to assess the progress made in implementing the 
committee’s recommendations (questions 4 and 5). Because the committee’s recommendations 
are population-based policy and system changes, it is expected that they could improve 
hypertension prevention, treatment and control across all population and subgroups. However, 
the committee also argues that hypertension is a sentinel indicator for how well the public health 
system is reducing health disparities (racial and ethnic, age, geographic). Chapter 6 briefly 
comments on the potential positive and negative impacts on health disparities (questions 6 and 
7). 
Much is known about the health consequences and costs associated with hypertension 
Robust clinical and public health research efforts have developed safe and cost-effective 
nonpharmacological and pharmacological interventions (Chapters 4 and 5) to prevent, treat, and 
control hypertension. Nonetheless, millions of Americans continue to develop, live with, and die 
from hypertension because we are failing to translate our public health and clinical knowledge 
into effective prevention, treatment and control programs. In the committee’s view this current 
state is one of neglect; as defined by Webster’s, “giving insufficient attention to something that 
merits attention.” The recommendations offered in this report outline a population-based policy 
and systems change approach to addressing hypertension that can be applied at the federal, state, 
and local level. It is time to give full attention and take concerted actions to prevent and control 
hypertension.  
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STUDY PROCESS 
In response to the study request, the IOM established the Committee on Public Health 
Priorities to Reduce and Control Hypertension. The committee comprised experts from the areas 
of public health, prevention, epidemiology, health care, hypertension, cardiovascular disease, 
health disparities, and community-based interventions. (See Appendix A for biographies of the 
committee members.)  
During the course of the study, the committee gathered information to address its charge 
through a variety of means. It conducted a review of pertinent literature and held three in-person 
information-gathering meetings with sessions that were open to the public. The first meeting 
included presentations from the sponsor and hypertension experts. The committee also received 
input on hypertension prevention and control strategies from representatives of a number of state, 
local, and nongovernmental agencies. The second meeting focused on learning more about the 
CDC Division of Heart Disease and Stroke Prevention’s activities and reviewing data on blood 
pressure trends. At that meeting the committee also received information on the lessons learned 
from the National High Blood Pressure Education Program, the Hypertension Detection and 
Follow-up Program, and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart 
Attack Trial (ALLHAT) sponsored by the National Institutes of Health. The third meeting 
included presentations on health disparities in hypertension; past large-scale community-based 
interventions; and the effectiveness, cost, and coverage of hypertension interventions. Appendix 
B contains the agendas for public meetings. The committee also met in executive session for 
deliberative discussions following the information-gathering meetings.  
Two additional meetings with open public sessions were held via teleconference calls. 
These sessions included presentations to the committee on blood pressure trends in birth cohorts, 
dietary interventions to reduce hypertension, the experiences of one State Heart Disease and 
Stroke Prevention Program, and specific aspects of the CDC’s Heart Disease and Stroke 
Prevention Program. In addition to these meetings, the committee held conference calls to further 
discuss findings and to formulate recommendations.  
STUDY APPROACH 
The overall public health impact of high blood pressure is a function of the distribution of 
blood pressure in the population as well as the outcomes or health consequences of high blood 
pressure. Because of the continuous and graded relationship between blood pressure and adverse 
health outcomes, the committee supports the notion that public health efforts to prevent the 
health consequences of high blood pressure must consider not only reducing blood pressure 
among those with high levels but also shifting the distribution of blood pressure in the population 
as a whole (Ahern et al., 2008; Rose, 2001; Whelton et al., 2002). The committee also decided 
that a framework would be useful in the process of identifying potential priority public health 
strategies to reduce and control hypertension. The following section provides the framework 
used by the committee and the selection criteria considered in identifying potential priority 
strategies.  
The population distribution of blood pressure and the health consequences of high blood 
pressure are the end results of a complex set of processes involving the action of factors at 
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multiple levels ranging from macro level and societal factors (e.g., policies related to the 
production and distribution of foods), to intermediate factors related to the characteristics of the 
living and working environments (e.g., access to healthy foods, physical activity resources), and 
to personal characteristics (e.g., genetic predisposition, behavioral choices). Health system 
factors also affect blood pressure levels through access to and quality of care. Additional 
examples of relevant factors at different levels are shown in Figure 1-3. This figure served as a 
heuristic to help the committee to think about the multiple factors that influence the population 
blood pressure distribution, the incidence and prevalence of hypertension and blood pressure 
control; it was not intended to be a full representation of the many factors affecting blood 
pressure or to concretely specify the inter-relationships among the factors.  
Within each of the levels shown in Figure 1-3, some factors may affect primarily the 
population distribution of blood pressure, whereas others may affect primarily the health 
consequences of hypertension (which in turn depend on early detection, treatment, and control of 
high blood pressure). In general the more “macro” factors (sometimes termed population-level 
factors) will affect primarily the distribution of blood pressure; in contrast the adequate control 
of high blood pressure will likely require the consideration of personal factors. However these 
distinctions are not clear-cut. For example, societal factors related to the sodium content of 
processed foods may primarily affect the population distribution of blood pressure, but may also 
have important effects on blood pressure control among individuals diagnosed with 
hypertension. In addition, blood pressure control, including adherence to medication, among 
hypertensive individuals will be affected by personal factors such as health insurance status, 
access to providers, socioeconomic resources and other behavioral factors, but may also be 
impacted by societal health system organization as well as access to follow-up and monitoring in 
communities and workplaces.  
In considering possible strategies for the prevention of high blood pressure and its 
adverse health consequences, the committee was guided by two basic features of the general 
framework illustrated in Figure 1-3: (1) the need to consider strategies aimed at shifting the 
population distribution of blood pressure (and thus preventing high blood pressure) as well as 
those targeted at persons considered to have hypertension based on current guidelines (to prevent 
the adverse consequences of high blood pressure); and (2) the need to consider factors at 
multiple levels, from societal to personal. Multiple categorizations of the possible interventions 
are possible. For simplicity, in this report, interventions are categorized in two broad domains: 
(1) population-wide strategies aimed at preventing high blood pressure by shifting the population 
distribution (referred to as population-based strategies) and (2) targeted strategies directed 
toward persons with, or at high risk, of high blood pressure aimed at reducing the adverse health 
consequences of hypertension through the early detection, treatment, and control hypertension 
(referred to as individual-based strategies).  
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FIGURE 1-3 Schematic framework of factors affecting blood pressure. 
Criteria for Identifying and Prioritizing Interventions 
The committee developed a series of criteria to identify and prioritize recommended 
strategies and interventions. It was recognized that the information available to assess each of 
these criteria is highly variable and sometimes limited. Nevertheless it was agreed that public 
health decisions and recommendations need to be based on the best available evidence to date, 
with the recognition that the evidence may not be perfect and may evolve over time. No attempt 
was made to give specific weights to each of these criteria; rather they were used by the 
committee as general qualitative guidelines to help identify the most promising strategies for the 
CDC to pursue at this juncture. The criteria represent various domains relevant to prioritizing 
CDC’s strategy. Two criteria (potential impact on population prevalence and evidence of 
effectiveness) assess the expected impact of the intervention on hypertension at the population 
level. A third criterion (relative cost or feasibility) incorporates the practical issues of cost and 
feasibility. Two additional criteria (unique contribution of CDC and synergy among other CDC 
programs) consider specific issues related to the role of CDC. Finally, the last criterion considers 
whether the interventions are likely to benefit the most vulnerable groups and reduce disparities. 
A brief description of each of the criteria is provided below and in Table 1-2. 
Health system factors 
           Treatment factors 
               Side effects 
   Complexity of treatment 
   Quality of care  
Provider training 
Insurance coverage (cost, co-pays) 
 
Population blood pressure distribution 
Incidence and prevalence of hypertension 






Health insurance status 
Access to healthcare, 
Trust in provider 
Societal factors 
Production and distribution of foods 
Regulations regarding food 
composition 
Transportation /urban design 
Organization and financing of the 
healthcare system 
Community/workplace factors 
Access to healthy foods and physical 
activity resources 
Design of communities and workplaces 
Local and workplace access to 
screening and treatment 
Social and cultural norms 
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TABLE 1-2 Criteria Considered for Selecting Priority Areas for the Prevention and Control of Hypertension 
Criteria Defining Questions Considerations 
Impact To what extent will the strategy or intervention 
reduce the incidence of hypertension or 
complications associated with hypertension? 
Effect size 
Proportion of people potentially affected 
 
Effectiveness What is the evidence of the strategy or 
intervention’s impact in real-world settings? 
Degree of generalizability to uncontrolled 
environments 
Relative cost or 
feasibility 
Is the strategy or intervention cost-effective? 
Qualitatively, how expensive is it to implement? 
Cost-effectiveness analysis 
Uniqueness Is there a special role for the CDC and its partners 
in implementing the strategy or intervention?  
Organizational authorities and mandates 
and roles 
Synergy with other 
CDC programs 
Will the strategy or intervention leverage or 
duplicate activities in other CDC units or activities 
conducted by other partners? 
Division of Heart Disease and Stroke 
Prevention core efforts and resources 
Reduction in 
disparities  
Will the strategy or intervention reduce disparities 
in risk factors or health care? 
Opportunity to narrow gaps in risk, 
disease burden, and care  
 
Potential Impacts of Interventions on Population Prevalence of Hypertension  
(or distribution of blood pressure) and on Adverse Health Consequences 
This first criterion assesses the potential impact of the intervention on the prevalence of 
hypertension (or its complications). Impact is a function of (1) the effect size of the intervention 
(as assessed by the relative risk or the risk difference) and (2) the proportion of people with the 
risk factor or condition at which the intervention is directed. Population impact is assessed 
through the calculation of the population attributable risk defined as the expected percentage 
reduction in the prevalence or incidence of the outcome in the population if the intervention were 
implemented in an ideal setting (i.e., the risk factor was entirely eliminated). The committee 
commissioned a review of the best available evidence on population attributable risk of a number 
of interventions intended to prevent hypertension. Although the ideal evidence would incorporate 
information on changes in blood pressure distributions rather than changes in arbitrarily defined 
dichotomous outcomes, very little information on the former exists. However, it is reasonable to 
make the assumption that the prevalence or incidence of hypertension is at least partly a function 
of the underlying blood pressure distribution.  
The potential benefits of interventions focused on the early detection, treatment, and 
control of hypertension are also considered. In this case the potential benefit is not the prevention 
of hypertension but the reduction of its adverse health consequences through early detection, 
treatment, and control of individuals with hypertension (sometimes referred to as secondary 
prevention).  
Evidence of Effectiveness in Real-World Settings 
In addition to the potential impact of interventions (as quantified by the population 
attributable risk) based on effect sizes under ideal conditions (i.e., efficacy) and population 
prevalence, the committee also considered evidence of the impact or outcomes of interventions 
in practice or real-life settings. This real-life impact is sometimes referred to as effectiveness 
(Zaza et al., 2005). More generally, this criterion refers to the extent to which estimates of effect 
sizes of the intervention obtained from a given study (often conducted under ideal circumstances 
with excellent participation, fidelity of the intervention, and compliance) can be generalized to 
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the slightly different circumstances that may arise in less controlled settings—for example, when 
the same intervention is implemented in the real world. Although efficacy and effectiveness are 
theoretically clearly distinguished in the extreme case, the extent to which a given study assesses 
efficacy or effectiveness is sometimes debatable. Therefore, the committee viewed this criterion 
in a qualitative way by considering the kinds of studies conducted and the extent to which their 
estimates are derived under conditions more akin to a laboratory or real-life setting. 
Relative Cost or Feasibility 
Despite the magnitude of hypertension-associated morbidity and mortality, current public 
health resources available for hypertension prevention and control are surprisingly limited, thus, 
hypertension interventions must be prioritized not only by effectiveness but also by cost, 
including both cost-effectiveness and absolute cost. Where possible, the committee reviewed 
available date on the cost of potential interventions and current Division resources.  
Unique Contribution of CDC and Partner Agencies 
In general, the CDC and state and local public health agencies are more experienced and 
skilled in population-based interventions than in interventions that provide health care directly to 
individuals. Government public health agencies are the only organizations with the mandate to 
provide population-wide services. Through leadership and convening strategies, government 
public health agencies can galvanize political commitment, develop policy, prioritize funding, 
and coordinate programs (Baker and Porter, 2005). In general, direct interventions providing 
health care to individuals (treatment) are much more distant from the unique skills and value-
added of CDC and state and local health partners.  
Synergy with Other CDC Programs and Gap Analysis 
Risk factors for and consequences of hypertension are common, overlap with other health 
conditions, and play a very large role in our overall population health. Thus, there already is 
substantial activity and prevention programming in place at the CDC and in state and local health 
departments. CDC priorities for hypertension prevention and control should not be duplicative 
of, but rather synergistic with, existing prevention programs in place within CDC and in state 
and local health departments and in the community or individual healthcare settings. A similar 
dynamic of cross-cutting activities should, in theory, be present for healthcare interventions for 
communities or individuals.  
Intervention Would Benefit the Most Vulnerable Groups and  
Reduce Disparities in Hypertension  
Hypertension is so common that broad-based interventions are essential. That said, it is 
also a disease for which there are major inequities across racial and economic groups— along the 
entire spectrum from risk factors to the delivery of medical care. Interventions directed toward 
general population groups historically do not correct these inequities and can even worsen them. 
Care was taken to identify a portfolio of interventions that might minimize existing inequities in 
the prevention, detection, and control of hypertension.  
Hypertension is also a disease of aging, becoming increasingly prevalent as one grows 
older. From the perspective of the proportion affected, attention must be directed toward groups 
with the highest prevalence. However, from the perspective of the individual, hypertension in 
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younger age groups has a greater potential for causing premature morbidity and mortality, so 
special attention needs to be paid to this at-risk population.  
In the next chapters the committee reviews trends in hypertension and then applies the 
framework and criteria, to the extent possible, to the selection of priority strategies for the CDC 
and its partners. 
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PUBLIC HEALTH IMPORTANCE OF HYPERTENSION 
Hypertension is an important public health challenge in the United States and other 
countries due to its high prevalence and strong association with cardiovascular disease and 
premature death (Cutler et al., 2008; Fields et al., 2004; Gu et al., 2002; Kearney et al., 2005; 
Lawes et al., 2008). Approximately 73 million U.S. adults (35 million men and 38 million 
women) had hypertension in 2006 (Lloyd-Jones et al., 2009). The estimated total number of 
adults with hypertension in the world in 2000 was 972 million: 333 million in economically 
developed countries and 639 million in economically developing countries (Kearney et al., 
2005).  
Hypertension is not only the most common, but also one of the most important, 
modifiable risk factors for coronary heart disease, stroke, congestive heart failure, chronic kidney 
disease, and peripheral vascular disease (Collins et al., 1990; Gu et al., 2008; Hebert et al., 1993; 
Kannel, 1996; Klag et al., 1996; Lewington et al., 2002; MacMahon et al., 1990; Staessen et al., 
2001; Stamler et al., 1993; Whelton, 1994). The positive relationship between blood pressure and 
the risk of vascular disease is strong, continuous, graded, consistent, independent, predictive, and 
etiologically significant for those with and without a previous history of cardiovascular disease 
(Whelton, 2003). Systolic blood pressure is a more important risk factor for cardiovascular 
disease than diastolic blood pressure (Gu et al., 2008; Klag et al., 1996; Stamler et al., 1993). 
Hypertension has also been identified as one of the leading preventable risk factor for all-cause 
mortality and is ranked third as a cause of disability-adjusted life-years (Ezzati et al., 2002; 
Lawes et al., 2008). Furthermore, randomized controlled trials have demonstrated that 
antihypertensive drug treatment reduces vascular disease incidence and mortality among patients 
with hypertension (Collins et al., 1990; Ezzati et al., 2002; Hebert et al., 1993; Staessen et al., 
2001).  
PREVALENCE OF HYPERTENSION IN THE U.S. POPULATION 
This section provides a discussion of the burden of hypertension by age, gender, and race 
or ethnicity and reviews data on levels of awareness, treatment, and control of hypertension. The 
relationship between behavioral risk factors and hypertension is addressed in Chapter 4, but 
trends in select risk factors are provided here. 
The prevalence of hypertension in the U.S. general population is high and increasing in 
recent years (Cutler et al., 2008; Fields et al., 2004). The National Health and Nutrition 
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Examination Survey (NHANES) conducted by the National Center for Health Statistics has been 
the principal means of tracking the burden of hypertension in the U.S. general population. 
Hypertension prevalence estimates derived from NHANES are defined as systolic blood pressure 
≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or receiving antihypertensive 
medication. 
The estimated prevalence of hypertension derived from the NHANES 1999-2004 was 
28.9 percent of the U.S. adult population (Cutler et al., 2008). The prevalence of hypertension 
varies by age, gender, and race or ethnicity. The prevalence of hypertension is also affected by 
behavior such as the intake of dietary sodium and potassium, weight management, alcohol 
consumption, and physical activity. Overall, the prevalence of hypertension is similar in men and 
women in the United States. In the NHANES 1999-2004, the age-adjusted prevalence of 
hypertension for all races was 28.5 percent in men and 28.8 percent in women (Cutler et al., 
2008). The relationship between gender and hypertension is modified by age. In young adults, 
the prevalence of hypertension is higher in men than in women. However, by their fifties, women 
tend to have blood pressure levels that equal or exceed those of men. The prevalence of 
hypertension is higher in women than in men later in life. The increase in the prevalence of 
hypertension by race and sex between the age groups of 18-29 years of age and >70 years of age 
was from 9.8 to 83.4 percent in black men, from 3.7 to 83.1 percent in black women, from 3.5 to 
69.1 percent in Mexican-American men, from 1.5 to 78.8 percent in Mexican-American women, 
from 5.5 to 63.3 percent in non-Hispanic White men and from 0.8 to 78.8 in non-Hispanic White 
women (Table 2-1). Isolated systolic hypertension (defined as systolic blood pressure ≥140 mm 
Hg and diastolic blood pressure <90 mm Hg) is common in older persons because systolic blood 
pressure tends to rise until the eighth or ninth decade, whereas diastolic blood pressure tends to 
remain constant or decline after the fifth decade (Whelton, 1994). 
The age-adjusted prevalence of hypertension among those surveyed in the NHANES 
1999-2004 was highest among non-Hispanic blacks at 40.1 percent, compared to 27.4 percent in 
non-Hispanic whites, and 27.1 percent in Mexican Americans. Non-Hispanic blacks also had the 
highest prevalence of hypertension among all races or ethnicities for every age group and for 
both gender groups (Cutler et al., 2008).  
TABLE 2-1 Age-Specific Prevalence (Standard Error) of Hypertension in the U.S. Adult Population: NHANES 
1999-2004 
Non-Hispanic White Non-Hispanic Black Mexican American Age (years) 
Men Women Men Women Men Women 
18-29  5.5 (1.1)  0.8 (0.3)  9.8 (1.9)  3.7 (1.0)  3.5 (1.1)  1.5 (0.6) 
30-39 12.5 (1.9)  5.4 (1.0) 18.5 (2.5) 14.5 (2.9) 10.6 (2.7)  5.7 (1.8) 
40-49 23.9 (2.1) 19.9 (2.1) 33.6 (2.8) 45.0 (3.0) 23.7 (2.4) 20.5 (3.0) 
50-59 36.5 (3.0) 39.8 (2.7) 57.3 (4.1) 61.2 (4.3) 30.4 (4.2) 38.9 (4.8) 
60-69 56.0 (2.3) 58.4 (2.2) 74.2 (2.8) 84.1 (2.6) 53.2 (3.4) 62.7 (2.6) 
≥70 63.3 (1.7) 78.8 (1.5) 83.4 (3.3) 83.1 (3.5) 69.1 (3.5) 78.8 (3.3) 
Total 27.5 (1.1) 26.9 (0.7) 39.1 (1.1) 40.8 (1.2) 26.2 (1.2) 27.5 (1.3) 
SOURCE: Adapted from Cutler et al., 2008. 
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Hypertension in Children and Adolescents 
The prevalence of high blood pressure among children and adolescents has been 
examined in the NHANES and other studies (Berenson et al., 2006; Din-Dzietham et al., 2007; 
Ostchega et al., 2009). Based on guidelines detailed in the Fourth Report on the Diagnosis, 
Evaluation, and Treatment of High Blood Pressure in Children and Adolescents, high blood 
pressure is defined as having systolic and/or diastolic blood pressure that ranks as ≥95th 
percentile for gender, age, and height (National High Blood Pressure Education Program 
Working Group on High Blood Pressure in and Adolescents, 2004). The guidelines recommend 
multiple blood pressure measurements at different times to define persistent high blood pressure. 
However, blood pressure was measured at only one clinic visit for the NHANES and thus might 
overestimate prevalence. Overall, the prevalence of elevated blood pressure during the period 
2003 to 2006 was 2.6 percent in boys and 3.4 percent in girls age 8-17 years in the United States 
(Ostchega et al., 2009). The gender- and race- or ethnicity-specific prevalence was 2.5 percent 
and 3.8 percent in non-Hispanic white boys and girls, among non-Hispanic black boys and girls 
it was 2.8 percent and 3.7 percent respectively, and among Mexican-American boys and girls it 
was 2.4 percent and 1.7 percent, respectively (Table 2-2).  
TABLE 2-2 Prevalence (Standard Error) of Elevated Blood Pressurea Among Children and Adolescents Age 8 
Through 17 Years: NHANES 2003-2006 
Non-Hispanic White Non-Hispanic Black Mexican American Age (years) 
Boys Girls Boys Girls Boys Girls 
 8-12 3.6 (1.2) 3.9 (1.2) 2.7 (1.2) 4.2 (1.4) 2.1 (1.0) 1.9 (0.8) 
13-17 1.6 (0.7) 3.7 (1.3) 2.9 (0.7) 3.1 (0.8) 2.7 (0.8) 1.5 (0.6) 
Total 2.5 (0.7) 3.8 (1.0) 2.8 (0.6) 3.7 (0.9) 2.4 (0.6) 1.7 (0.5) 
a Elevated blood pressure was defined as average systolic blood pressure and/or diastolic blood pressure that is 
≥95th percentile for gender, age, and height. 
SOURCE: Adapted from Ostchega et al., 2009. 
Secular Trends in the Prevalence of Hypertension 
Effective monitoring and surveillance systems need to be in place to monitor progress in 
reducing the prevalence of hypertension and increasing the awareness, treatment, and control of 
hypertension. Repeated independent cross-sectional surveys in the same populations over time 
can provide important information about secular trends in blood pressure. However, attention 
must be paid to the comparability of survey methods with respect to sampling and blood pressure 
measurement as well as the definition of hypertension. In the general U.S. population, 
government surveys (NHES I [National Health Examination Survey]; NHANES I, II, and III; 
HHANES [Hispanic Health and Nutrition Examination Survey]) may provide the best data to 
examine secular trends in hypertension; however, there have been significant modifications in 
the protocol for blood pressure measurement, sample sizes, and other factors that make these 
data not completely comparable (Burt et al., 1995).  
Between 1960 and the early 1990s, blood pressure data collection changed in significant 
ways. Changes include the number of measurements taken per occasion (one, two, or three 
measures before 1988; two sets of three measures after 1988); the number of occasions that 
blood pressure was measured (one or two occasions); and the posture in which blood pressure 
was taken (sitting or supine). Current national guidelines recommend three blood pressure 
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measurements on multiple days for a clinical diagnosis of hypertension. One blood pressure 
measurement taken on a single occasion cannot represent the usual blood pressure level of 
individuals because of random variation in the measurement over time. The first blood pressure 
measurement, for example, is typically higher than subsequent measurements (Chobanian et al., 
2003b). Further, blood pressure can also be subject to the white coat effect1 (Chobanian et al., 
2003; Pickering et al., 2005). 
Another important change is the size of blood pressure cuffs available to measure blood 
pressure. In early years (1960-1962), adult blood pressure cuffs were primarily used; over time, 
blood pressure cuffs suitable for children and different adult size cuffs were added (adult large 
and thigh cuff). Blood pressure measurements could be biased if the cuff size is too small or too 
large relative to the patient’s arm circumference (Pickering et al. 2005). There were also 
differences in maintenance of the blood pressure equipment used (unknown, daily, weekly, 
monthly calibration protocols). The personnel responsible for taking blood pressures varied 
(physician, nurse or interviewer) as did the levels of training received (unknown, 1.5 days or 3 
days).  
The quality of blood pressure measurements is partially reflected by the digit preference. 
A high proportion of zero-end digits in blood pressure measures indicated the poor quality of 
blood pressure measurement. Approximately one-half of blood pressure measures had a zero-end 
digit in the NHANES 1971-1974 and 1976-1980 compared to approximately one-quarter in 
NHANES 1988-1991 (Burt et al., 1995). In addition, the definition of diastolic blood pressure 
changed from measurement at the fourth Korotkoff sound (muffling of sound and point of 
disappearance) to the fifth Korotkoff sound (complete cessation of sound, NHANES III). Finally, 
the definitions used to define hypertension changed from 160/95 mm Hg in earlier studies to 
140/90 mm Hg in NHANES III (Chobanian et al., 2003). This change, in particular, has made it 
more difficult to determine secular trends. Having noted these methodological issues, the next 
section describes the secular trends in hypertension based upon available data. 
Based on NHANES surveys, the prevalence of hypertension in the U.S. adult population 
generally declined between 1971 and 1991 (Burt et al., 1995). The decline in the prevalence of 
hypertension was consistent across age, gender, and racial groups. For example, the age-adjusted 
prevalence of hypertension defined as blood pressure ≥140/90 mm Hg and/or current use of 
antihypertensive medication decreased from 48.2 percent in blacks (49.0 percent in men and 47.5 
percent in women) in 1971-1974 to 30.2 percent in blacks (32.6 percent in men and 28.1 percent 
in women) in 1988-1991. A similar decrease was seen among whites; hypertension prevalence 
decreased from 35.0 percent in 1971-1974 (40.1 percent in men and 30.2 percent in women) to 
19.2 percent (21.6 percent in men and 16.7 percent in women) in 1988-1991 (Burt et al., 1995). 
However, the prevalence of hypertension began to increase in the later NHANES surveys. For 
example, the age-standardized prevalence among U.S. adults age 18 years and older increased 
from 24.4 to 28.9 percent (p < 0.001) between the NHANES 1988-1994 and the NHANES 1999-
2004, with the largest increases among non-Hispanic women from 21.7 to 26.9 (Cutler et al., 
2008). The change in hypertension prevalence seems independent from the obesity epidemic in 
the U.S. population because the secular trends of hypertension were consistent across body mass 
index categories (<25, 25.0-29.9, and ≥30 kg/m2) (Gregg et al., 2005).  
                                                 
1 A white coat effect refers to higher blood pressure readings when taken by a healthcare provider or in a medical 
setting than would occur if blood pressure were taken at home. 
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Secular Trends Among the Elderly 
Ostchega and colleagues reported a significant increase in hypertension prevalence in the 
U.S. population among those aged 60 years and older from 1988 to 2004. The prevalence of 
hypertension in the total population increased from 58 percent in NHANES 1988-1994 to 67 
percent in NHANES 1999-2004 (Ostchega et al., 2007). A significant increase was seen in each 
age group studied (60-69: from 48 to 60 percent; 70-79: from 62 to 72 percent; and ≥80: from 69 
to 77 percent), in both sexes (men: from 54 to 61 percent; women: from 60 to 72 percent). Figure 
2-1 shows the increase in hypertension prevalence by age group and gender (Ostchega et al., 
2007). Hypertension prevalence also increased in three racial or ethnicity categories (non-
Hispanic whites: from 56 to 66 percent; non-Hispanic blacks: from 71 to 82 percent; Mexican 


























































FIGURE 2-1 Age-specific prevalence of hypertension in U.S. adults age 60 and older for men and women: 
NHANES: 1988-1994 and NHANES 1999-2004. SOURCE: Adapted from Ostchega et al., 2007. 
Secular Trends in Children 
Secular trends in mean blood pressure level and hypertension prevalence among children 
and adolescents aged 8 to 17 years were examined by various investigators using data from 
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NHANES (Din-Dzietham et al., 2007; Ostchega et al., 2009; Ostchega et al., 2007). Muntner and 
colleagues found that mean systolic blood pressure increased between 1988-1994 and 1999-
2000. After controlling for differences in age, race, and sex, they found a 1.4 mm Hg increase in 
systolic blood pressure and a 3.3 mm Hg increase in diastolic blood pressure between the two 
surveys. The greatest differences were increases in mean systolic blood pressure (2.3 mm Hg 
increase) and mean diastolic blood pressure (4.4 mm Hg increase) of Mexican American 
children. The increase in mean systolic and diastolic blood pressure was also higher in children 
aged 8 to 12 years compared to children aged 13-17 years (Muntner et al, 2004).  
A more recent analysis of NHANES data surveys conducted in 1988-1994, 1999-2002 
and 2003-2006 also shows an overall increase in elevated blood pressure in children and 
adolescents aged 8 though 17 years (Ostchega et al., 2009). The percent prevalence of elevated 
blood pressure increased from 2.1 percent in 1988-1994 to 3.0 percent in 2003-2006. In the 
2003-2006 survey, 2.6 percent of boys and 3.4 percent of girls had elevated blood pressure. 
Figure 2-2 shows the prevalence of elevated blood pressure by gender and race or ethnicity. 
After conducting multivariate analyses controlling for weight status, age, and race and ethnicity, 
the authors concluded that the prevalence of elevated blood pressure increased among girls aged 
8-17 but had decreased among boys aged 13-17. 
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FIGURE 2-2 Prevalence of elevated blood pressure among children and adolescents age 8 through 17 years: United 
States, NHANES: 1988-1994, 1999-2002, and 2003-2006. 
SOURCE: Adapted from Ostchega et al., 2009.  
Incidence and Lifetime Risk of Hypertension 
Although the prevalence of hypertension is a useful indicator of the burden of disease in 
the community, it does not provide information regarding the risk for individuals of developing 
hypertension. The individual risk for developing hypertension is best described by incidence or 
lifetime cumulative incidence statistics. Limited information is available about the incidence of 
hypertension because it requires follow-up of a large population for a prolonged period of time 
(Apostolides et al., 1982; Cornoni-Huntley et al., 1989; Fuchs et al., 2001; Manolio et al., 1994). 
Several longitudinal cohort studies have shown that African Americans have a higher 
incidence of hypertension than whites (Apostolides et al., 1982; Cornoni-Huntley et al., 1989; 
Fuchs et al., 2001; Manolio et al., 1994). In the Atherosclerosis Risk in Communities Study, the 
six-year incidence of hypertension was 13.9 percent and 12.6 percent in white men and women, 
and 24.9 percent and 30.3 percent in African-American men and women aged 45-49 years, 
respectively (Fuchs et al., 2001). The corresponding incidence of hypertension among 
participants age 50-64 years was 18.0 percent and 17.0 percent in white men and women, and 
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28.3 percent and 29.9 percent in African-American men and women, respectively. Other 
longitudinal cohort studies indicate that the incidence of hypertension in African Americans was 
an average of two times higher than in whites (Apostolides et al., 1982; Cornoni-Huntley et al., 
1989; Manolio et al., 1994).  
The lifetime risk for developing hypertension was estimated among 1,298 study 
participants who were 55 to 65 years of age and free of hypertension at baseline during 1976-
1998 (Vasan et al., 2002). For 55-year-old participants, the cumulative risk of developing 
hypertension was calculated through age 80 years, while for 65-year-old participants, the risk for 
developing hypertension was calculated through age 85. These follow-up time intervals (25 years 
for 55-year-olds and 20 years for 65-year-olds) correspond to the current average number of 
remaining years of life for white individuals at these two ages in the United States. The lifetime 
risk for developing hypertension was 90 percent for both 55- and 65-year-old participants 
(Figure 2-3). The lifetime probability of receiving antihypertensive medication was 60 percent 
(Vasan et al., 2002). 
 
FIGURE 2-3 Residual lifetime risk of hypertension in women and men age 65 years. Cumulative incidence of 
hypertension in 65-year-old women and men. Data for 65-year-old men in the 1952-1975 period are truncated at 15 
years since there were few participants in this age category who were followed up beyond this time  
SOURCE: Vasan et al., Journal of the American Medical Association, February 27, 2002, 287: 1008 Copyright © 
(2002) American Medical Association. All rights reserved. 
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INTERNATIONAL COMPARISON 
Kearney and colleagues estimated the global burden of hypertension in 2000 by pooling 
prevalence data from different regions of the world (Kearney et al., 2005). In their estimation, 
overall, 26.4 percent of the worldwide adult population age 20 years and older in 2000 had 
hypertension (26.6 percent of men and 26.1 percent of women). The prevalence of hypertension 
varied greatly by world regions. For men, the highest estimated prevalence was in Latin America 
and the Caribbean (40.7 percent), and for women, the highest estimated prevalence was in the 
former socialist economies (39.1 percent). The lowest estimated prevalence of hypertension for 
both men (17.0 percent) and women (16.5 percent) was in the region encompassing Asia and 
Pacific islands. In comparison, the prevalence of hypertension in the U.S. adult population was 
28.9 percent, slightly higher than the estimated world prevalence of 26.4 percent.  
Hypertension is costly to the global health care system. A recent analysis by Gaziano et al 
2009, estimated that the global direct medical cost of nonoptimal blood pressure (defined as 
systolic blood pressure above 115 mmHg and includes prehypertension and hypertension) was 
US $370 billion for the year 2001. This cost represents about 10 percent of global healthcare 
expenditures (Gaziano et al., 2009). 
AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION 
IN THE COMMUNITY 
Treatment and control of hypertension in the community requires that elevated blood 
pressure be recognized and that individuals with hypertension receive adequate treatment. In the 
United States, there has been remarkable improvement in the awareness, treatment, and control 
of hypertension since the late 1970’s (Burt et al., 1995; Cutler et al., 2008; Hajjar and Kotchen, 
2003; Ostchega et al., 2007). The proportion of hypertensive patients who are aware of their 
condition increased from 51 percent (42 percent in men and 63 percent in women) in NHANES 
1976-1980, to 69 percent (62 percent in men and 75 percent in women) in NHANES 1988-1994, 
and to 72 percent (69 percent in men and 74 percent in women) in NHANES 1999-2004 (Burt et 
al., 1995; Cutler et al., 2008). The increase in awareness of hypertension between 1976-1980 and 
1999-2004 was accompanied by an increase in the proportion of individuals with hypertension 
who receive treatment with antihypertensive medications. Overall, the percentage of individuals 
with hypertension who receive treatment increased from 31 percent (21 percent in men and 43 
percent in women) in 1976-1980 to 53 percent (45 percent in men and 61 percent in women) in 
1988-1991 and to 61 percent (58 percent in men and 65 percent in women) in 1999-2004. The 
proportion of controlled hypertension increased more than threefold at the 140/90 mm Hg cut-
point from 10 percent (5 percent in men and 15 percent in women) in 1976-1980, to 26 percent 
(21 percent in men and 31 percent in women) in 1988-1994 and to 35 percent (36 percent in men 
and 34 percent in women) in 1999-2004 (Burt et al., 1995; Cutler et al., 2008).  
The degree of awareness, treatment, and control (blood pressure <140/90 mm Hg) of 
hypertension varies considerably by gender, race or ethnicity, socioeconomic status, education, 
and quality of health care (He et al., 2002; Hyman and Pavlik, 2001; Muntner et al., 2004). 
Differences in gender and race or ethnicity are considered here. Based on NHANES 1999-2004 
data, black women have the highest awareness (81.8 percent) and treatment (71.7 percent) rates, 
while white men have the highest control (39.3 percent) rate (Table 2-3). On the other hand, 
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Mexican-American men have the lowest awareness (55.9 percent), treatment (40.4 percent), and 
control (21.4 percent) rates. Awareness and treatment rates were higher for women than men 
across all racial or ethnic groups. The control rate was higher for women among blacks and 
Mexican-Americans but higher for men among whites (Cutler et al., 2008).  
Among individuals with untreated or uncontrolled hypertension, elevated systolic blood 
pressure with a diastolic pressure of less than 90 mm Hg often remains a problem. Hyman and 
Pavlik, using the same NHANES data set conducted an analysis of blood pressure levels in 
individuals with uncontrolled hypertension (Hyman and Pavlik, 2001). They found that close to 
80 percent of individuals with hypertension present but who were unaware had a systolic blood 
pressure of 140 mm Hg or more and a diastolic blood pressure less than 90 mm Hg. 
TABLE 2-3 Hypertension Awareness, Treatment and Control in the U.S. Adult Hypertensive Population: NHANES 
1988-1994 and NHANES 1999-2004 
Awareness (%) Treatment (%) Control (%)  
1988-1994 1999-2004 1988-1994 1999-2004 1988-1994 1999-2004 
Total 68.5 71.8 53.1 61.4 26.1 35.1 
   Men 61.6 69.3 44.6 57.9 20.7 36.2 
   Women 74.8 73.9 61.0 64.5 31.2 34.2 
Non-Hispanic 
white 
69.1 72.0 54.2 62.1 27.3 36.8 
   Men 63.0 70.4 46.2 60.0 22.0 39.3 
    Women 74.7 73.4 61.6 64.0 32.2 34.5 
Non-Hispanic 
black 
71.0 75.8 54.8 65.1 24.0 33.4 
   Men 62.5 67.8 42.3 56.4 16.6 29.9 
   Women 77.8 81.8 64.6 71.7 30.0 36.0 
Mexican American 57.5 61.3 38.6 47.4 16.2 24.3 
   Men 47.8 55.9 30.9 40.4 13.5 21.4 
   Women 69.3 66.9 47.8 54.9 19.4 27.4 
SOURCE: Adapted from Cutler et al., 2008. 
The actual awareness, treatment, and control rates are likely higher than the NHANES estimates 
due to the definition of hypertension in the study. In the NHANES, the diagnosis of hypertension 
was based on blood pressure measurement at a single clinical visit, whereas national guidelines 
recommend that the classification of hypertension be based on the mean of two or more blood 
pressure readings taken during two or more office visits (Chobanian et al., 2003). Thus, some of 
the individuals classified as unaware and untreated hypertensive might not meet the criteria for 
hypertension in the clinical setting. 
Although the proportion of individuals with controlled hypertension has increased 
substantially, the majority (65 percent) of individuals with hypertension are not under control. 
Wang and Vasan highlighted factors associated with uncontrolled hypertension in the United 
States, categorized by patient and physician factors (Wang and Vasan, 2005). Patient factors 
related to uncontrolled hypertension include lack of insurance and provider, increased 
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susceptibility due to advanced age and obesity, therapy nonadherence because of medication 
cost, complicated regimens, lack of social support, and poor physician-patient communication. 
Physician factors related to uncontrolled hypertension include lack of knowledge about 
guidelines, overestimating guideline adherence, concerns about medication side effects, and 
limited office visit time.  
Many barriers to hypertension control in the general population affect African 
Americans, especially African-American men, disproportionally (Cooper, 2009). Barriers to 
hypertension include higher pre-treatment blood pressure levels, healthcare access and 
medication costs, social barriers related to urban life, personal barriers (i.e., tobacco, drug, and 
alcohol addiction), physician inertia in initiation and intensification of blood pressure 
medication, and time constraints during outpatient visits that impair physician-patient 
communication and patient adherence.  
In general, compared to the United States, the rates of awareness, treatment, and control 
of hypertension were lower in other developed countries (Falaschetti et al., 2009; Joffres et al., 
1997). The most recent Canadian Heart Health Surveys 1986-1992 for which data are available, 
reported that 58 percent (53 percent in men and 65 percent in women) of individuals with 
hypertension were aware of their condition, 39 percent (32 percent in men and 49 percent in 
women) of them were treated, and 16 percent (13 percent in men and 20 percent in women) had 
their blood pressure controlled (Joffres et al., 1997). The Health Survey for England 2006 
reported that the awareness, treatment, and control rates of hypertension were 66 percent (62 
percent in men and 71 percent in women), 54 percent (47 percent in men and 62 percent in 
women), and 28 percent (24 percent in men and 32 percent in women), respectively (Falaschetti 
et al., 2009). The rates of awareness, treatment, and control of hypertension were even lower in 
developing countries. The China National Nutrition and Health Survey 2002 reported that among 
individuals with hypertension, only 24 percent were aware of their condition, 19 percent were 
receiving antihypertensive medications, and less than 5 percent had adequate control of blood 
pressure (Wu et al., 2008). 
HYPERTENSION DATA QUALITY AND MONITORING CONCERNS 
Throughout its review, the committee struggled to clearly understand the trends in 
hypertension over time. As noted earlier, government surveys (NHES I; NHANES I, II, and III; 
HHANES) that collect blood pressure data and related information (hypertension awareness) 
have varied significantly in their methods over the years. While methodological adjustments to 
reduce bias in survey data collected over 1971-1991 have allowed survey data to be compared, 
the degree to which these adjustments allow an accurate assessment of secular hypertension 
trends remains unclear especially since it is difficult to explain the pronounced reduction in 
hypertension prevalence over that period. 
Therefore, at the request of the committee, the Centers for Disease Control and 
Prevention (CDC) provided unpublished data of secular trends in mean and median systolic and 
diastolic blood pressure and hypertension prevalence among children (8-17 years) and adults (20 
years and above) based on the first blood pressure measurement taken from the National Health 
and Nutrition Examination Surveys from 1971 onward (NHANES I, 1971-1975; NHANES II, 
1976-1980; NHANES III, 1988-1994; NHANES 1999-2002; NHANES 2003-2006). The data 
were provided in this way to minimize the problem of inconsistent number of blood pressure 
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measurements taken over the survey periods and to facilitate comparison of the data over time 
(Table 2-4). The reader should note that even with this adjustment, data are insufficient to assess 
whether blood pressure levels and hypertension prevalence truly fell between 1971 and 1988, 
because other significant quality control problems with the 1971 survey are not accounted for in 
this analysis. 
A comparison was made of the first blood pressure reading in NHANES participants over 
time. The age-, sex- and race adjusted prevalence of hypertension in the U.S. adult population 
age 20 years and older decreased from 41.1 percent in 1971-1975 to 28.6 in 2003-2006. The 
mean blood pressure also decreased from the early 1970s (systolic 131.5 and 138.6 mm Hg, and 
diastolic 82.5 and 87.4 mm Hg in whites and blacks, respectively) to the late of 1980s (systolic, 
121.7 and 127.5 mm Hg; and diastolic, 73.0 and 75.5 mm Hg in whites and blacks, respectively) 
(Figure 2-4). This is partially due to differences in the definition of diastolic blood pressure 
(Korotkoff phase 4 or 5 in NHANES 1971-1975 and Korotkoff phase 5 only in NHANES 1988-
1994 (Din-Dzietham et al., 2007). Subsequently, mean systolic blood pressure increased slightly 
and diastolic blood pressure decreased slightly during the 1990s and 2000s. These changes in 
mean blood pressure could reflect both changes in risk factors of blood pressure and treatment of 
hypertension.  
TABLE 2-4 Median and Mean Systolic and Diastolic Blood Pressure and Prevalence of Hypertension for Adults 
and Children Based on First Blood Pressure Measurement—NHANES Data 
 
Adults (20+) 
1971-1975 1976-1980 1988-1994 1999-2002 2003-2006 
HTN prevalence      
(%) (SE) 41.1 (1.2) 42.0 (1.8) 21.2 (0.7) 27.0 (1.4) 28.6 (0.8) 
Median systolic  












Mean systolic       
(mm Hg) (SE) 132.2 (0.4) 129.0 (0.6) 122.4 (0.3) 124.1 (0.4) 122.9 (0.4) 
 
























      
Children (8-17 years)      
HTN prevalence (%) 
(SE) 
17.3 (1.1) 15.8 (1.1) 3.8 (1.1) 4.9 (1.1) 5.1 (1.1) 
Median systolic  

















































NOTE: HTN = hypertension; SE = standard error. SOURCE: CDC unpublished data 
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FIGURE 2-4 Age- and sex-adjusted mean systolic blood pressure (upper panel) and diastolic blood pressure (lower 
panel) by race or ethnicity in adults age 20 years or older: United States, NHANES: 1971-1975, 1976-1980, 1988-
1994, 1999-2002, and 2003-2006. SOURCE: CDC unpublished data. 
A comparison of the first blood pressure measurement among children and adolescents 
aged 8-17 years from NHANES over the same survey periods also found a significant decrease 
in hypertension. Hypertension prevalence dropped from 17.3 in 1971-75 to 5.1 in 2003-2006.  
Comparisons of the age- and sex-adjusted mean blood pressures during 1971-2006 
(Figure 2-5) in children are also informative. The age- and sex-adjusted systolic blood pressure 
decreased from 110.1 mm Hg in whites and 108.9 in blacks in NHANES 1971-1975 to 105.1 
mm Hg in whites and 106.2 in blacks in NHANES 1988-1994. Mean diastolic blood pressure 
decreased even more dramatically, from 68.1 mm Hg in whites and 68.1 in blacks to 57.8 mm 
Hg in whites and 57.3 in blacks. During the late 1980s and the early 2000s, mean systolic blood 
pressure increased slightly: from 105.1, 106.2, and 105.5 mm Hg in NHANES 1988-1994 to 
107.5, 108.1, and 107.4 mmHg in NHANES 2003-2006 for whites, blacks, and Mexican-
Americans, respectively.  
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FIGURE 2-5 Age- and sex-adjusted mean systolic blood pressure and diastolic blood pressure by race or ethnicity 
in children aged 8-17 years: United States, NHANES: 1971-1975, 1976-1980, 1988-1994, 1999-2002, and 2003-
2006. 
SOURCE: CDC unpublished data. 
TRENDS IN ASSOCIATED RISK FACTORS 
Overweight and obesity, high sodium intake, physical inactivity, heavy alcohol intake, 
low potassium intake, and a Western-style diet make up the major modifiable risk factors for 
hypertension (Chobanian et al., 2003; Forman et al., 2009). The literature supporting the 
associations between these risk factors and hypertension is well established (Chobanian et al., 
2003; He et al., 2002). Thus, it is not the intent of this section to synthesize that literature but 
rather to comment on the direction of risk factor trends.  
Risk factor data for overweight, obesity, sodium intake, and hypertension prevalence 
available from National Center for Health Statistics (NCHS) Health, United States, 2008 report 
show substantial increases since 1960. For example, the prevalence of obesity has increased from 
13.3 to 33.4 percent between 1960-1962 to 2003-2006. Mean salt intake increased from 2,200 to 
3,500 mg per day between 1971-1974 and 1999-2000. These data are presented in Table 2-5 and 
Figure 2-6.  
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
PUBLIC HEALTH IMPORTANCE OF HYPERTENSION 51 
PREPUBLICATION COPY: UNCORRECTED PROOF 
TABLE 2-5 Prevalence of Hypertension (averaged measures), Overweight, Obesity, and Average intake of Dietary 
Sodium per 1,000 Adults 1960-2006 
 1960-1962 1971-1974 1976-1980 1988-1994 1999-2000 1999-2002 2001-2004 2003-2006 
Hypertension 38.1 39.8 40.4 25.5 32.8 30.0 30.9 31.3 
Overweight 44.8 44.7 47.4 56.0 64.5 65.1 66.0 66.7 











   
a Sodium intake estimates are based on the average of salt intake from 24-hour recalls for men and women from 
NHANES data. Data from NHANES 1971-1974 include naturally occurring sodium in foods and that added by 
processors. Data for NHANES 1999-2000 includes naturally occurring sodium in foods and that added by 












































FIGURE 2-6 Secular trends in hypertension, overweight, obesity and sodium intake in the United States 
*Sodium data from Briefel and Johnson, 2004 (note, the right Y axis is in thousands of mg per day of sodium intake 
(e.g. 2200 mg per day). 
SOURCE: NCHS, 2009.  
 
Additional CDC data from 1998 to 2006 show that 30 to 60 percent of adults across the 
lifespan in the United States are physically inactive and rates have not changed considerably over 
time (NCHS, 2009). Heavy drinking rates among adults age 18 years and older have been 
estimated at 5 to 6 percent between 1998 and 2006 (NCHS, 2009). There has been some increase 
in heavy drinking among subgroups of the population age 45-54 years and 65 to 74 years 
(NCHS, 2009). 
A good source of dietary potassium can be found in fruits and vegetables. Although 
consumption of the recommended five servings of fruits and vegetables will not meet the 
recommended daily intake for potassium, it can certainly contribute (along with consumption of 
dairy products) to reaching that goal. Trends in fruit and vegetable consumption in the U.S. 
population, however, do not appear to be helping to reach that goal. In fact, trends show that the 
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1990 Dietary Guideline recommendations of two servings of fruit and three servings of 
vegetables every day are not being met. Data from the Behavioral Risk Factor Surveillance 
System (BRFSS) found a slight decrease in the mean frequency of fruit and vegetable 
consumption among men and women from 1994 to 2005 (standardized change: total, –0.22 time 
per day; men, –0.26 time per day; women, –0.17 time per day). From 1994 to 2005, the 
proportion of men and women eating fruits and vegetables or both five or more times per day 
remained nearly unchanged (men, 20.6 percent vs. 20.3 percent; women, 28.4 percent vs. 29.6 
percent).  
Kant et al. analyzed differences in diets between blacks and whites in the United States 
using the National Health Examination Survey data (Kant et al., 2007). From 1971 to 2002, 
black men and women reported lower intakes of vegetables, potassium, and calcium (p < 0.001) 
than whites (Kant et al., 2007).  
In 2007, CDC’s BRFSS and the Youth Risk Behavior Surveillance System found that 
only 14 percent of adults and 9 percent of teens meet Healthy People 2010 goals for fruit and 
vegetable consumption (CDC, 2009). 
RECOMMENDATIONS  
Data collection is fundamental to addressing any public health problem. Data are critical 
for determining the burden of hypertension, characterizing the patterns among subgroups of the 
population, assessing changes in the problem over time, and evaluating the success of 
interventions. Given the challenges posed by the changing methodologies used to collect blood 
pressure measurements, the committee believes that efforts to strengthen hypertension 
surveillance and monitoring are critical.  
2.1 The committee recommends that the Division for Heart Disease and Stroke 
Prevention (DHDSP)  
• Identify methods to better use (analyze and report) existing data on the 
monitoring and surveillance of hypertension over time.  
• Develop norms for data collection, analysis, and reporting of future 
surveillance of blood pressure levels and hypertension. 
In developing better data collection methods and analyses, the DHDSP should 
increase and improve analysis and reporting of understudied populations 
including: children, racial and ethnic minorities, the elderly, and socioeconomic 
groups. 
In responding to these recommendations, the DHDSP may want to consider conducting a 
thorough analytical assessment of available data, including data from the NHANES, to determine 
if these data are sufficiently comparable for evaluating secular trends of hypertension prevalence 
in the U.S. population. The analysis would determine at which year the data are robust enough to 
start analyzing secular trends, make recommendations regarding the use of less robust data, and 
standardize the use of appropriate age groups for reporting data so that secular trends are 
reported more consistently in the literature. The DHDSP may also consider conducting analysis 
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of data on the prevalence of hypertension that account for differences in data collection methods 
used in NHANES (measurement on a single day, variable number of blood pressure measures 
taken) and the diagnosis of hypertension in clinical practice (blood pressure measurements based 
on at least two different days). Because of practical issues in conducting the NHANES survey, 
this might be done by statistical adjustment using multiple measures of blood pressure in a 
random sub-sample. 
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THE ROLE OF THE DIVISION OF HEART DISEASE AND STROKE 
PREVENTION IN THE PREVENTION AND CONTROL OF 
HYPERTENSION 
Critical to any organization is its capacity to achieve its mission and goals; thus, the 
resources available and the authority it has to address its charge are fundamental to its ability to 
act. This chapter provides a brief overview of the Centers for Disease Control and Prevention’s 
(CDC’s) Division of Heart Disease and Stroke Prevention, its resources, the legislative history of 
relevant programs, and an overview of activities directed at preventing and reducing 
hypertension in the United States. 
The Cardiovascular Health Studies Branch, established in 1989 within the Division of 
Adult and Community Health in the National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), was the focal point for limited cardiovascular prevention and control 
activities at the CDC. Over the ensuing 17 years, CDC’s activities in this area grew in part as a 
result of the increasing concern about the growing burden of cardiovascular disease and 
congressional action that provided CDC with funds to improve the cardiovascular health of 
Americans. Today, cardiovascular disease prevention and control activities are under the 
purview of the Division of Heart Disease and Stroke Prevention (DHDSP). The charge of the 
Division is to lead the nation’s cardiovascular health initiatives and to reduce the burden of 
disparities associated with heart disease and stroke. The DHDSP’s core functions include 
programs, surveillance, research, evaluation, and partnerships. Its activities are distributed 
among four primary programs: (1) the National Heart Disease and Stroke Prevention Program, 
(2) WISEWOMAN, (3) the Paul Coverdell National Acute Stroke Registry, and (4) the State 
Cardiovascular Health Examination Survey. Although not listed as a specific program, Congress 
directed the DHDSP to address sodium reduction in the American diet, but it did not appropriate 
funding for this activity. 
Programmatic Funding 
In 1998, the DHDSP budget was $10.7 million. Its budget increased gradually to about 
$44 million in 2005 and remained relatively constant until 2008 when the budget increased to 
about $50 million. The DHDSP budget appropriated for fiscal year (FY) 2009 was 
approximately $54 million. The Division’s administrative budget is divided among five core 
functions, which are listed in Table 3-1 with their respective budgets; program expenditures, 
which represent almost 75 percent of the DHDSP budget, are also itemized. The budget 
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distribution shown is for FY 2008 because the final resource allocation for 2009 had not been 
determined at the time of this writing.  
TABLE 3-1 DHDSP Administrative and Program Budgets (FY 2008) 
Core Function Administrative 
Budget 
Percentage of Total 
Administrative Budget 
Programs $49,259,915 (74%) 
Surveillance $5,672,580 (8%) 
Research $3,915,689 (6%) 
Evaluation $4,155,207 (6%) 
Partnerships $3,862,683 (6%) 
   
Programs Program Budget Percentage of Total 
Program Budget 
State Heart Disease and Stroke Prevention Program  $27,770,783 (56%) 
WISEWOMAN $15,499,336 (32%) 
Paul Coverdell National Acute Stroke Registry  $4,400,000 (9%) 
State Cardiovascular Health Examination Survey  $399,751 (1%) 
Other  $1,190,045 (2%) 
National Heart Disease and Stroke Prevention Program 
Established in 1998, the State Heart Disease and Stroke Prevention Program is the 
Division’s largest program. The program funds or provides tools, guidance, and other assistance 
to all 50 states; thus, it is now referred to as a national program. While there is no specific 
language authorizing the program, funds are appropriated each year in the Labor, Health and 
Human Service appropriations bill (or in continuing appropriations resolutions). The program 
was initially established in response to congressional concern that nearly one million Americans 
were dying each year from cardiovascular disease and the knowledge that the major risk factors 
for cardiovascular disease were modifiable and often preventable. Of further concern was that 
states did not receive specific federal funds and many states had limited resources to dedicate to 
the prevention of cardiovascular disease. The congressional vision was that of an integrated, 
comprehensive, and nationwide program to provide assistance to states; support research, 
surveillance, and laboratory capacity; and reduce risk factors for cardiovascular disease by 
promoting healthy behaviors. The program was to give priority to those states with the highest 
age-adjusted death rates due to cardiovascular disease. To carry out this responsibility, Congress 
appropriated $8.1 million to CDC for the program.  
Currently the program provides funds to state health departments in 41 states and the 
District of Columbia. The six primary program priorities are to (1) control high blood pressure, 
(2) control high cholesterol, (3) improve emergency response, (4) improve the quality of care, (5) 
increase awareness of the signs and symptoms of heart attack and stroke and of the need to call 
911, and (6) eliminate health disparities related to heart disease and stroke. Within these broad 
priorities, states are encouraged to focus on policy and system change, effect population-based 
change, ensure cultural competency, engage partners, and work within the healthcare, worksite, 
and community settings. 
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Under the program, states can be funded at the level of Capacity Building or Basic 
Implementation. Twenty-eight states receive $300,000 annually at the Capacity Building level. 
Their priorities include increasing collaboration between public and private partners, defining the 
existing burden of heart disease and stroke in the state, assessing ongoing population-based 
interventions, and developing a comprehensive state plan. There is also an emphasis on 
identifying culturally appropriate approaches to raise awareness and promote healthy behaviors. 
Fourteen states receive Basic Implementation funding in the amount of $1 million dollars 
annually. These states implement and evaluate policies, offer environmental and educational 
interventions in various settings, and facilitate provider education and training.  
In an effort to assist in the outcome evaluation of heart disease and stroke prevention 
activities within states, the DHDSP developed policy and systems outcome indicators for 
controlling high blood pressure. State HDSP Programs may use these indicators to support the 
development of an evaluation plan. The Logic Model for Strategies and Interventions to Reduce 
High Blood Pressure (Figure 3-1) provides parameters for effective intervention strategies. Each 
high blood pressure control outcome indicator identified in the DHDSP’s draft document can be 
nested within a component outlined in the logic model. The model includes a spectrum of 
intervention approaches, including healthcare system changes, provider changes, individual 
changes, worksite changes, and community changes, that can effectively reduce the burden of 
risk factors and disease. 
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1
Overall Logic Model for Strategies and Interventions to Reduce High Blood Pressure [HBP]
Input Activities Outputs Short-term Outcomes Intermediate Outcomes Long-term Outcomes
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FIGURE 3-1 Overall logic model for strategies and interventions to reduce high blood pressure (HBP) 
SOURCE: Gallagher, 2009. 
State programs decide where along the logic model they will focus their program efforts 
and resources. The committee did not attempt to conduct a systematic review of state programs; 
however, based on a highlight of state activities provided by the DHDSP, many states tend to 
focus on secondary prevention activities. Such activities include improving the quality of care for 
individuals through clinical performance measurement (North Carolina, Utah), education and 
training of healthcare providers (Georgia, South Carolina, Virginia), and worksite wellness 
programs (Maine, Kansas, Missouri). Some primary and secondary prevention activities are 
addressed through programs that increase awareness and educate about risk factors and lifestyle 
changes (Oregon).  
WISEWOMAN (Well-Integrated Screening and Evaluation for Women Across the Nation) 
Congress, through the Breast and Cervical Cancer Mortality Prevention Act of 1990 
(Public Law 101-354) provided the authority and funding for the CDC's National Breast and 
Cervical Cancer Early Detection Program and the WISEWOMAN program. The WISEWOMAN 
provision allowed for: 
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(a) Demonstration projects. In the case of States receiving grants under section 
1501 [42 U.S.C. § 300k], the Secretary, acting through the Director of the Centers 
for Disease Control and Prevention, may make grants to not more than 3 such 
States to carry out demonstration projects for the purpose of– (1) providing 
preventive health services in addition to the services authorized in such section, 
including screenings regarding blood pressure and cholesterol, and including 
health education; (2) providing appropriate referrals for medical treatment of 
women receiving services pursuant to paragraph (1) and ensuring, to the extent 
practicable, the provision of appropriate follow-up services; and (3) evaluating 
activities conducted under paragraphs (1) and (2) through appropriate surveillance 
or program-monitoring activities.  
The legislation specifically required that grants for the program be provided only through 
entities that screen women for breast or cervical cancer through the National Breast and Cervical 
Cancer Program. As the name of the program suggests, the legislation integrates and leverages 
the services and efforts of a cancer screening and evaluation program with a primary prevention 
program to reduce cardiovascular risk in women.  
The program was initially funded in 1996 at the amount of $3 million and was situated in 
the Division of Physical Activity and Nutrition; in 1998, the program was transferred to DHDSP. 
By FY 2009, the budget had increased to $19.5 million, with an average of $600,000 dedicated 
to each of the 21 programs operating throughout the United States. Of WISEWOMAN funding, 
80 percent is directed to programs, and within that amount, 60 percent is allocated to primary 
prevention through screening for hypertension, cholesterol, and (more recently) diabetes. The 
remaining 40 percent of funding is directed to administration, data collection, and evaluation.  
The WISEWOMAN program provides screening and lifestyle interventions to low-
income, uninsured, or underinsured woman between the ages of 40 and 64. WISEWOMAN has 
reached more than 84,000 women in need since the year 2000, providing approximately 149,000 
health screenings and 210,500 lifestyle interventions through its 21 state and tribal programs. 
More than 7,674 new cases of hypertension have been identified through WISEWOMAN 
screenings, as well as 7,928 cases of high cholesterol and 1,140 cases of diabetes. Women who 
participated in WISEWOMAN are reportedly more likely to return for regular health screenings. 
A recent review of 14 WISEWOMAN programs found that the average reduction in systolic 
blood pressure after 1 year was 2.7 mm Hg, although it ranged from an increase of 5.0 mm Hg to 
a decrease of 8 mm Hg in the programs studied (Farris et al., 2007). 
The Nebraska WISEWOMAN program was highlighted by Secretary of Health and 
Human Services Dr. Kathleen Sebelius in a recent report describing healthcare success stories. 
She observed that 19,000 women have been reached in Nebraska alone, helping to reduce their 
risk of heart attack and stroke. Dr. Sebelius encouraged building on the success of the 
WISEWOMAN program, which she said has provided evidence of the importance and success of 
prevention programs (Montz and Seshamani, 2009). 
The Paul Coverdell National Acute Stroke Registry 
The CDC’s effort to create state-based stroke registries was initiated in 2001 as a result of 
congressional language in the CDC Heart Disease and Stroke appropriations budget line. The 
program is also included in FY 2002-2005 appropriations; since then, no specific congressional 
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language regarding the program has been included in appropriations, but CDC has maintained 
funding for the program through the appropriations for Heart Disease and Stroke. Through the 
initial legislative language, Congress awarded CDC $4.5 million to track and improve the 
delivery of care to patients with acute stroke. As a first step, the CDC was to consult with stroke 
organizations and others to develop specific data elements for a stroke registry and to design and 
pilot registry prototypes. The focus of the registry data collection effort was to measure the 
quality of care delivered to stroke patients from emergency response to hospital care. Between 
2001 and 2002, eight states participated in piloting prototype projects (Georgia, Massachusetts, 
Michigan, Ohio, California, Illinois, North Carolina, and Oregon). Results from these pilot 
projects revealed disparities between generally recommended standards for treating stroke 
patients and actual hospital practices. In 2004, four of the pilot states were funded to establish 
statewide registries (Georgia, Illinois, Massachusetts, and North Carolina) to collect and analyze 
data and implement quality improvement interventions at the hospital level. In 2007, funding 
was extended to six state health departments (Georgia, Massachusetts, Michigan, Minnesota, 
Ohio, and North Carolina) for a new five-year period. In that same year, the CDC, along with the 
Joint Commission’s Primary Stroke Center Certification Program and the American Stroke 
Association’s (a division of the American Heart Association) Get with the Guidelines Stroke 
Program formed an agreement to jointly release a set of standardized stroke performance 
measures. These guidelines are intended to foster collaboration and encourage hospital 
participation. 
State Cardiovascular Health Examination Survey 
The State Cardiovascular Health Examination Survey was initiated in 2005 in an attempt 
to advance state capacity in the development of hypertension and cholesterol control strategies. 
A Heart Disease and Stroke Prevention Program funding opportunity announcement provided 
the initial funding, but the program now has its own funding opportunity announcement. States 
must receive funding from the DHDSP as a prerequisite to receiving state cardiovascular health 
examination funds. Three state health departments (Arkansas, Kansas, and Washington) were the 
initial awardees; Oklahoma was added in 2007. State awardees design a survey to collect data on 
blood pressure, cholesterol, and other relevant cardiovascular health information, including risk 
factors and health behaviors. The goal of the program is to provide data with which to monitor 
progress toward the Healthy People 2010 objectives related to control of high blood pressure and 
high cholesterol.  
Activities to Reduce Sodium Intake 
Congress, through the Omnibus Appropriations Act (Public Law 111-8) in the Joint 
Explanatory Statement: Division F—Labor, Health and Human Services, and Education, and 
Related Agencies Appropriations, 2009, included an unfunded mandate for the CDC to engage in 
activities to reduce sodium. The statement specifically states:  
A diet high in sodium is a major cause of heart disease and stroke. CDC is 
encouraged to work with major food manufacturers and chain restaurants to 
reduce sodium levels in their products. The agency is directed to submit to the 
Committees on Appropriations and the House of Representatives and the Senate 
an evaluation of its sodium-reduction activities by no later than 15 months after 
the enactment of this Act, and annually thereafter.  
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In January 2009, the DHDSP commissioned the Food and Nutrition Board of the Institute 
of Medicine (IOM) to form an ad hoc Committee on Strategies to Reduce Sodium Intake. The 
committee is cosponsored by the Health and Human Services’ Food and Drug Administration 
and the Office of Disease Prevention and Health Promotion (Office of Public Health and 
Science, Office of the Secretary). The committee is tasked with identifying means to reduce 
dietary sodium intake to levels recommended by the Dietary Guidelines for Americans (HHS 
and USDA, 2005). A range of approaches will be reviewed, including regulatory and legislative 
actions, new product development, and food reformulation, as well as public health and 
educational interventions. Opportunities to foster collaborations between industry, government, 
and the healthcare enterprise will be considered. The anticipated publication date of the 
consensus report is early 2010.  
Other Programmatic Activities 
Healthy People 
The DHDSP, along with the National Institutes of Health (NIH), is responsible for 
monitoring progress toward reaching Healthy People goals related to cardiovascular health. 
Healthy People is a national prevention agenda that was first articulated in 1979 by the 
Department of Health, Education, and Welfare through Healthy People: The Surgeon General’s 
Report on Health Promotion and Disease Prevention (DHEW, 1979). The Institute of Medicine 
and the 1978 Departmental Task Force on Disease Prevention and Health Promotion contributed 
to its preparation. The report’s central theme emphasized the role of individuals, as well as 
public and private sector decision makers, in promoting healthier lifestyles. Blood pressure 
screening, along with the elimination of cigarette smoking and dietary changes to reduce intake 
of excess calories, fat, salt, and sugar, were identified as health-enhancing measures “within the 
practical grasp of most Americans.” The reduction of heart attacks and strokes was a subgoal 
identified in the report’s section dedicated to healthy adults. Increased efforts in “preventive 
measures such as high blood pressure detection and control, reduction of smoking, prudent diet, 
increased exercise and fitness, and better stress management” were suggested strategies in 
working towards this subgoal. Promoting Health/Preventing Disease: Objectives for the Nation 
(HHS, 1980) was released as a companion to this report in 1980; it identified 226 specific, 
measurable, health objectives and strategies for achieving them.  
Healthy People 2000 (HHS, 1991), released in 1990, set forth 22 priority areas, including 
one on heart disease and stroke (priority area 15). At that time, the National Heart, Lung, and 
Blood Institute (NHLBI) was designated as the lead agency assigned to this area. The objectives 
identified in this area included the reduction of coronary heart disease and stroke deaths and also 
addressed cholesterol, smoking, dietary fat, physical activity, and overweight. The objectives 
relating to hypertension included efforts to increase control of high blood pressure, increase 
therapeutic actions by those with high blood pressure, and increase blood pressure screening.  
Released in 2000, the Healthy People 2010 report builds on Healthy People 2000. It 
consolidated 16 objectives for heart disease and stroke prevention into one section (Focus Area 
12). The CDC joined with the NHLBI to co-lead and share accountability for progress toward 
achieving these objectives. The following objectives relate specifically to hypertension: 
• Reduce the proportion of adults with high blood pressure.  
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• Increase the proportion of adults with high blood pressure whose blood pressure is 
under control.  
• Increase the proportion of adults with high blood pressure who are taking action (for 
example, losing weight, increasing physical activity, and reducing sodium intake) to 
help control their blood pressure.  
• Increase the proportion of adults who have had their blood pressure measured within 
the preceding two years and can state whether their blood pressure was normal or 
high.  
• Increase the proportion of persons aged 2 years and older who consume 2,400 mg or 
less of sodium daily.  
Other partners engaged in working with the DHDSP and NHLBI to achieve these goals 
included other CDC units, other federal agencies, and the American Heart Association. The 
Memorandum of Understanding signed by these partners in 2001 created the Healthy People 
2010 Partnership for Heart Disease and Stroke Prevention, which in 2003 became the National 
Forum for Heart Disease and Stroke Prevention and includes a much broader array of 
participants. The Partnership/Forum began charting a public health action plan to work toward 
achieving the Healthy People goals. The action plan follows later in this section.  
The Healthy People 2010 Midcourse Review (HHS, 2006) assessed progress toward the 
10 (out of 16) objectives related to heart disease and stroke for which data were available. The 
results are summarized in Figure 3-2. 
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FIGURE 3-2 Progress quotient chart for Healthy People 2010 Focus Area 12: Heart Disease and Stroke. 
SOURCE: HHS, 2006. 
The problem of hypertension is addressed in the following paragraphs:  
… prevalence of high blood pressure is cause for serious concern. The baseline 
level was 26% and the target is 14%. On the basis of the same NHANES 
[National Health and Nutrition Examination Survey] sources as cholesterol levels, 
prevalence of high blood pressure increased by 33% of the target change as of 
1999-2002, a change in prevalence from 26% to approximately 30% among adults 
aged 20 years or older. This change, coupled with the striking increase in 
prevalence of diabetes and obesity, adds to the total cardiovascular disease burden 
and threatens to slow progress toward the goals for heart disease and stroke 
mortality through the remainder of the decade. 
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Adding to concern about the nation’s course with respect to high blood pressure is 
the report of increasing blood pressure among children and adolescents from 
1988-1994 to 1999-2000.. . . During this period, the national population mean 
levels of systolic and diastolic blood pressure increased for each of two age 
groups, 8-12 and 13-17 years. Increases were greatest for non-Hispanic blacks 
and Mexican Americans and reached +4.8 mm/Hg overall for those aged 8-12 
years. These increases were only partially accounted for by the concurrent 
increase in body mass index. (HHS, 2008, p. 34) 
Clearly, there is concern that the increasing prevalence of high blood pressure in adults 
and increasing blood pressure levels in children is moving in the wrong direction from the 
specified goals. 
A Public Health Action Plan to Prevent Heart Disease and Stroke 
DHDSP, as a co-lead partner in the National Forum for Heart Disease and Stroke 
Prevention, initiated the development of the Public Health Action Plan to Prevent Heart Disease 
and Stroke (HHS, 2003). It was responsible for overall planning and execution and for 
coordinating input from partners, working groups, and expert panels. The resulting Action Plan, 
issued in 2003 and updated in 2008, was viewed as a “call to action for tackling one our nation’s 
foremost challenges, to prevent and control chronic diseases” (HHS, 2003, p. v). The plan 
provides a vision for the future and a framework of action for public health practitioners and 
policy makers in the areas of preventing the development of risk factors for heart disease and 
stroke; detecting and treating risk factors; achieving early identification and treatment of 
cardiovascular disease and stroke, especially in the acute phases; and preventing the recurrence 
and complications of heart disease and stroke.  
The Action Plan is not specific to the prevention and control of hypertension; rather, it is 
written for the most part in the general terms of preventing heart disease and stroke. Two 
recommendations were considered fundamental to the plan:  
Effective Communication: 
• The urgency and promise of preventing heart disease and stroke and their precursors 
(i.e., atherosclerosis, high blood pressure, and their risk factors and determinants) 
must be communicated effectively by the public health community through a new 
long-term strategy of public information and education. This new strategy must 
engage national, state, and local policy makers and other stakeholders. (Revised in 
2008 to include: As a matter of emphasis, special consideration must be paid to those 
most at risk. Communication strategies should utilize the most current forms of 
available technology as well at those communication devices that are accessible in 
various communities in the U.S. and globally.) 
Strategic Leadership, Partnership and Organization:  
• The nations’ public health agencies and their partners, (revised in 2008 to include: 
and the public) must provide the necessary leadership for a comprehensive public 
health strategy to prevent heart disease and stroke.” (HHS, 2008) 
Among the remaining 22 recommendations, two included direct reference to blood pressure. 
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Advancing Policy: Defining the Issues and Finding the Needed Solutions: 
• Conduct and facilitate research by means of collaboration among interested parties to 
identify new policy, environmental, and sociocultural priorities for CVH 
[cardiovascular health] promotion. Once the priorities are identified, determine the 
best methods for translating, disseminating, and sustaining them. Fund research to 
identify barriers and effective interventions in order to translate science into practice 
and thereby improve access to and use of quality health care and improve outcomes 
for patients with or at risk for CVD [cardiovascular disease]. Conduct economics 
research, including cost-effectiveness studies and comprehensive economic models 
that assess the return on investment for CVH promotion as well as primary and 
secondary CVD prevention.  
As an example, research to assess community-wide interventions aimed at maintaining 
and restoring low blood cholesterol levels and low blood pressure, which help prevent 
atherosclerosis and high blood pressure, are suggested. This recommendation was designated a 
2008-2009 priority. 
• Design, plan, implement, and evaluate a comprehensive intervention for children and 
youth in school, family, and community settings. This intervention must address 
dietary imbalances, physical inactivity, tobacco use, and other determinants in order 
to prevent development of risk factors and progression of atherosclerosis and high 
blood pressure. 
A full list of the updated 22 recommendations is included in Appendix C. 
Division of Heart Disease and Stroke Prevention Strategic Plan 
The DHDSP’s Strategic Plan is modeled on the Healthy People 2010 goals related to 
heart disease and stroke and the recommendations set forth in A Public Health Action Plan to 
Prevent Heart Disease and Stroke. The division is focused on efforts to (1) prevent risk factors 
for heart disease and stroke; (2) increase detection and treatment of risk factors; (3) increase 
detection and treatment of heart disease and stroke; (4) decrease recurrences of heart disease and 
stroke; and (5) foster a skilled and engaged public health workforce (Appendix D). Several 
priority areas were identified as areas of emphasis over the course of the next several years. The 
first priority is the enhancement of collaboration by CDC with federal, state, and local agencies 
and with nongovernmental organizations to mobilize prevention efforts. The division will also 
prioritize efforts to identify and address at-risk populations to prevent disparities associated with 
heart disease and stroke. An internal Disparities Workgroup was formed in 2007 in support of 
this effort.  
DHDSP Collaboration with Other CDC Units 
Many of DHDSP’s programmatic efforts focus on secondary prevention of heart disease 
and stroke with limited primary prevention activities. Some of the relevant primary prevention 
activities are the domain of other divisions of the National Coordinating Center for Chronic 
Disease Prevention and Health Promotion that focus broadly on preventing chronic diseases and 
their risk factors. These divisions work as separate organizational units, each with its own budget 
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and mission related to a specific disease, risk factor(s), or vulnerable population. Some of these 
units also address adolescents and young adults.  
According to division staff, the DHDSP maintains an ongoing working relationship with 
its sister divisions and will collaborate on relevant efforts. Table 3-2 lists FY 2009 funding and 
program descriptions for CDC units with which DHDSP collaborates.  
For example, DHDSP leads the Cardiovascular Health (CVH) Collaboration, a monthly 
meeting of NCCDPHP division leadership and representatives from other CDC centers to discuss 
important and timely cardiovascular health-related issues. DHDSP collaborated with the Office 
on Smoking and Health (OSH) on an IOM report about the effects of secondhand smoke and 
acute cardiac events and connected the WISEWOMAN programs with tobacco quit lines. As 
noted earlier, DHDSP is also working with the Division of Nutrition, Physical Activity, and 
Obesity on an IOM consensus study to identify strategies for reducing sodium in the food supply 
as well as a broader salt initiative and related issues such as menu labeling. 
TABLE 3-2 CDC Units or Programs, Funding and Program Description 









Division of Adolescent and School Health 
(DASH) 
$57.6 DASH funds education and health agencies in 22 states 
and 1 tribal government to help schools implement a 
coordinated school health approach, with an emphasis on 
promoting physical activity, healthy eating, and a tobacco-
free lifestyle. CDC also funds 50 state education agencies 
(including the District of Columbia), 1 tribal government, 
6 territorial education agencies, and 16 large urban school 
districts for school-based HIV prevention. Ten large urban 
school districts receive CDC support for school-based 
asthma management programs  
 
Division of Nutrition, Physical Activity, 
and Obesity (DNPAO) 
$44.3 DNPAO funds health departments in 23 states to 
coordinate statewide efforts with multiple partners to 
address obesity. The program’s focus is on policy and 
environmental change initiatives directed toward 
increasing physical activity; consumption of fruits and 
vegetables; breastfeeding initiation, duration, and 
exclusivity; and decreasing television viewing and 
consumption of sugar-sweetened beverages and high-
energy-dense foods (foods high in calories) 
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 Division of Adult and Community Health 
(DACH) 
Racial and Ethnic Approaches to 





REACH supports community coalitions that design, 
implement, evaluate, and disseminate community-driven 
strategies to eliminate health disparities in key areas. 
REACH supports CDC’s strategic goals by addressing 
health disparities throughout infancy, childhood, 
adolescence, adulthood, and older adulthood. This 
program has developed innovative approaches that focus 
on racial and ethnic groups and is improving people’s 
health in communities, healthcare settings, schools, and 
work sites  
 
 Healthy Communities $22.8 DACH currently provides guidance, technical assistance, 
and training to 12 Strategic Alliance for Health 
communities selected to represent a mix of urban, rural, 
and tribal communities. DACH will also train and support 
more than 200 ACHIEVE (Action Communities for 
Health, Innovation, and Environmental Change) 
communities over the next several years. ACHIEVE 
selects communities to participate in an Action Institute, 
which convenes community action teams and trains 
community leaders making policy, systems, and 
environmental changes to prevent and control chronic 
diseases and their risk factors. DACH also supports the 
YMCA of the Pioneering Healthier Communities initiative
 
 Preventive Health and Health Services 
(PHHS) Block Grant  
$102.0 The PHHS block grant provides funding for all 50 states, 
the District of Columbia, 2 tribes, and 8 territories to tailor 
prevention and health promotion programs to their 
particular public health needs. The block grant gives its 
grantees the flexibility to target funds to prevent and 
control chronic diseases such as heart disease, diabetes, 
and arthritis and helps them to respond quickly to 
outbreaks of food-borne infections and waterborne 
diseases 
 Prevention Research Centers (PRCs) $31.1 CDC supports 33 centers associated with schools of public 
health or medicine throughout the country. Each center 
conducts at least one core research project with an 
underserved population that has a disproportionately large 
burden of disease and disability. All centers share a 
common goal of addressing behaviors and environmental 
factors that contribute to chronic diseases such as cancer, 
heart disease, and diabetes. Several PRCs also address 
injury, infectious disease, mental health, oral health, and 
global health 
Office of Smoking and Health (OSH) $106.2 OSH funds programs in all 50 states, the District of 
Columbia, 8 U.S. territories or jurisdictions, and 7 tribal-
serving organizations. In addition, CDC funds national 
networks to reduce tobacco use among specific 
populations. CDC also provides funding to 22 state 
education agencies and 1 tribal government for 
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coordinated school health programs to help prevent 
tobacco use 
SOURCE: Personal communication, D. Dunet, Centers for Disease Control and Prevention, May 9, 2009. 
REFERENCES 
DHEW. 1979. Healthy people: The Surgeon General's report on health promotion and disease 
prevention. Washington, DC: US Government Printing Office. 
Farris, R. P., J. C. Will, O. Khavjou, and E. A. Finkelstein. 2007. Beyond effectiveness: 
Evaluating the public health impact of the WISEWOMAN program. American Journal of 
Public Health 97(4):641-647. 
Gallagher, K. M. 2009. CDC hypertension program and budget, Division for Heart Disease and 
Stroke Prevention. PowerPoint Presentation at Meeting 4: Committee on Public Health 
Priorities to Reduce and Control Hypertension in the U.S. Population, April 9, 2009, 
Washington, DC. 
HHS. 1980. Promoting health/preventing disease: Objectives for the nation. Washington, DC: 
Public Health Service. 
———. 1991. Healthy people: National health promotion and disease prevention objectives. 
Washington, DC: Public Health Service. 
———. 2003. A Public Health Action Plan to prevent heart disease and stroke. Atlanta, GA: US 
Department of Health and Human Services, Centers for Disease Control and Prevention. 
———. 2006. Healthy People 2010 midcourse review. Washington, DC: U.S. Government 
Printing Office. 
———. 2008. 2008 Public Health Action Plan update: Celebrating our first five years. Atlanta, 
GA: US Department of Health and Human Services, Centers for Disease Control and 
Prevention. 
HHS and USDA. 2005. Dietary guidelines for Americans. 6th ed. Washington, DC: U.S. 
Government Printing Office. 
Montz, E., and M. Seshamani. 2009. A success story in American health care: Community-based 
prevention in Nebraska. http://healthreform.gov/reports/success_nebraska/ (accessed 
December 18, 2009). 
 
Copyright © National Academy of Sciences. All rights reserved.









INTERVENTIONS DIRECTED AT THE GENERAL POPULATION 
This chapter focuses on a number of interventions to address population-based risk 
factors—overweight, obesity, high sodium intake, low intake of potassium, unhealthy diet, high 
levels of alcohol consumption, low levels of physical activity—that are known to increase the 
risk of hypertension in the general population. Some trends in these risk factors, as noted in 
Chapter 2, are concerning because they are on the rise or have not decreased over time. This 
chapter includes an examination of the attributable fraction of hypertension due to each risk 
factor and an estimate of the benefit associated with interventions directed toward reducing these 
risk factors and their potential effectiveness relative to one another. Estimating the percentage of 
hypertension cases in a population attributable to different risk factors is useful as part of the 
process of setting public health priorities. However, these estimates do not apply to individual 
patients with hypertension, who may each have a different combination of factors contributing to 
their elevation in blood pressure.  
The chapter also discusses community and environmental health determinants of 
hypertension, and the importance of considering health disparities. Potential interventions such 
as community and environmental interventions and public education and medial and social 
marketing campaigns are considered. Finally, the chapter ends with a concluding statement and 
recommendations.  
METHODOLOGY  
This section addresses the methodology used in prioritizing modifiable risk factors for 
intervention. The committee’s selection of priority interventions was based primarily on the 
potential impact on the population if the risk factor were eliminated (population attributable 
risk). One method to compute population attributable fractions for hypertension is to identify 
prospective observational studies that have analyzed the association between a given risk factor 
and the incidence of hypertension. Using the relative risk (RR) between a given risk factor and 
incident hypertension, as well as the prevalence of that risk factor in the population, the 
attributable fraction can be computed as follows, where Pe is the prevalence of the exposure in 
the population: 
AF = { (RR-1) x Pe }f ÷ { ([RR-1] x Pe) + 1 } 
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To compute the attributable fractions for various risk factors, the committee used 
dichotomized RR estimates and estimates of the prevalence of these risk factors in the 
population.  
Prospective studies pertaining to each of the modifiable risk factors (i.e., overweight and 
obesity, physical inactivity, heavy alcohol use, high salt intake, low potassium intake, and 
western-style diet) were examined. A range of relative risks or odds ratios were extracted from 
these analyses, and accordingly, a range of attributable fractions for hypertension were 
computed. In addition, an aggregate relative risk was derived from the available literature, and a 
corresponding aggregate attributable fraction was computed.  
A second method to compute population attributable fractions for hypertension is to 
identify randomized controlled trials which report the effect of lifestyle modification 
interventions on blood pressure. Preferably, large-scale systemic reviews which pool the data 
from multiple randomized trials could provide a useful aggregate effect estimate (and range of 
estimates). In order to use these effect estimates to compute attributable fractions, a estimation of 
the mean blood pressure (and standard deviation) among the exposed population (i.e., the 
population with the risk factor) must be made, and two assumptions must then be made: (1) that 
the blood pressure follows a normal distribution, and (2) that applying the intervention to the 
exposed population would lead to a change in the mean blood pressure of that population that is 
identical to the pooled estimates reported from meta-analyses. Using a normal distribution 
function for systolic blood pressure (because most hypertension is systolic hypertension) and 
computing the percent of exposed individuals with a systolic blood pressure ≥140 mmHg, the 
change in hypertension prevalence as a result of the intervention can then be estimated as the 
change in prevalence of hypertension using the normal distribution multiplied by the prevalence 
of the risk factor in the population. Finally, the attributable fraction of hypertension due to the 
risk factor can then be computed by dividing the intervention-induced change in hypertension 
prevalence by the prevalence of hypertension in the whole population. Using this methodology, 
attributable risks were computed for the viable modifiable risk factors. 
The committee also notes that much of the evidence contained in the following sections 
comes primarily from observational epidemiological investigations, which are mainly cross-
sectional or prospective in nature, and randomized intervention trials. Each of these has its 
strengths and limitations. The observational studies are often large and long term and are thus 
able to evaluate both the incidence of hypertension and blood pressure as outcomes, but results 
can be distorted by unmeasured or poorly measured confounding factors. Randomized trials can 
directly evaluate an intervention, or change in exposure, and reduce the likelihood of 
confounding, thus providing valuable evidence for causation. However, most of these trials have 
only evaluated changes in blood pressure rather than incidence of hypertensions because of their 
limited size and duration. Estimates of attributable risks were generally similar when obtained 
using the different approaches, which enhances the validity of conclusions.  
PROMOTE WEIGHT LOSS AMONG OVERWEIGHT PERSONS 
According to data from the National Center for Health Statistics, approximately two-
thirds of U.S. adults are overweight or obese (Table 4-1). In the prospective studies that have 
examined body mass index (BMI) in relation to adjusted risks of incident hypertension, 
overweight and obesity have been consistently and significantly associated with a higher risk of 
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incident hypertension (Ascherio et al., 1992; Friedman et al., 1988; Gelber et al., 2007; Hu et al., 
2004; Huang et al., 1998; Ishikawa-Takata et al., 2002). The most modest association was 
observed in 17,441 Finish men and women who were followed for 11 years (Hu et al., 2004). 
Compared to individuals with a normal BMI, the adjusted relative risk for hypertension among 
those who were overweight was 1.24(1.05-1.46) in women and 1.18 (1.01-1.39) in men; among 
obese individuals, the relative risk of hypertension was 1.32(1.07-1.62 in women and 1.66 (1.35-
2.04) in men. The authors did not provide a summary estimate for a BMI ≥ 25 compared to 
normal-weight men, but if these relative risks are projected onto the current U.S. population 
(with roughly equal proportions of overweight—34 percent—and obese—32 percent), then an 
averaged relative risk of 1.3 may be a reasonable estimate of the association of overweight and 
obesity with hypertension among women (and a somewhat stronger association among men). 
The prospective study with the strongest association between BMI and hypertension was the 
Nurses’ Health Study. Nurses who had a BMI of 25.0 to 25.9 had a 2.6-fold (2.3-2.8)increased 
risk of developing hypertension during the subsequent 16 years compared to the leanest women, 
and the risk increased stepwise with higher BMIs (Huang et al., 1998). The relative risk 
estimates for the other prospective studies fell between these values, and the mean relative risk 
was 1.7. Using this mean and range of effect estimates and a population prevalence of 
overweight and obesity of 66 percent, it can be estimated that approximately 32 percent (range 
between 17 and 51 percent) of new hypertension cases occurring in the United States can be 
attributed to overweight and obesity (Table 4-1). 
TABLE 4-1 Risk Factor: Overweight and Obesity 
Modifiable risk Factor Definition Prevalence (source) 
Overweight & obesity  BMI ≥ 25 kg/m2 0.66 (NCHS, 2006) 
  Relative risk,  
mean (range) 
Attributable fraction,  
mean (range) 
  1.7 (1.3-2.6) 32% (17-51%) 
      
Lifestyle 
intervention 




Weight loss (Horvath et al., 2008) 
(Ebrahim and Smith, 
1998) 
135 (18) -6 (-3 to -10) 
 
-5 (-3 to -8) 
8% (4 to 13%) 
 




Important supportive evidence for these epidemiological findings has been provided by a 
series of randomized trials that have analyzed the effect of weight loss interventions on blood 
pressure; the majority of these studies succeeded in reducing weight in the intervention group by 
about 5 kg (Anderssen et al., 1995; Croft et al., 1986; Jalkanen, 1991; Stevens et al., 2001; The 
Trials of Hypertension Prevention Collaborative Research Group, 1992, 1997; Wassertheil-
Smoller et al., 1992). Two meta-analyses have been performed that pool the results of these 
trials. The more recent meta-analysis, by Horvath et al. (2008), demonstrated a 6 mm Hg (–3 to –
10 mm Hg) decrease in systolic blood pressure with weight loss. The older study by Ebrahim and 
Smith (1998) found a 5 mm Hg (–3 to –8 mm Hg) fall in systolic blood pressure with weight loss 
Based on these results, an intervention (to reduce weight by about 5 kg, or 10 pounds) applied to 
overweight and obese members of the population would hypothetically reduce the overall 
population prevalence of hypertension by 7-8 percent. Additionally, an estimated 24-28 percent 
of hypertension in the United States may be attributable to overweight and obesity, an estimate 
that is consistent with the attributable fractions computed using observational data. 
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DECREASE SODIUM INTAKE 
Based upon 2004 statistics using calculated intakes of sodium, 87 percent of U.S. adults 
consumed what the Centers for Disease Control and Prevention (CDC) considers excess sodium 
(>100 mmol of sodium ≅ >2,400 mg sodium ≅ >6,000 mg of salt [sodium chloride]) (NCHS, 
2008) (Table 4-2)1. Further, the American Heart Association and the US Dietary Guidelines, 
2005 recommend that African Americans and persons who are middle aged or older or who have 
hypertension should consume less than 1,500 mg of sodium daily; with this added criterion the 
number consuming excess sodium is substantially higher than 87 percent (AHA, 2009). 
However, calculated sodium intake may not be accurate because the large majority of sodium in 
the U.S. food supply is added in the processing and manufacturing of foods and a large and 
increasing amount is used in the fast-food industry. The amounts added can vary widely by brand 
and with time, making calculations difficult, and the smaller amounts added at home can also be 
challenging to quantify. Unfortunately, 24-hour urinary sodium excretion, which provides the 
best measure of sodium intake, has never been assessed in a nationally representative sample of 
the U.S. population, so that the true distribution of intakes in the United States is not known.  
TABLE 4-2 Risk Factor: High Salt Intake 
Modifiable risk factor Definition Prevalence (source) 
High salt intake ≥ 2,400 mg/day sodium 0.87 (HHS, 2008)  
  Relative risk,  
mean (range) 
Attributable fraction,  
mean (range) 
  1.3 (1.2-1.4) 32% (17-51%) 
      
Lifestyle 
intervention 
References Initial SBP Change in SBP Anticipated 




Reduce salt intake (He and 
MacGregor, 2003) 
131 (19) -4 (-3 to -5) 6% (5 to 8%) 21% 
Very few prospective studies have addressed the association between antecedent dietary 
salt intake and the risk of developing hypertension. This is probably due mainly to the difficulty 
in accurately ascertaining sodium intake in large cohorts because most sodium is added in the 
manufacturing and processing of food rather than being intrinsic to food itself. As mentioned by 
the authors, misclassification of sodium intake potentially explains the absence of an association 
between estimated sodium intake and hypertension in the Nurses’ Health Study and the Health 
Professionals Follow-up Study (Ascherio et al., 1996; Ascherio et al., 1992). In cross-sectional 
observational studies, positive associations have been seen between sodium intake (as assessed 
by 24-hour urine collections) and blood pressure or prevalent hypertension (Karppanen and 
Mervaala, 2006; Stamler, 1997).  
                                                 
1 Conversion factors: In view of the variability of the published data referred to in this report the following 
conversion information is provided.  To convert millimoles (mmol) to milligrams (mg) of sodium, chloride, or of 
sodium chloride, multiply mmol by 23, 35.5, or 58.5 (the respective molecular weights of sodium, chloride, and 
sodium chloride), respectively. To convert millimoles (mmol) of potassium to mg of potassium multiply by 39, the 
molecular weight of potassium.   
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Numerous interventional studies of salt intake and blood pressure (analyzed as a 
continuous variable) of various quality and duration have been performed. Some of these sodium 
reduction trials had sufficiently long periods of follow-up to ascertain hypertension as a 
secondary end point (Goldstein, 1990; The Trials of Hypertension Prevention Collaborative 
Research Group, 1992, 1997). The Hypertension Prevention Trial randomized men and women 
age 25-49 years to one of five counseling groups, including no counseling, counseling to reduce 
sodium, counseling to reduce sodium and increase potassium, counseling to reduce sodium and 
calories, and counseling to reduce calories. After three years of follow-up, sodium intake was 
reduced 10 percent (34 mmol per day), and the odds ratio for incident hypertension among the 
no-counseling group compared to the low-sodium group was 1.4. Phase I of the Trials of 
Hypertension Prevention (TOHP-I) enrolled more than 2,000 men and women age 30 to 54 years 
with diastolic blood pressures of 80 to 89 mm Hg, and randomized them to one of four groups: 
control (no intervention), low sodium, weight loss, and stress reduction (The Trials of 
Hypertension Prevention Collaborative Research Group, 1992). Participants were followed for 
18 months. Compared to the control, the sodium intervention led to a reduction in sodium intake 
of 44 mmol per day; the odds ratio for incident hypertension among controls was 1.3 (The Trials 
of Hypertension Prevention Collaborative Research Group, 1992). Phase II (TOHP-II) 
randomized more than 2,000 overweight men and women age 30 to 54 years with diastolic blood 
pressures of 83-89 mm Hg and systolic blood pressures <140 mm Hg to usual care, counseling to 
achieve an 80-mmol-per-day (2 grams) sodium diet, weight loss, or a combination of weight loss 
and low-sodium diet (The Trials of Hypertension Prevention Collaborative Research Group, 
1997). Counseling on sodium restriction led to a 40-mmol-per-day reduction in sodium intake. 
Through four years of follow-up, the odds ratio of incident hypertension among the control 
group compared to the sodium restriction group was 1.2 (The Trials of Hypertension Prevention 
Collaborative Research Group, 1997). While other randomized trials that included sodium 
restriction as one intervention also had extended follow-up and ascertainment of hypertension 
incidence (e.g., the Primary Prevention Trial and the PREMIER clinical trial of comprehensive 
lifestyle modification for blood pressure control; (Elmer et al., 2006; Stamler et al., 1989), 
sodium restriction was examined in combination with other factors rather than in isolation. Using 
this range of effect estimates and a population prevalence of 87 percent for high salt intake, it can 
be estimated that between 15 and 26 percent of new hypertension cases occurring in the United 
States could be attributed to a high salt intake with an average estimate from the available studies 
of 21 percent. 
The most up-to-date systematic reviews of blood pressure lowering trials via sodium 
restriction were published by He and MacGregor (2008) and Dickinson et al. (Dickinson et al., 
2006); both studies reported essentially identical pooled estimates. He et al. analyzed 31 trials of 
at least one-month duration in which the sodium intake (measured by sodium excreted in 24-hour 
urine) in the treatment group was reduced by at least 40 mmol (approximately 1,000 mg of 
sodium, or 2,300 mg of salt-sodium chloride). The average sodium reduction in these studies was 
76 mmol (about 1,750 mg of sodium, or 4,438 mg of salt); this represents less than half the daily 
salt intake (9-12 grams) of average Americans (He and Macgregor, 2008). The pooled estimate 
for systolic blood pressure reduction from sodium restriction was 4 mm Hg (–3 to –5 mm Hg). 
By using these estimates and a prevalence of sodium excess in the general population of 0.87, the 
prevalence of hypertension could potentially be reduced by 5-8 percent if all Americans 
consuming a high-salt diet lowered their salt intake by about 4.5 grams per day. The 
corresponding attributable fraction of hypertension due to sodium excess is approximately 21 
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percent, precisely what was found when data from intervention studies with hypertension as the 
dichotomous outcome were analyzed. 
INCREASE POTASSIUM AND INTAKE OF FRUITS AND VEGETABLES 
Of all of the modifiable risk factors for hypertension, one of the most prevalent is an 
inadequate consumption of potassium based on the current Dietary Reference Intakes (DRI) 
criteria (IOM, 2005). In a recent report from the CDC (NCHS, 2008), approximately 2 percent of 
U.S. adults met the current guidelines for dietary potassium intake (≥4.7 grams per day, or 4,700 
mg), but insufficient potassium intake is most prevalent among blacks and Hispanics, among 
whom the proportion consuming an adequate amount of potassium was close to 0 percent. Of 
note, the primary basis for the DRI of 4.7 grams per day for potassium is its beneficial effect on 
blood pressure and stroke (IOM, 2005). Specifically, this amount of potassium, provided as a 
supplement, was needed to counteract the effect of a high salt load among 10 black men; among 
white men, 2.7 grams per day appeared to be adequate. In the 2005 U.S. Dietary Guidelines, the 
value of 4.7 grams per day based on supplemental potassium was translated into 
recommendations for high consumption of fruits, vegetables, and dairy products, which are 
major sources of this nutrient (HHS and USDA, 2005) (Table 4-3). 
TABLE 4-3 Risk Factor: Low Potassium Intake 
Modifiable risk factor Definition Prevalence (source) 
Low Potassium Intake < 4,700 mg/day potassium 0.98 (Sondik, 2008) 
 
      
Lifestyle 
intervention 
References Initial SBP Change in SBP Anticipated 






(Whelton et al., 
1997) 
131 (19) -3 (-2 to -4) 5% (4 to 7%) 17% 
Observational studies that have examined the association between potassium intake and 
incident hypertension are conflicting (Ascherio et al., 1996; Ascherio et al., 1992; Chien et al., 
2008; Dyer et al., 1994; Lever et al., 1981). While some cross-sectional analyses of 24-hour 
urinary potassium excretion and blood pressure have demonstrated an inverse association (Dyer 
et al., 1994; Lever et al., 1981), prospective studies have not shown clear associations. In both 
the large-scale Nurses’ Health Study and the Health Professionals Follow-up Study, higher 
intakes of potassium ascertained from repeated food-frequency questionnaires were inversely 
associated with risk of hypertension, but it was difficult to determine the independence from 
other dietary factors in multivariate analyses (Ascherio et al., 1996; Ascherio et al., 1992). In a 
recent study among 1,523 men and women in Taiwan, the incidence of hypertension was 
ascertained during eight years of follow-up after a baseline 24-hour urine collection; the relative 
risk comparing the highest to lowest quartile of potassium excretion was 0.98 (0.78-1.23) after 
multivariate adjustment (Chien et al., 2008). Whether a single measure of urinary potassium is 
adequate for characterizing long-term potassium intake in this population is unclear.  
Numerous randomized trials have examined whether potassium supplementation lowers 
blood pressure, and the overall evidence indicates a benefit although this has not been seen in all 
studies (Appel et al., 2006). Four meta-analyses have been published that have pooled these 
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studies (Cappuccio and MacGregor, 1991; Dickinson et al., 2006; Geleijnse et al., 2003; Whelton 
et al., 1997). Three studies found significant pooled blood pressure reductions with potassium 
supplementation (Cappuccio and MacGregor, 1991; Geleijnse et al., 2003; Whelton et al., 1997), 
while the most recent (which excluded trials of very short duration, those that included children 
and pregnant women, and those that included participants on blood pressure medications that 
were altered during the study period) did not detect a significant effect (Dickinson et al., 2006). 
Nevertheless, the pooled estimate from that meta-analysis suggested a favorable effect of 
potassium (a 3.9 mm Hg decrease in blood pressure), despite the insignificant p-value 
(Dickinson et al., 2006). In the most comprehensive of these meta-analyses, Whelton et al. 
synthesized 33 randomized trials of potassium supplementation and reported a pooled reduction 
of systolic blood pressure by 3 mm Hg (–2 to –4 mm Hg), and a pooled reduction in diastolic 
blood pressure of 2 mm Hg (–1 to –4 mm Hg) (Whelton et al., 1997).  
Although recommendations for high intakes of fruits and vegetables in the U.S. Dietary 
Guidelines are based largely on studies of potassium supplementation and blood pressure, the 
effect of increasing fruits and vegetables on blood pressure was investigated directly in the 
Dietary Approaches to Stop Hypertension (DASH) study (Appel et al., 1997). In this study, one 
intervention group was fed 8.5 servings of fruits and vegetables (analyzed potassium intake 
4,101 mg per day), whereas the comparison group received 3.6 servings per day (analyzed 
potassium intake 1,752 mg per day). The fruits-and-vegetables diet reduced systolic blood 
pressure by 2.8 mm Hg more (p < 0.001) and diastolic blood pressure by 1.1 mm Hg more than 
the control diet (p = 0.07), which is consistent with the potassium content of these foods. DASH 
results showing reduced systolic and diastolic blood pressure with an increase in dietary fruit and 
vegetables have also been reported by researchers in the United Kingdom (John et al., 2002). 
Using the results of the meta-analysis of Whelton and colleagues in which the dose of 
potassium supplementation was typically 60 mmol per day, and the assumption that the entire 
population could increase its intake to 4,700 mg per day, the prevalence of hypertension could 
hypothetically be reduced by 4-7 percent. Further, the attributable fraction corresponding to 
insufficient potassium intake is approximately 17 percent. 
There is evidence that increasing the potassium intake of the general U.S. population 
would have favorable effects on blood pressure, but the methods of doing this need to be 
considered. The high intake of fruits and vegetables in the DASH study (8.5 servings per day) is 
a desirable goal, but increases to this level will be difficult to achieve in the medium-term future 
because there has been little increase in these foods in the United States (if french-fried potatoes 
are not included) despite strong encouragement to do so. Whether smaller increases would have 
similar benefits is not clear. Potassium supplements for the general population are not usually 
advised because of possible adverse gastrointestinal effects (Cohn et al., 2000) and concern 
about the development of hyperkalemia among individuals with chronic renal failure or on 
potassium-sparing diuretics. However, maintenance of normal potassium homeostasis typically 
does not become problematic in people with kidney disease until the glomerular filtration rate 
falls below 20 mL/min. This severity of kidney disease is uncommon in the general population 
(about 0.1 percent of the population), and awareness is higher among these individuals (Coresh 
et al., 2005). Another strategy to increase potassium intake is by the use of “modified salt” in 
food preparation in which part of the sodium chloride is replaced by potassium chloride. This has 
the double advantage of decreasing sodium and increasing potassium intake, and the likelihood 
of excessive potassium intake is limited by its effect on flavor. The more widespread use of these 
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substitutes, accompanied by clear labeling for those whose intake of potassium should be limited 
for medical reasons, deserves further consideration.  
CONSUME A HEALTHY DIET  
In many studies of vegetarians and rural populations of developing countries, the eating 
patterns of these groups have been associated with lower blood pressure and lower rates of 
hypertension (Armstrong et al., 1977; Cruz-Coke et al., 1964; He et al., 1991; Klag et al., 1995; 
Poulter et al., 1990; Poulter et al., 1985; Sacks and Kass, 1988; Sacks et al., 1974; Sever et al., 
1980). For example, among young men and women living in the Boston area, the prevalence of 
hypertension was approximately 20 percent among nonvegetarians versus 0 percent among 
vegetarians (Sacks and Kass, 1988). In a study of South African blacks, the odds ratio for 
prevalent hypertension comparing urban versus tribal dwelling Xhosa and Zulu people was 2.1, 
although this was unadjusted. When comparing migrants from a rural to an urban area of China 
with those who had not migrated, the adjusted odds ratio for prevalent hypertension was 1.91 
(standardized for slightly different odds ratios in men and women) (He et al., 1991). These 
observations led to the hypothesis that interventions involving a healthy overall eating pattern 
might be more clearly related to lower blood pressure than those focused on single nutrients. 
This led investigators of the DASH trial to propose a healthy eating plan that would lower blood 
pressure (Appel et al., 2006). This diet was high in fruits, vegetables, and low-fat dairy products 
and low in saturated fat and sweets (Appel et al., 1997), and was thus high in potassium, calcium, 
magnesium, and fiber.  
Published data from observational studies that provide an estimate of the association 
between an overall healthy diet or the DASH dietary pattern and incident hypertension are 
generally limited. Investigators at the European Investigation into Cancer and Nutrition (EPIC)-
Potsdam Study did analyze the association between a DASH dietary pattern and incident 
hypertension, but among the population with sufficient dietary data, only 123 incident 
hypertension cases occurred; a DASH-style diet was inversely associated with hypertension, but 
this was not statistically significant (Schulze et al., 2003). The one prospective study that did find 
a significant association between a DASH-style diet and incident hypertension was the Nurses’ 
Health Study II (Forman et al., 2009). Among more than 83,000 women followed for 14 years, 
those in the lowest compared to the highest quintile of DASH score (a score generated from 
factor analysis to reflect a DASH eating style) had a 1.22-fold increased risk of incident 
hypertension (1.15-1.30) after adjustment for multiple factors (Forman et al., 2009).  
The DASH trial itself had insufficiently long-term follow-up to demonstrate a persistent 
change in blood pressure at one year, or a change in hypertension incidence (Ard et al., 2004), 
despite providing clear evidence that the DASH diet lowers blood pressure. Although the 
PREMIER trial analyzed incident hypertension at 18 months of follow-up, the DASH diet was 
not analyzed in isolation (Elmer et al., 2006). Rather, the DASH diet was combined with weight 
loss, sodium restriction, and physical activity. Compared to the group receiving weight loss, 
sodium restriction, and physical activity without the DASH eating plan, the addition of the 
DASH eating plan was associated with a relative risk for incident hypertension of 0.93 (0.75-
1.15) (Elmer et al., 2006). By using the range of effect estimates from comparisons of 
populations and cohort studies and a conservative estimate of the population prevalence of a 
Western-style diet of 75 percent (it is probably higher), it can be estimated that between 13 and 
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40 percent of new hypertension cases occurring in the United States can be attributed to a 
Western-style diet, with an aggregate estimate from the few available studies of 31 percent 
(Table 4-4). 
TABLE 4-4 Risk Factor: Western Style (Unhealthy Diet) 
Modifiable risk factor Definition Prevalence (source) 
Western Style Diet A diet emphasizing red and processed 
meats, refined grains, fats, and 
sweetened foods 
0.75 (conservative estimate)* 
  Relative risk,  
mean (range) 
Attributable fraction, 
 mean (range) 
  1.6 (1.2-1.9) 31% (13-40%) 
      
Lifestyle 
intervention 
References Initial SBP Change in SBP Anticipated 




DASH eating plan (Appel et al., 
1997) 
131 (11) -6 (-4 to -7) 8% (6 to 10%) 28% 
There are no meta-analyses of dietary pattern interventions and blood pressure lowering. 
Therefore, the attributable fraction of hypertension as a consequence of a Western-style diet was 
computed from the DASH randomized trial, in which the combination (DASH) diet lowered 
blood pressure by approximately 6 mm Hg (–4 to –7 mm Hg) (Appel et al., 1997). The reduction 
in blood pressure on the DASH diet was greater than in a parallel intervention that only increased 
fruit and vegetable consumption; however, the DASH diet also contained more fruits and 
vegetables, thus complicating the conclusions. The DASH-sodium trial is not included in this 
estimation because dietary pattern change was not the sole intervention (Sacks et al., 2001). 
Again, by assuming a prevalence of a Western-style diet in the United States of 0.75, a DASH 
diet intervention targeted to all adults who ate this type of diet could potentially reduce the 
prevalence of hypertension in the population by 6-10 percent. The estimated attributable fraction 
of hypertension prevalence due to a Western-style diet is consequently 28 percent. 
Subsequent to the initial DASH study, two important enhancements have been 
documented. The first is salt reduction, discussed later under “Multiple Dietary Interventions,” 
which led to an additional decrease in blood pressure. The second is partial replacement (10 
percent of energy) of the high amount of carbohydrate in the DASH diet with either unsaturated 
fat or protein, which was addressed in the OmniHeart study (Appel et al., 2005). Both 
substitutions significantly reduced systolic blood pressure (by 1.3 to 1.4 mm Hg overall and by 
about 3 mm among those with hypertension) and also improved blood lipids. The finding that 
replacement of carbohydrate by either unsaturated fat or protein reduces blood pressure suggests 
a role of carbohydrate reduction rather than increased intake of protein or unsaturated fat in 
control of hypertension. 
The initial DASH diet has an important benefit in reducing blood pressure, but the 
OmniHeart study showed that further reduction in blood pressure is possible if the high 
carbohydrate content of the DASH diet is reduced by partial replacement with either protein or 
unsaturated fat and that blood lipids are also improved. These findings are consistent with many 
controlled feeding studies that show improvements in blood lipids when carbohydrate is replaced 
with unsaturated fats (Mensink et al., 2003). Also, in the Nurses’ Health Study a dietary pattern 
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lower in carbohydrates and higher in unsaturated fats and vegetable sources of protein was 
associated with lower risk of coronary heart disease and type 2 diabetes (Halton et al., 2008; 
Halton et al., 2006). The high consumption of dairy products in the DASH diet is of concern 
because many studies have found this to be associated with fatal prostate cancer, particularly the 
aggressive form, and a recent review concluded that high consumption of dairy products 
probably increases the risk of prostate cancer (World Cancer Research Fund, 2007). Thus, an 
overall diet for good health would probably include lower amounts of carbohydrate and dairy 
products than the original DASH diet. 
REDUCE EXCESSIVE ALCOHOL INTAKE  
According to 2001-2007 government data, the prevalence of heavy drinking (defined as 
≥3 drinks per day in men and ≥2 drinks per day in women) among U.S. adults is 5 percent (CDC, 
2008a) (Table 4-5). At least nine prospective cohort studies have examined the independent 
association between alcohol consumption and the risk of hypertension (Ascherio et al., 1992; 
Friedman et al., 1988; Fuchs et al., 2001; Lorenzo et al., 2002; Ohmori et al., 2002; Sesso et al., 
2008; Stranges et al., 2004; Thadhani et al., 2002; Witteman et al., 1990). Although they varied 
in the way in which alcohol intake was classified and not all examined the association using 
currently recommended thresholds of ≥3 alcoholic beverages per day for men and ≥2 alcoholic 
beverages per day for women (on average), they provide useful information in determining the 
attributable risk of alcohol use for hypertension. The lowest relative risk was observed among 
white men in the Atherosclerosis Risk in Communities (ARIC) Study who consumed 3 or more 
alcoholic beverages per day (relative risk = 1.2 (0.85-1.67)) (Fuchs et al., 2001). The same study 
also reported the strongest association (relative risk = 2.3 (1.11-4.86) among black men who 
drank 3 or more alcoholic beverages per day. The other eight studies reported risk estimates that 
fell between 1.2 and 2.3. The average relative risk of hypertension for those drinking alcohol in 
excess from all nine cohorts was 1.7. Supportive evidence regarding the potential benefit of 
interventions to reduce alcohol use comes from a systematic review of 15 randomized controlled 
trials of alcohol reduction in heavy drinkers that demonstrated a significant pooled reduction in 
blood pressure (Xin et al., 2001). Given the consistency of observational and interventional 
evidence, a program to reduce alcohol consumption among adults drinking excessive amounts is 
a viable option to reduce the prevalence of hypertension. However, based upon a relative risk of 
1.7 and a prevalence of heavy alcohol use of 5 percent, the estimated fraction of hypertension 
attributable to excess alcohol use is low: 3 percent (range, 1-6 percent) (Forman, 2009).  
One meta-analysis pooled results from 14 randomized trials of alcohol reduction among 
heavy drinkers, with 13 of the 14 studies having a follow-up of at least one month (Xin et al., 
2001). The authors reported that alcohol restriction resulted in a pooled reduction of systolic 
blood pressure of 3 mm Hg (–2 to –4 mm Hg). Using these figures in conjunction with the 
prevalence of excess alcohol intake, an alcohol restriction program applied in all population 
members who drink alcohol to excess (i.e., ≥2 drinks per day in women and ≥3 drinks per day in 
men) may reduce the overall population prevalence of hypertension by 0.2-0.4 percent. The 
estimated attributable fraction of hypertension due to alcohol excess using this method (1 
percent) is consistent with the estimates derived from observational studies.  
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TABLE 4-5 Risk Factor: Heavy alcohol intake 
Modifiable risk factor Definition Prevalence (source) 
Heavy alcohol intake Mean of ≥ 3 (in men) or ≥ 2 (in 
women) alcoholic beverages per day 
0.05 (BRFSS 2007 survey) (CDC, 
2008b) 
  Relative risk,  
mean (range) 
Attributable fraction,  
mean (range) 
  1.7 (1.2-2.3) 3% (1-6%) 
      
Lifestyle 
intervention 
References Initial SBP Change in SBP Anticipated 






(Xin et al., 2001) 132 (18) -3 (-2 to -4) 0.3% (0.2 to 
0.4%) 
1% 
INCREASE PHYSICAL ACTIVITY  
Approximately 69 percent of the U.S. adult population in 2001 did not meet the CDC 
guidelines for leisure time physical activity of 5 days per week of moderate-intensity exercise or 
3 days per week of vigorous exercise (CDC, 2006). Several large, prospective, cohort studies 
have examined the association between physical activity and incident hypertension, although 
none have categorized physical activity according to current guidelines for moderate or vigorous 
physical activity (Graham et al., 2007; Hayashi et al., 1999; Hu et al., 2004; Parker et al., 2007; 
Pereira et al., 1999). Although most of these studies supported an inverse relation between 
physical activity and risk of hypertension, the ARIC study reported an inverse association only 
among white men. The lack of apparent benefit in other demographic groups may have been due 
to their lower levels of recreational activity (Pereira et al., 1999). However, the Coronary Artery 
Risk Development in Young Adults (CARDIA) study found that increased levels of physical 
activity reduced the risk of incident hypertension, and the association remained constant after 
adjusting for race, gender, and other variables (Parker et al., 2007). The most impressive 
association was present among Finnish men, in whom a lack of moderate or vigorous regular 
physical activity was associated with a 64 percent increase in the risk of developing hypertension 
(Hu et al., 2004). Other cohort studies reported more modest, although significant, inverse 
associations. The mean relative risk estimate from these cohort studies is 1.3. Using this estimate 
and a population prevalence of 69 percent for lack of regular exercise, it can be estimated that 17 
percent of new hypertension cases (range 0 to 29 percent) occurring in the United States can be 
attributed to lack of regular exercise (Table 4-6). 
TABLE 4-6 Risk Factors: Physical Inactivity 
Modifiable risk Factor Definition Prevalence (source) 
Physical Inactivity No sessions of light/moderate or 
vigorous physical activity lasting ≥ 10 
minutes 
0.69 (NHIS 2006 survey) (NCHS, 
2003) 
  Relative risk,  
mean (range) 
Attributable fraction,  
mean (range) 
  1.3 (1.0-1.6) 17% (0-29%) 
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Lifestyle 
intervention 
References Initial SBP Change in SBP Anticipated 











131 (17) -4 (-3 to -5) 
 
-2 (-1 to -4) 
6% (4 to 7%) 
 




Two large scale meta-analyses have analyzed randomized trials of exercise interventions 
and reduction in blood pressure (Kelley and Sharpe Kelley, 2001; Whelton et al., 2002). The 
more recent, by Whelton and colleagues, reported that exercise led to a 4 mm Hg (–3 to –5 mm 
Hg) reduction in systolic blood pressure. The older study by Kelley and Sharpe Kelley (2001) 
documented a more modest reduction by 2 mm Hg (–1 to -–4 mm Hg). (Kelley and Sharpe 
Kelley, 2001; Whelton et al., 2002)The meta-analysis published by Dickinson et al. (2006) 
examining multiple lifestyle interventions found a pooled effect for exercise similar to that found 
by Whelton et al. (2002). As with overweight and obesity, the anticipated change in hypertension 
prevalence and the attributable fraction can be estimated from these values using similar 
techniques. Implementation of an exercise program among members of the population who are 
physically inactive would hypothetically reduce the overall prevalence of hypertension by 4-6 
percent. Furthermore, the fraction of hypertension attributable to physical inactivity is estimated 
by this method to be 14-21 percent, consistent with estimates using observational data. 
MULTIPLE DIETARY INTERVENTIONS  
Several high-quality randomized trials have investigated the effects of multiple risk factor 
reduction on blood pressure. The DASH-sodium trial was a 2 x 2 factorial trial that randomized 
participants to either a Western-style diet or the DASH diet and to one of three levels of sodium 
intake (150 mmol, 100 mmol, and 50 mmol) (Sacks et al., 2001). The achieved sodium intakes 
were similar to these targeted intakes, and the highest- versus lowest-sodium groups were 
separated by 77 mmol per day. Comparing the Western-style, high-sodium diet with the DASH 
lowest-sodium diet, the reduction in systolic blood pressure was approximately 9 mm Hg (–4 to 
–14 mm Hg). If U.S. adults on a Western-style, high-salt diet were fed a DASH-style, low-salt 
diet, hypertension prevalence might be reduced by 14-22 percent (Table 4-7). The corresponding 
attributable fraction of hypertension due to a Western-style, high-salt diet is estimated to be 59 
percent. 
TABLE 4-7 Risk Factors: Multiple Interventions 
Modifiable risk Factor Definition Prevalence (source) 
Lifestyle 
intervention 
References Initial SBP Change in SBP Anticipated 




 (Sacks et al., 
2001) 




-9 (-4 to -14) 
-2 (0 to -4) 
17% (14 to 22%) 
6% (0 to 11%) 
59% 
21% 
The second trial of multiple risk factor reduction was the PREMIER trial, which 
randomized participants either to usual counseling; to a behavioral intervention targeted to 
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reduce sodium intake, reduce weight, and improve physical conditioning; or to a behavioral 
intervention that combined these interventions with the DASH diet (Elmer et al., 2006). The 
PREMIER trial, unlike DASH-sodium, was not a feeding trial, and as a consequence the 
separation between the groups was not as dramatic; this has been seen in most lifestyle 
intervention studies conducted in environments that are generally not supportive of healthy 
behaviors. For example, the sodium intake at 18 months of follow-up was 168 mmol per day 
(nearly 10 grams of salt) in the control group and 153 mmol (nearly 9 grams of salt) in the 
targeted multiple intervention groups (Elmer et al., 2006). Both of these sodium intake levels 
would be considered sodium excess. At 18 months, systolic blood pressure was reduced by 2 mm 
Hg (0 to – 4 mm Hg).  
The overall potential for reduction of hypertension by dietary factors, weight control, and 
regular physical activity has not been addressed directly. The attributable risks shown for 
individual factors in Table 4-8 cannot simply be added because this would not take into account 
their interactions, and for this reason the sum can be more than 100 percent. However, if the 59 
percent of risk attributable to the DASH diet with sodium reduction is taken as a base, to which 
reduction in carbohydrate, weight loss, and increased physical activity could be added, it can be 
appreciated qualitatively that a very large majority of hypertension is potentially preventable.  
TABLE 4-8 Modifiable Risk Factors and Attributable Fractions Based on Interventional Studies 









135 (18) –6 (–3 to –10) 
 








Reduce salt intake (He and 
MacGregor, 
2008) 
131 (19) –4 (–3 to –5) 6% (5-8%) 21% 
 
DASH eating plan 
(healthy eating) 
(Appel et al., 
1997) 














131 (17) –4 (–3 to –5) 
 
 










Reduce alcohol intake (Xin et al., 
2001) 
132 (18) –3 (–2 to –4) 0.3% (0.2-0.4%) 1% 
OTHER POTENTIAL INTERVENTIONS 
The committee considered other interventions that have been hypothesized to reduce 
blood pressure including increasing intakes of calcium, magnesium, folic acid, fiber, fish oil, and 
vitamin D and reducing stress and use of analgesics. For each, the evidence was considered to be 
inadequate to consider as a priority area of intervention. 
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COMMUNITY AND ENVIRONMENTAL INTERVENTIONS 
Public health policies that make it easier for Americans to engage in regular, physical 
activity (leisure-time and transportation) and reduce exposure to foods containing high levels of 
sodium while increasing exposure to foods containing appropriately high levels of potassium are 
likely to be the most effective means to lower the mean blood pressure of the U.S. population as 
a whole (Rose, 1992). Thus, approaches to shift the population distribution of blood pressure 
through the behavioral strategies described above will require addressing community and 
environmental factors that may limit the ability of individuals to make healthy behavioral 
choices in the communities where they live and work.  
A growing body of work has examined features of neighborhood built environments such 
as land use patterns, density, and access to destinations; street connectivity and transportation 
systems; features of urban design; and access to healthy foods and recreational resources in 
relation to the behaviors of diet and physical activity and related health outcomes of obesity, 
diabetes, and hypertension. Observational studies have generally concluded that greater 
population density, land use mix, proximity of nonresidential destinations, pedestrian 
infrastructure, aesthetics, and safety are linked to more walking (Saelens and Handy, 2008). 
There is also observational evidence that the presence of resources for physical activity in parks 
and recreational facilities relates to residents’ physical activity levels (Kaczynski and Henderson, 
2008). A growing body of work has linked access to healthy foods (as proxied by the presence of 
supermarkets or other measures of availability) to better diets (Franco et al., 2009; Larson et al., 
2009; Moore et al., 2008). Recent work has also shown that neighborhood physical activity and 
food environments are related to levels and changes over time in obesity, hypertension, and 
diabetes (Black and Macinko, 2008; Larson et al., 2009; Papas et al., 2007); (Mujahid et al., 
2008a); (Sturm and Datar, 2005, 2008).  
Although existing evidence remains limited due to its observational nature, there is 
growing consensus that efforts to improve population levels of physical activity, diet, and related 
conditions will have to encompass interventions that address the environments that promote and 
sustain healthy behaviors (IOM, 2009a). For example, it has been argued that public health 
efforts to improve physical activity should include design and land use policies that support 
physical activity, as well as creating and/or increasing access to places for physical activity 
(Heath et al., 2006; Kahn et al., 2002). Similarly, public health efforts to improve diet will need 
to address the limited access to healthy foods that has been documented in many communities 
(Franco et al., 2008; Moore and Diez Roux, 2006; Morland et al., 2002). Rigorous evaluation of 
efforts to improve physical activity and food environments will be necessary to guide future 
action.  
Public Education and Media and Social Marketing Campaigns 
Public education is an important component of many public health intervention activities. 
Public education campaigns use a variety of methods and tools—from the dissemination of 
printed educational materials to very sophisticated, targeted social marketing techniques. Public 
education campaigns generally strive to raise awareness and disseminate messages, while social 
marketing techniques focus on changing behaviors. This section discusses the impact of the 
National High Blood Pressure Education Program and the results of local efforts associated with 
the Pawtucket Heart Health Program, Minnesota Heart Health Program, and Stanford Five City 
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Project, which were funded by the National Heart, Lung, and Blood Institute between 1978 and 
1980 and included public education efforts to reduce risk factors associated with cardiovascular 
disease. The section also reviews the VERB™ campaign that targeted physical activity as an 
example of a successful public education campaign. 
National High Blood Pressure Education Program 
The National High Blood Pressure Education Program (NHBPEP) was initiated in 1972 
and is coordinated by the National Heart, Lung, and Blood Institute (NHLBI) of the National 
Institutes of Health. The program engages the efforts of federal agencies, professional and 
voluntary health organizations, state health departments, and community groups to “reduce death 
and disability related to high blood pressure through programs of professional, patient, and 
public education.” The NHBPEP utilizes strategic partnerships and the development and 
dissemination of educational materials and programs to work toward achieving the Healthy 
People 2010 heart disease and stroke objectives. The coordinating committee is engaged in 
examining critical issues, promoting national activities, and fostering collaboration between 
organizations, as well as identifying national priorities for the NHBPEP. The mass media efforts 
directed by the NHBPEP employ the use of fact sheets, brochures, planning kits, posters, print 
ads, and radio messages to promote professional, patient, and public education. The program also 
publishes the Report of the Joint National Committee on Detection, Evaluation, and Treatment of 
High Blood Pressure, which provides current guidelines and recommendations for clinicians and 
community organizations and is widely distributed to state health departments, primary care 
clinicians, and hypertension control programs. The most recent version of the report was 
published in 2003, and its update will be released in summer of 2010. The issues and scope 
identified on the NHBPEP website include the following: 
• Excessive stroke mortality in the southeastern United States  
• Effective treatment practices  
• Utility of lowering the systolic blood pressure in older Americans  
• Role of lifestyle changes in preventing and treating hypertension  
• Population-based strategies for primary prevention of high blood pressure  
• Issues regarding special populations and situations (e.g., African Americans, renal 
disease, women, children, adolescents)  
• Educational strategies directed at professional, patient, and public audiences and 
community organizations  
• Development and support of HEDIS (Healthcare Effectiveness Data and Information Set) 
hypertension measures  
The NHBPEP measures its progress against the National Health and Nutrition 
Examination Survey (NHANES) trends in hypertension awareness, treatment, and control, as 
well as the progress made toward the Healthy People 2010 goals. At the program’s outset, less 
than one-quarter of Americans were aware of the relationship between hypertension and stroke 
and hypertension and heart disease. Hypertension awareness has increased to three-quarters of 
the population, and three-quarters of Americans have their blood pressure measured every six 
months. In 1972, only 16 percent of hypertensive individuals had blood pressure at or below 
160/95 mm Hg (the goal at that time). Recent data show that 64 percent would meet the old goal 
of 160/95 mm Hg, and 29 percent would meet the current goal of 140/90 mm Hg (Jones and 
Hall, 2002). Hypertension has become a leading reason for physician visits among adults. There 
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has been a 59.6 percent decline in age-adjusted mortality for stroke in the total population since 
the program’s inception and a 55.6 percent decline in coronary heart disease.  
Pawtucket Heart Health Program 
The Pawtucket Heart Health Program (PHHP) was a community-based research and 
demonstration project that took place in Pawtucket, Rhode Island, between 1981 and 1993. The 
program utilized a mass media campaign as well as screening and counseling, grocery store shelf 
labeling, and educational programs offered in schools and libraries. It focused on modifying 
major risk factors for cardiovascular disease including high blood cholesterol levels, high blood 
pressure, smoking, sedentary lifestyle, and obesity. Random-sample, cross-sectional surveys 
were administered to residents of Pawtucket and residents of a comparison community who were 
between the ages of 18 and 64. The resulting analysis showed small, statistically insignificant 
reductions in blood cholesterol and blood pressure in the Pawtucket community. The projected 
cardiovascular disease rates were 16 percent lower in Pawtucket during the education program, 
but fell to 8 percent in the post-intervention period. A study by Carleton et al. (1995) concluded 
that “[a]ccelerating risk factor changes will likely require a sustained community effort with 
reinforcement from state, regional, and national policies and programs” (p.777).  
Minnesota Heart Health Program 
The Minnesota Heart Health Program took place between 1980 and 1989 and included 
approximately 400,000 persons in six communities (three intervention and three comparison 
communities). The program utilized mass and personalized media; adult, youth, and professional 
education; and community-based health promotion activities. The intervention communities 
experienced a modest but statistically insignificant decline in measures of systolic and diastolic 
blood pressure. Baseline and follow-up surveys demonstrated that “[m]any intervention 
components proved effective in targeted groups. However, against a background of strong 
secular trends of increasing health promotion and declining risk factors, the overall program 
effects were modest in size and duration and generally within chance levels” (Luepker et al., 
1994) The authors further concluded that “… even such an intense program may not be able to 
generate enough additional exposure to risk reduction messages and activities in a large enough 
fraction of the population to accelerate the remarkably favorable secular trends in health 
promotion activities and in most coronary heart disease risk factors present in the study 
communities” (p. 1383). 
Sanford Five City Program  
The Stanford Five City Program took place between 1979 and 1992. The program 
involved the use of multiple media, educational, and health promotion activities to reduce risk 
factors including blood pressure, blood cholesterol, salt intake, smoking, physical activity, and 
adherence to antihypertensive medication regimens. A decrease in cardiovascular morbidity and 
mortality was observed during the intervention period; however this occurred similarly in the 
control cities.  
In summary, of the four public education efforts, the findings of the NHBPEP were most 
remarkable for achieving both a significant increase in awareness and a reduction in blood 
pressure. The program, however, currently functions at a lower level of activity than in the past. 
It was recently described as “a virtual program,” with much of the educational materials and 
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other resources provided online.2 Results from the public education efforts in Pawtucket and 
Minnesota, although significant, were very modest and the Stanford Five City Program failed to 
detect significant differences between the intervention and control groups.  
The VERB Campaign 
The VERB campaign was an effort of the Centers for Disease Control and Prevention to 
increase and maintain physical activity among youth age 9 to 13 (“tweens”). The campaign was 
conducted between 2002 and 2006 and involved the use of social marketing strategies such as 
paid advertisements, school and community promotions, and Internet activities. The campaign 
included television commercials as well as national print and radio advertisements. 
Advertisements were targeted to multiple ethnic groups, including African- American, Asian, 
Hispanic or Latino, and Native American audiences. The goals of the campaign were the 
following: 
• Increase knowledge and improve attitudes and beliefs about tweens’ regular participation 
in physical activity.  
• Increase parental and influencer support and encouragement of tweens’ participation in 
physical activity.  
• Heighten awareness of options and opportunities for tween participation in physical 
activity.  
• Facilitate opportunities for tweens to participate in regular physical activity.  
• Increase and maintain the number of tweens who regularly participate in physical 
activity.  
A 2005 study by Huhman et al. utilized a prospective, longitudinal, quasi-experimental 
design to determine the effects of the VERB campaign on physical activity among the target 
audience. Participants included 3,120 parent-child pairs. Baseline and follow-up surveys using 
random-digit dialing were used to measure the campaign’s influence on awareness and physical 
activity. The authors found that after one year, 74 percent of children surveyed were aware of the 
VERB campaign—a 24 percent increase over the campaign’s goal for the first year. Median free-
time physical activity increased for several subgroups, including 9- to 10-year-old children, girls, 
children whose parents had less than a high school education, children in urban areas, and 
children engaging in low levels of physical activity at baseline. Among 9-10-year-olds, physical 
activity increased by 34 percent compared to youth who were unaware of the program. The 
authors concluded that “promoting physical activity with child-focused commercial advertising 
shows promise” (Huhman et al, 2005, p. 277). 
A recent report by the Institute of Medicine (IOM, 2009a), identified promising actions 
that local governments can take to prevent childhood obesity, and specified media and social 
marketing as a recommended action. Developing media campaigns and utilizing multiple 
channels to promote healthy eating and physical activity using consistent messages were 
recommended. The rationale supporting the goal and action step was based on the positive 
outcomes of the VERB campaign (Berkowitz et al., 2008) and research that shows that high-
frequency television and radio advertising, as well as signage, may stimulate improvements in 
attitudes toward a healthy diet (Beaudoin et al., 2007).  
                                                 
2 Personal comment by Dr. Ed Roccella in a presentation to the committee, June 2009. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
88 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
RELATIVE COSTS OF POPULATION-BASED INTERVENTIONS 
The comparative cost-effectiveness of population-based interventions compared to 
individual-level approaches to reduce blood pressure and cardiovascular disease risk has been the 
focus of researchers at the international level. Murray and colleagues conducted a review of the 
effectiveness and costs of a number of strategies to reduce blood pressure and cholesterol with 
the ultimate goal of reducing cardiovascular disease risk (Murray et al., 2003). They compared 
the effectiveness of four community-based interventions targeted at changing diets (salt 
reduction through voluntary agreements with industry, population-wide reduction in salt intake 
through legislation, health education through mass media, and a combination of salt intake 
legislation and mass media education) to individual-based interventions based on the 
pharmacological management of hypertension and cholesterol (individual-based hypertension 
treatment and education, individual treatment and education for high cholesterol concentrations, 
individual treatment and health education for systolic blood pressure and cholesterol 
concentration, and absolute risk approach).3  
The researchers found that population-wide interventions were more cost-effective than 
individual-based approaches. There was a 30 percent reduction in the salt content of food 
through legislative action and a 15 percent reduction in the salt content of food through voluntary 
agreements. The mass media campaign to reduce cholesterol through better diets and increase 
physical activity came in third. Based on the analysis, the researchers suggest that population-
based interventions could avert more than 21 million disability-adjusted life-years (DALYs). 
These interventions, although more cost-effective, have a smaller absolute effect on population 
health than individual-based strategies. Individual-based strategies, on the other hand, were 
shown to have a greater potential to reduce cardiovascular disease burden and improve 
population health, albeit at a higher cost. Pharmacological treatment based on the absolute-risk 
approach at a threshold of 35 percent risk would avert 65 million DALYs. This intervention was 
not as cost-effective as the population-based interventions. The authors suggest that a 
combination of population-based and individual-based strategies could lower the incidence of 
cardiovascular events by as much as 50 percent. 
Palar and Sturm (2009) recently reported on the potential societal savings from polices 
that reduce sodium consumption in the United States. The researchers used NHANES 1999-2004 
data (blood pressure, antihypertension medication use, and salt intake) to model a number of 
sodium-reduction scenarios to determine the change in health care costs and quality of life that 
could be expected from a reduction in population-level sodium consumption. The scenarios 
simulated reductions in sodium intake from 3,400mg per day to one of the following levels: 
2,300 mg, 1,700mg, 1,500 mg, and 1,200 mg per day. The model used dose-response estimates 
for sodium and hypertension reported in the literature to calculate changes in hypertension 
prevalence that would result from the associated decrease in salt intake (100-mmol reduction in 
sodium intake results in a 7.2 mm Hg reduction in systolic blood pressure and a 3.8 mm Hg 
reduction in diastolic blood pressure). The model input for annual hypertension costs per case 
was $1,598 (based on 2005 data) and is based on analyses of Medical Expenditure panel Survey 
data for 2000-2003 (Trogdon et al., 2007). 
                                                 
3 The absolute risk approach consisted of providing individuals with an estimated combined risk of a cardiovascular 
event (35 percent, 25 percent, 15 percent, 5 percent) over the next decade above a given specific threshold of risk 
with a statin, diuretic, beta-blocker, and aspirin) based on their risk level 
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The researchers found that lowering dietary sodium is likely to have sizable financial and 
health benefits. Reducing salt intake from 3,400 mg to 2,300 mg per day, for example, could 
reduce the number of individuals with hypertension by an estimated 11.1 million. A substantial 
reduction of salt intake down to 1,200 mg was estimated to reduce hypertension cases by 17.7 
million. The annual, direct health care costs saved related to a reduction in population sodium 
consumption was equally significant. The reduction from 3,400 mg to 2,300 mg of sodium per 
day was estimated to result in $17.8 billion (in 2005) in annual, direct health care cost savings 
and a reduction of sodium to 1,200 mg per day was associated with an estimated $28.3 in annual, 
direct health care cost savings. With respect to quality-of–life savings, the reduction to 2,300 mg 
of sodium per day was associated with 312,021 QALYs saved annually and the 1,200 mg per day 
was associated with 496,897 QALYs saved. Finally, the value of the QALYs saved with a 
reduction to 2,300 mg and 1,200 mg of sodium per day was $31.6 billion and $50.3 billion, 
respectively.  
POPULATION-BASED INTERVENTIONS AND HEALTH DISPARITIES 
Not only are highly educated and affluent subgroups better positioned than the poor to 
benefit from innovations in medical care, they are also better positioned to respond quickly to 
public health messages and policies designed to either prevent or postpone lifestyle-related 
diseases such as hypertension. Hence, population-based interventions aimed at increasing 
physical activity and promoting healthy eating that fail to give due attention to differential 
response capabilities by race, ethnicity, socioeconomic position, and geographical location may 
inadvertently contribute to an increase in health disparities even as overall population health 
improves (Link and Phelan, 1995; Mechanic, 2007; Phelan and Link, 2005). Even if such 
increases in health disparities are time limited (i.e., returning to the baseline difference once 
disadvantaged populations make appropriate lifestyle adjustments, this nevertheless constitutes 
an unsatisfactory outcome if the objective is to reduce the overall population burden of 
hypertension while also reducing related health disparities.  
Achieving these dual objectives will not be easy. A large and growing body of research 
(Acevedo-Garcia et al., 2008; Cutler et al., 1999, 2008; Massey and Denton, 1993; Williams and 
Collins, 2001b) documents that U.S. racial and ethnic minorities, especially African Americans 
and Hispanics, are overrepresented in urban areas that lack community-level resources to support 
healthy living. African Americans are simultaneously the most highly segregated racial group in 
the country (Acevedo-Garcia et al., 2008; Massey and Denton, 1993; Williams and Collins, 
2001) and the group at highest risk for hypertension and its serious clinical sequelae. As 
discussed by Williams and Collins (2001), a high level of racial residential segregation can 
contribute to health disparities (hypertension and otherwise) through multiple pathways. These 
pathways include restricted opportunities for stable, meaningful employment that provides 
adequate family income and healthcare benefits; restricted access to high-quality, primary health 
care; restricted access to supermarkets containing fresh produce and foods low in sodium; 
restricted access to safe, well- maintained parks where residents can easily engage in regular, 
leisure-time physical activity; and finally, heightened exposure to air pollution, noise, and 
violence, which generate high levels of psychological stress.  
More than 30 years ago, Harburg and colleagues (1973) were the first to demonstrate that 
mean blood pressures among African Americans in the city of Detroit varied with their place of 
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residence. Specifically, blacks (especially black males under age 40) who lived in census tracts 
characterized by high unemployment, low median household income and educational attainment, 
high rates of crime, and high rates of marital breakup had significantly higher age- and BMI-
adjusted hypertension prevalence than blacks living in more socioeconomically stable census 
tracts (Harburg E., 1973). Interestingly, the mean blood pressure of whites did not vary by 
residence in high versus low “socio-ecological stress” areas, suggesting either a differential 
impact of socioenvironmental stressors on the blood pressure of blacks or substantive 
inequalities in the cut-points used to define “high”- and “low”-stress neighborhoods for blacks 
versus whites in a place that was fast becoming the country’s most racially segregated 
metropolitan area (Cutler et al., 1999).  
The scientific literature documenting the relative lack of community-level resources to 
support healthy living in geographical areas characterized by low neighborhood wealth or high 
levels of racial residential segregation continues to grow. Morland and colleagues, for example, 
reported that the prevalence of supermarkets in the Atherosclerosis Risk in Communities Study 
increased linearly with increasing median home values and decreased linearly as the percentage 
of African-American residents increased (Morland et al., 2002). Franco and colleagues rated 226 
food stores in Baltimore City and County on a healthy food availability index (HFAI) and found 
that HFAI scores were positively correlated with median household income of census tracts and 
inversely correlated with the percentage of African-American residents (Franco et al., 2008). 
Using data from the Multi-Ethnic Study of Atherosclerosis (MESA), Mujahid et al. (2008a) 
found that residents in neighborhoods characterized by greater (self-reported) walkability, 
availability of healthy foods, aesthetic quality, safety, and social cohesion had lower BMIs 
(especially among women) than residents in neighborhoods with lower scores on these 
dimensions. Using this same indicator of neighborhood quality, Mujahid et al. (2008b) observed 
an inverse association between neighborhood quality and hypertension prevalence in the MESA 
sample; however, the association was significantly attenuated when race or ethnicity was 
controlled, suggesting that neighborhood social cohesion, safety, walkability, food availability, 
and so forth, may play an important role in racial or ethnic differences in risk of hypertension in 
urban settings (Mujahid et al., 2008a). 
Compared to African Americans, disparities in hypertension and selected cardiovascular 
disease (CVD) risk factors by place of residence are less well studied in other racial or ethnic 
minorities. Again, using data from MESA, Osypuk et al. (2009) found that living in census tracts 
with higher proportions of foreign-born persons from China was associated with lower 
consumption of high-fat foods. Although living in census tracts with higher proportions of recent 
immigrants from Latin America was also associated with lower consumption of high-fat foods, 
residents of these census tracts reported significantly lower levels of physical activity. Osypuk 
and colleagues also found that residents of neighborhoods with higher proportions of foreign-
born persons reported greater healthy food availability, but their neighborhoods were also 
reported to be less walkable, to have fewer exercise resources, and to have lower social cohesion. 
The researchers concluded that living in a contemporary immigrant enclave in the United States 
is not uniformly beneficial since these enclaves have varying patterns of healthy and unhealthy 
behaviors that can contribute to CVD risk (Osypuk et al., 2009).  
Finally, in the Chicago Community Adult Health Study, Morenoff et al. (2007) found that 
mean blood pressure was inversely associated with neighborhood affluence (i.e., a concentration 
of well-educated residents with high-paying, managerial jobs). Although the prevalence of 
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hypertension among blacks and whites was statistically significant even after controlling for 
individual-level income and education, adjusting for neighborhood affluence score completely 
eliminated this difference between the races. Interestingly, awareness of being hypertensive was 
greater in more disadvantaged neighborhoods and in areas containing large percentages of 
African Americans. Conversely, awareness levels were lower in neighborhoods containing large 
percentages of Hispanics and immigrants. After controlling for awareness, no differences in 
treated hypertension by race or ethnicity were observed; however, among persons taking 
antihypertensive medication, blacks were only 40-50 percent as likely as whites to be controlled. 
Neighborhood affluence did not modify hypertension control levels.  
The above research findings of how mean blood pressures and hypertension prevalence 
vary within U.S. communities by race, ethnicity, and neighborhood affluence underscore the 
need to be attentive to the differential capacity of population subgroups to respond quickly and 
appropriately to population-based interventions aimed at reducing the overall burden of 
hypertension in this country. Healthy food has become increasingly scarce in many of our 
nation’s older inner cities (Franco et al., 2008; IOM, 2009b; Morland et al., 2002; Zenk et al., 
2005), where large numbers of new immigrants and historically disadvantaged native-born 
Americans (e.g., black Americans) live. Whereas the passage of national or state-level policies 
designed to reduce the exposure of Americans to foods high in sodium and increase their 
exposure to foods high in potassium will benefit all Americans to some extent, extra steps would 
seem to be necessary to ensure that residents in isolated, low-wealth communities benefit just as 
much as their wealthier counterparts. One example of a step in this direction is the CDC’s 
partnership with the National Urban League’s Health and Wellness Initiative (National Urban 
League, 2009) to increase access by African Americans and other inner-city populations to 
community-level resources (e.g., supermarkets, community gardens, safe places for physical 
activity, affordable primary health care) that would increase the capacity of these populations to 
fully benefit from a national hypertension reduction initiative. Similar opportunities are 
potentially available through other partnerships such as the Mexican American Grocers 
Association (BUSCA pique Network) to ensure that healthy, affordable foods remain available 
to the country’s Hispanic population, especially in new settlement areas such as the U.S. South.  
CONCLUSIONS 
Based on the review of the literature there is strong evidence linking overweight and 
obesity, high salt intake, low potassium intake, unhealthy diet, and decreased physical activity to 
hypertension. These risk factors contribute substantially to the burden of hypertension in the US, 
further; the prevalence of many of these risk factors is increasing. The observational and 
randomized clinical trial literature on interventions to reduce overweight and obesity, decrease 
salt intake, support eating a healthy diet, increase potassium intake and increase physical activity 
also indicate that these risk factors are modifiable (Table 4.8) and that they can help reduce 
blood pressure levels. The committee concludes in light of : 1) the high prevalence of these risk 
factors that contribute significantly to the development of high blood pressure, 2) existing 
interventions to reduce these risk factors, and 3) the potential to reduce the burden of 
hypertension if the interventions are implemented, that actions to reduce these risk factors merit 
a high priority. Reducing heavy alcohol consumption was also considered; based on the low 
attributable fraction and the extremely low anticipated change in hypertension prevalence if 
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heavy drinkers were to reduce their intake; it was not considered a priority for intervention to 
reduce hypertension.  
DHDSP programs as described in Chapter 3 have focused primarily on secondary 
prevention activities and to a limited degree on the population-based approaches to hypertension. 
While secondary prevention is critical since it helps identify, treat, and rehabilitate people with 
established hypertension, stroke, and other cardiovascular disease, these activities should not 
preclude greater attention to conducting activities that prevent the onset of hypertension (primary 
prevention).  
A stronger focus on primary prevention of hypertension is consistent with DHDSP’s 
responsibility as co-lead of Healthy People 2010 in achieving progress in reducing the proportion 
of adults with high blood pressure, and in increasing the proportion of persons aged 2 years and 
older who consume 2,400 mg or less of sodium daily. Broad primary prevention of hypertension 
is also consistent with DHDSP’s role as co-lead of the Public Health Action Plan to Prevent 
Heart Disease, and its recommendation for primary prevention activities related to children and 
youth:  
Design, plan, implement, and evaluate a comprehensive intervention for children 
and youth in school, family, and community settings. This intervention must 
address dietary imbalances, physical inactivity, tobacco use, and other 
determinants in order to prevent development of risk factors and progression of 
atherosclerosis and high blood pressure. 
The committee acknowledges that within the CDC, the DHDSP is not the focal point for 
addressing dietary imbalances, physical inactivity, and other determinants in order to prevent the 
development of risk factors and progression of high blood pressure. It also acknowledges that the 
focus of DHDSP activities is primarily adults, not children. The committee is aware that the 
DHDSP, through the Cardiovascular Health Collaboration of the National Center for Chronic 
Disease Prevention and Health Promotion, collaborates with units across CDC. The committee 
believes, however, that this collaboration can be strengthened and extended to leverage the 
efforts and resources of those programs to ensure proper attention to the prevention of 
hypertension and the reduction of risk factors for hypertension.  
4.1 The committee recommends that the Division of Heart Disease and Stroke 
Prevention integrate hypertension prevention and control in programmatic efforts 
to effect system, environmental, and policy changes through collaboration with 
other CDC units and their external partners, to ensure that population-based 
lifestyle or behavior change interventions where delivered, are delivered in a 
coordinated manner that includes a focus on the prevention of hypertension. High 
priority programmatic activities to collaborate on include interventions for:  
• reducing overweight and obesity 
• promoting the consumption of a healthy diet that includes a higher intake 
of fruits, vegetables, whole gains, and unsaturated fats and reduced 
amounts of overall calories, sugar, sugary beverages, refined starches, and 
saturated and trans fats (for example a diet that is consistent with the 
OmniHeart diet)  
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• increasing potassium rich fruits and vegetables in the diet 
• increasing physical activity 
4.2 The committee recommends that population-based interventions to improve 
physical activity and food environments (typically the focus of other CDC units) 
should include an evaluation of their feasibility and effectiveness and their specific 
impact on hypertension prevalence and control.  
The committee notes that, consistent with the DHDSP’s focus on secondary prevention 
activities, its state program grantees have also focused heavily on secondary prevention.  
4.3 To create a better balance between primary and secondary prevention of 
hypertension the committee recommends that the Division of Heart Disease and 
Stroke Prevention leverage its ability to shape state activities, through its grant 
making and cooperative agreements, to encourage state activities to shift toward 
population-based prevention of hypertension.  
The committee finds the evidence base to support policies to reduce dietary sodium as a 
means to shift the population distribution of blood pressure levels in the population convincing. 
The newly reported analysis of the substantial health benefits (reduced number of individuals 
with hypertension) and the equally substantial health care cost savings and QALYs saved by 
reducing sodium intake to the recommended 2300mg per day and lower, provide resounding 
support to place a high priority on policies to reduce sodium intake (Palar and Sturm, 2009).  
The committee is aware of the Congressional directive to CDC to engage in activities to 
reduce sodium intake and the DHDSP’s role in these activities. The DHDSP’s sponsorship of an 
IOM study to identify a range of interventions to reduce dietary sodium intake is an important 
first step. The committee believes that the DHDSP is well positioned at CDC to take greater 
leadership in this area through it role as co-leader of Healthy People 2010, Co-Leader of the 
National Forum for Heart Disease and Stroke Prevention and as the sponsor of grants to state 
health departments and other entities.  
4.4 The committee recommends that The Division of Heart Disease and Stroke 
Prevention take active leadership in convening other partners in the federal, state, 
local government, and industry to advocate for and implement strategies to reduce 
sodium in the American diet to meet dietary guidelines, which are currently less 
than 2.3 grams (100mmol)/day and 1.5 grams (100mmol)/day for blacks, middle-
aged and older adults, and individuals with hypertension.  
The committee recognizes other work in progress by the IOM Committee on Strategies to 
Reduce Sodium Intake therefore it did not develop recommendations for specific strategies to 
reduce sodium in the American diet.  
4.5 The committee recommends that the Division of Heart Disease and Stroke 
Prevention specifically consider as a strategy, advocating for the greater use of 
potassium/sodium chloride combinations as a means of simultaneously reducing 
sodium intake and increasing potassium intake. 
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As noted in Chapter 2, accurate information on sodium intake or the content of sodium in 
specific foods that contribute importantly to sodium intake is necessary for monitoring progress 
in its reduction. These data are not currently available in a systematic or timely fashion. The lack 
of data presents a significant gap that will hamper efforts to evaluate the progress made in 
reducing sodium intake in the American population.  
4.6 The committee recommends that the Division of Heart Disease and Stroke 
Prevention and other CDC units, explore methods to develop and implement data-
gathering strategies that will allow for more accurate assessment and tracking of 
specific foods that are important contributors to dietary sodium intake by the 
American people.  
4.7 The committee recommends that the Division of Heart Disease and Stroke 
Prevention and other CDC units, explore methods to develop and implement data 
gathering strategies that will allow for a more accurate assessment and the 
tracking of population-level dietary sodium and potassium intake including the 
monitoring of 24-hour urinary sodium and potassium excretion. 
Possible concerns about the impact on survey participation in national surveys such as the 
NHANES could be addressed by sampling an additional small number of subjects who would be 
asked only for a 24-hour urine sample and basic demographic data.  
The committee is concerned with the differential burden of hypertension among 
subgroups of the U.S. population as described in Chapter 2. It is equally concerned that some 
population-based interventions aimed at preventing or postponing the development of 
hypertension may increase health disparities even as overall population health improves. This is 
because some groups have a differential response capability to respond to population-based 
interventions related to their race, ethnicity, socioeconomic position, and geographical location. 
To assure that all Americans will benefit from population-based interventions; steps may have to 
be taken to target that these populations are specifically. Although the committee is not 
proposing a specific recommendation in this area, it strongly encourages the Division of Heart 
Disease and Stroke Prevention to build community partnerships that will help bring interventions 
to the populations who might need them the most, especially those in racial or ethnic and low-
wealth communities. 
The committee considered public education and social marketing campaigns as a 
potential priority strategy. The committee acknowledges the extraordinary progress that has been 
made to educate the public about hypertension. In the early days of the National High Blood 
Pressure Education Program, less than 25 percent of Americans were aware of the relationship 
between hypertension, stroke and heart disease. Since that time extraordinary gains have been 
made in the population’s awareness of hypertension; close to 75 percent of Americans are aware 
and 75 percent of Americans have their blood pressure measured every six months. Results to 
educate communities at the local level, however, have had mixed results, some changes in blood 
pressure were modest but statistically insignificant or did not endure over time. Sophisticated 
social marketing campaigns, such as the VERB Campaign, are significantly more refined with 
social change theory underpinnings, targeting of audiences, and expectations for behavioral 
change than the earlier national and local education campaigns. Given the mixed outcomes 
associated with public education campaigns, the committee does not consider these efforts to be 
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a priority for the DHDSP. Well executed social marketing campaigns may have more promise, 
however, the committee believes that such campaigns should not be focused solely on 
hypertension but rather, they should be integrated in general social marketing campaigns to 
promote healthy living through healthy eating and increased physical activity as suggested in the 
IOM’s 2009 report, Local Government Actions to Prevention Childhood Obesity. The DHDSP’s 
role, as suggested in recommendation 4.1, would be to collaborate with other CDC units and 
external partners, to ensure that social marketing campaign designed to promote healthy living 
also include a focus on the prevention of hypertension. 
REFERENCES 
Acevedo-Garcia, D., T. L. Osypuk, N. McArdle, and D. R. Williams. 2008. Toward a policy-
relevant analysis of geographic and racial/ethnic disparities in child health. Health Affairs 
27(2):321-333. 
AHA. 2009. Make healthy food choices. 
http://www.americanheart.org/presenter.jhtml?identifier=537 (accessed November 5, 2009). 
Anderssen, S., I. Holme, P. Urdal, and I. Hjermann. 1995. Diet and exercise intervention have 
favourable effects on blood pressure in mild hypertensives: The Oslo Diet and Exercise 
Study (ODES). Blood Pressure 4(6):343-349. 
Appel, L. J., M. W. Brands, S. R. Daniels, N. Karanja, P. J. Elmer, and F. M. Sacks. 2006. 
Dietary approaches to prevent and treat hypertension: A scientific statement from the 
American Heart Association. Hypertension 47(2):296-308. 
Appel, L. J., T. J. Moore, E. Obarzanek, W. M. Vollmer, L. P. Svetkey, F. M. Sacks, G. A. Bray, 
T. M. Vogt, J. A. Cutler, M. M. Windhauser, P. H. Lin, and N. Karanja. 1997. A clinical trial 
of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. 
New England Journal of Medicine 336(16):1117-1124. 
Appel, L. J., F. M. Sacks, V. J. Carey, E. Obarzanek, J. F. Swain, E. R. Miller, 3rd, P. R. Conlin, 
T. P. Erlinger, B. A. Rosner, N. M. Laranjo, J. Charleston, P. McCarron, and L. M. Bishop. 
2005. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and 
serum lipids: Results of the OmniHeart randomized trial. JAMA: Journal of the American 
Medical Association 294(19):2455-2464. 
Ard, J. D., C. J. Coffman, P. H. Lin, and L. P. Svetkey. 2004. One-year follow-up study of blood 
pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium 
participants. American Journal of Hypertension 17(12 Pt 1):1156-1162. 
Armstrong, B., A. J. van Merwyk, and H. Coates. 1977. Blood pressure in Seventh-day 
Adventist vegetarians. American Journal of Epidemiology 105(5):444-449. 
Ascherio, A., C. Hennekens, W. C. Willett, F. Sacks, B. Rosner, J. Manson, J. Witteman, and M. 
J. Stampfer. 1996. Prospective study of nutritional factors, blood pressure, and hypertension 
among US women. Hypertension 27(5):1065-1072. 
Ascherio, A., E. B. Rimm, E. L. Giovannucci, G. A. Colditz, B. Rosner, W. C. Willett, F. Sacks, 
and M. J. Stampfer. 1992. A prospective study of nutritional factors and hypertension among 
US men. Circulation 86(5):1475-1484. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
96 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
Beaudoin, C. E., C. Fernandez, J. L. Wall, and T. A. Farley. 2007. Promoting healthy eating and 
physical activity short-term effects of a mass media campaign. American Journal of 
Preventive Medicine 32(3):217-223. 
Berkowitz, J. M., M. Huhman, and M. J. Nolin. 2008. Did augmenting the VERB campaign 
advertising in select communities have an effect on awareness, attitudes, and physical 
activity? American Journal of Preventive Medicine 34(6 Suppl):S257-266. 
Black, J. L., and J. Macinko. 2008. Neighborhoods and obesity. Nutrition Reviews 66(1):2-20. 
BUSCA pique Network. Mexican - American grocers association (MAGA) 
http://www.buscapique.com/latinusa/buscafile/oeste/maga.htm (accessed November 5, 
2009). 
Cappuccio, F. P., and G. A. MacGregor. 1991. Does potassium supplementation lower blood 
pressure? A meta-analysis of published trials. Journal of Hypertension 9(5):465-473. 
Carleton, R. A., T. M. Lasater, A. R. Assaf, H. A. Feldman, and S. McKinlay. 1995. The 
Pawtucket Heart Health Program: Community changes in cardiovascular risk factors and 
projected disease risk. American Journal of Public Health 85(6):777-785. 
CDC. 2008a. Alcohol and public health. http://www.cdc.gov/alcohol/ (accessed November 5, 
2009). 
———. 2008b. Prevalence of binge drinking and heavy drinking among adults in the United 
States, 1993-2007. 
http://www.cdc.gov/print.do?url=http://www.cdc.gov/alcohol/datatable.htm (accessed 
February 12, 2010). 
Chien, K. L., H. C. Hsu, P. C. Chen, T. C. Su, W. T. Chang, M. F. Chen, and Y. T. Lee. 2008. 
Urinary sodium and potassium excretion and risk of hypertension in Chinese: Report from a 
community-based cohort study in Taiwan. Journal of Hypertension 26(9):1750-1756. 
Cohn, J. N., P. R. Kowey, P. K. Whelton, and L. M. Prisant. 2000. New guidelines for potassium 
replacement in clinical practice: A contemporary review by the National Council on 
Potassium in Clinical Practice. Archives of Internal Medicine 160(16):2429-2436. 
Coresh, J., D. Byrd-Holt, B. C. Astor, J. P. Briggs, P. W. Eggers, D. A. Lacher, and T. H. 
Hostetter. 2005. Chronic kidney disease awareness, prevalence, and trends among U.S. 
Adults, 1999 to 2000. Journal of the American Society of Nephrology 16(1):180-188. 
Croft, P. R., D. Brigg, S. Smith, C. B. Harrison, A. Branthwaite, and M. F. Collins. 1986. How 
useful is weight reduction in the management of hypertension? Journal of the Royal College 
of General Practitioners 36(291):445-448. 
Cruz-Coke, R., R. Etcheverry, and R. Nagel. 1964. Influence of migration on blood-pressure of 
Easter Islanders. Lancet 1(7335):697-699. 
Cutler, D. M., E. L. Glaeser, and J. L. Vigdor. 1999. The rise and decline of the American ghetto. 
Journal of Political Economy 107(3):455-506. 
Dickinson, H. O., J. M. Mason, D. J. Nicolson, F. Campbell, F. R. Beyer, J. V. Cook, B. 
Williams, and G. A. Ford. 2006. Lifestyle interventions to reduce raised blood pressure: A 
systematic review of randomized controlled trials. Journal of Hypertension 24(2):215-233. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
GENERAL POPULATION INTERVENTIONS 97 
PREPUBLICATION COPY: UNCORRECTED PROOF 
Dyer, A. R., P. Elliott, and M. Shipley. 1994. Urinary electrolyte excretion in 24 hours and blood 
pressure in the INTERSALT Study II. Estimates of electrolyte-blood pressure associations 
corrected for regression dilution bias. The intersalt cooperative research group. American 
Journal of Epidemiology 139(9):940-951. 
Ebrahim, S. 1998. Detection, adherence and control of hypertension for the prevention of stroke: 
A systematic review. Health Technology Assessment 2(11):i-iv, 1-78. 
Ebrahim, S., and G. D. Smith. 1998. Lowering blood pressure: A systematic review of sustained 
effects of non-pharmacological interventions. Journal of Public Health Medicine 20(4):441-
448. 
Elmer, P. J., E. Obarzanek, W. M. Vollmer, D. Simons-Morton, V. J. Stevens, D. R. Young, P. 
H. Lin, C. Champagne, D. W. Harsha, L. P. Svetkey, J. Ard, P. J. Brantley, M. A. Proschan, 
T. P. Erlinger, and L. J. Appel. 2006. Effects of comprehensive lifestyle modification on diet, 
weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. 
Annals of Internal Medicine144(7):485-495. 
Forman, J. P. 2009. (unpublished). Data produced for the Institute of Medicine. 
Forman, J. P., M. J. Stampfer, and G. C. Curhan. 2009. Diet and lifestyle risk factors associated 
with incident hypertension in women. JAMA: Journal of the American Medical Association 
302(4):401-411. 
Franco, M., A. V. Diez-Roux, J. A. Nettleton, M. Lazo, F. Brancati, B. Caballero, T. Glass, and 
L. V. Moore. 2009. Availability of healthy foods and dietary patterns: The Multi-Ethnic 
Study of Atherosclerosis. American Journal of Clinical Nutrition 89(3):897-904. 
Franco, M., A. V. Diez Roux, T. A. Glass, B. Caballero, and F. L. Brancati. 2008. Neighborhood 
characteristics and availability of healthy foods in Baltimore. American Journal of Preventive 
Medicine 35(6):561-567. 
Friedman, G. D., J. V. Selby, C. P. Quesenberry, Jr., M. A. Armstrong, and A. L. Klatsky. 1988. 
Precursors of essential hypertension: Body weight, alcohol and salt use, and parental history 
of hypertension. Preventive Medicine 17(4):387-402. 
Fuchs, F. D., L. E. Chambless, P. K. Whelton, F. J. Nieto, and G. Heiss. 2001. Alcohol 
consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities 
Study. Hypertension 37(5):1242-1250. 
Gelber, R. P., J. M. Gaziano, J. E. Manson, J. E. Buring, and H. D. Sesso. 2007. A prospective 
study of body mass index and the risk of developing hypertension in men. American Journal 
of Hypertension 20(4):370-377. 
Geleijnse, J. M., F. J. Kok, and D. E. Grobbee. 2003. Blood pressure response to changes in 
sodium and potassium intake: A metaregression analysis of randomised trials. Journal of 
Human Hypertension 17(7):471-480. 
Goldstein, M. 1990. The hypertension prevention trial. Archives of Internal Medicine 
150(11):2408-2409. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
98 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
Graham, I., D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. 
De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. 
Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. S. 
Op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano, E. Walma, T. Fitzgerald, M. 
T. Cooney, A. Dudina, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, C. 
Funck-Brentano, G. Filippatos, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. 
Silber, M. Tendera, P. Widimsky, A. Altiner, E. Bonora, P. N. Durrington, R. Fagard, S. 
Giampaoli, H. Hemingway, J. Hakansson, S. E. Kjeldsen, L. Larsen, G. Mancia, A. J. 
Manolis, K. Orth-Gomer, T. Pedersen, M. Rayner, L. Ryden, M. Sammut, N. Schneiderman, 
A. F. Stalenhoef, L. Tokgozoglu, O. Wiklund, and A. Zampelas. 2007.European guidelines 
on cardiovascular disease prevention in clinical practice: Full text. Fourth Joint Task Force of 
the European Society of Cardiology and other societies on cardiovascular disease prevention 
in clinical practice (constituted by representatives of nine societies and by invited experts). 
European Journal of Cardiovascular & Rehabilitation 14 Suppl 2:S1-113.  
Halton, T. L., S. Liu, J. E. Manson, and F. B. Hu. 2008. Low-carbohydrate-diet score and risk of 
type 2 diabetes in women. American Journal of Clinical Nutrition 87(2):339-346. 
Halton, T. L., W. C. Willett, S. Liu, J. E. Manson, C. M. Albert, K. Rexrode, and F. B. Hu. 2006. 
Low-carbohydrate-diet score and the risk of coronary heart disease in women. New England 
Journal of Medicine 355(19):1991-2002. 
Harburg E., E. J. C., Chape C., Hauenstein L.S., Schull W.J., Schork M.A. 1973. Socioecological 
stressor areas and black-white blood pressure: Detroit. Journal of Chronic Diseases 26:595-
611. 
Hayashi, T., K. Tsumura, C. Suematsu, K. Okada, S. Fujii, and G. Endo. 1999. Walking to work 
and the risk for hypertension in men: The Osaka Health Survey. Annals of Internal Medicine 
131(1):21-26. 
He, F. J., and G. A. MacGregor. 2003. How far should salt intake be reduced? Hypertension 
42(6):1093-1099. 
He, F. J., and G. A. Macgregor. 2008. A comprehensive review on salt and health and current 
experience of worldwide salt reduction programmes. Journal of Human Hypertension. 
He, J., M. J. Klag, P. K. Whelton, J. Y. Chen, J. P. Mo, M. C. Qian, P. S. Mo, and G. Q. He. 
1991. Migration, blood pressure pattern, and hypertension: The Yi Migrant Study. American 
Journal of Epidemiology 134(10):1085-1101. 
Heath, G. W., R. C. Brownson, and J. Kruger. 2006. The effectiveness of urban design and land 
use and transport policies and practices to increase physical activity: A systematic review. 
Journal of Physical Activity and Health 3(Supplement 1):S55-76. 
HHS. 2008. Progress review: Nutrition and overweight. 
http://healthypeople.gov/data/2010prog/focus19/default.htm (accessed February 12, 2010). 
HHS and USDA. 2005. Dietary guidelines for Americans. 6th ed. Washington, DC: U.S. 
Government Printing Office. 
Horvath, K., K. Jeitler, U. Siering, A. K. Stich, G. Skipka, T. W. Gratzer, and A. Siebenhofer. 
2008. Long-term effects of weight-reducing interventions in hypertensive patients: 
Systematic review and meta-analysis. Archives of Internal Medicine 168(6):571-580. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
GENERAL POPULATION INTERVENTIONS 99 
PREPUBLICATION COPY: UNCORRECTED PROOF 
Hu, G., N. C. Barengo, J. Tuomilehto, T. A. Lakka, A. Nissinen, and P. Jousilahti. 2004. 
Relationship of physical activity and body mass index to the risk of hypertension: A 
prospective study in Finland. Hypertension 43(1):25-30. 
Huang, Z., W. C. Willett, J. E. Manson, B. Rosner, M. J. Stampfer, F. E. Speizer, and G. A. 
Colditz. 1998. Body weight, weight change, and risk for hypertension in women. Annals of 
Internal Medicine 128(2):81-88. 
Huhman, M., L. D. Potter, F. L. Wong, S. W. Banspach, J. C. Duke, and C. D. Heitzler. 2005. 
Effects of a mass media campaign to increase physical activity among children: Year-1 
results of the VERB campaign. Pediatrics 116(2):e277-284. 
IOM. 2005. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. 
Washington, D.C.: The National Academies Press. 
———. 2009a. Local government actions to prevent childhood obesity. Washington, DC: The 
National Academies Press. 
———. 2009b. The public health effects of food deserts: Workshop summary. Washington, DC: 
The National Academies Press. 
Ishikawa-Takata, K., T. Ohta, K. Moritaki, T. Gotou, and S. Inoue. 2002. Obesity, weight change 
and risks for hypertension, diabetes and hypercholesterolemia in Japanese men. European 
Journal of Clinical Nutrition 56(7):601-607. 
Jalkanen, L. 1991. The effect of a weight reduction program on cardiovascular risk factors 
among overweight hypertensives in primary health care. Scandinavian Journal of Social 
Medicine 19(1):66-71. 
John, J. H., S. Ziebland, P. Yudkin, L. S. Roe, and H. A. W. Neil. 2002. Effects of fruit and 
vegetable consumption on plasma antioxidant concentrations and blood pressure: A 
randomised controlled trial. The Lancet 359(9322):1969-1974. 
Jones, D. W., and J. E. Hall. 2002. The National High Blood Pressure Education Program: Thirty 
years and counting. Hypertension 39(5):941-942. 
Kaczynski, A. T., and K. A. Henderson. 2008. Parks and recreation settings and active living: A 
review of associations with physical activity function and intensity. Journal of Physical 
Activity and Health 5(4):619-632. 
Kahn, E. B., L. T. Ramsey, R. C. Brownson, G. W. Heath, E. H. Howze, K. E. Powell, E. J. 
Stone, M. W. Rajab, and P. Corso. 2002. The effectiveness of interventions to increase 
physical activity. A systematic review. American Journal of Preventive Medicine 22(4 
Suppl):73-107. 
Karppanen, H., and E. Mervaala. 2006. Sodium intake and hypertension. Progress in 
Cardiovascular Diseases 49(2):59-75. 
Kelley, G. A., K. A. Kelley, and Z. V. Tran. 2001. Aerobic exercise and resting blood pressure: 
A meta-analytic review of randomized, controlled trials. Preventive Cardiology 4(2):73-80. 
Kelley, G. A., and K. Sharpe Kelley. 2001. Aerobic exercise and resting blood pressure in older 
adults: A meta-analytic review of randomized controlled trials. Journals of Gerontology. 
Series A, Biological Sciences and Medical Sciences 56(5):M298-303. 
Klag, M. J., J. He, J. Coresh, P. K. Whelton, J. Y. Chen, J. P. Mo, M. C. Qian, P. S. Mo, and G. 
Q. He. 1995. The contribution of urinary cations to the blood pressure differences associated 
with migration. American Journal of Epidemiology 142(3):295-303. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
100 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
Larson, N. I., M. T. Story, and M. C. Nelson. 2009. Neighborhood environments: Disparities in 
access to healthy foods in the U.S. American Journal of Preventive Medicine 36(1):74-81. 
Lever, A. F., C. Beretta-Piccoli, J. J. Brown, D. L. Davies, R. Fraser, and J. I. Robertson. 1981. 
Sodium and potassium in essential hypertension. British Medical Journal (Clinical Research 
Ed.) 283(6289):463-468. 
Link, B. G., and J. Phelan. 1995. Social conditions as fundamental causes of disease. Journal of 
Health and Social Behavior:80-94. 
Lorenzo, C., M. Serrano-Rios, M. T. Martinez-Larrad, R. Gabriel, K. Williams, C. Gonzalez-
Villalpando, M. P. Stern, H. P. Hazuda, and S. Haffner. 2002. Prevalence of hypertension in 
Hispanic and non-Hispanic white populations. Hypertension 39(2):203-208. 
Luepker, R. V., D. M. Murray, D. R. Jacobs, Jr., M. B. Mittelmark, N. Bracht, R. Carlaw, R. 
Crow, P. Elmer, J. Finnegan, A. R. Folsom, and et al. 1994. Community education for 
cardiovascular disease prevention: Risk factor changes in the Minnesota Heart Health 
Program. American Journal of Public Health 84(9):1383-1393. 
Massey, D. S., and N. A. Denton. 1993. American apartheid : Segregation and the making of the 
underclass. Cambridge, Mass.: Harvard University Press. 
Mechanic, D. 2007. Population health: Challenges for science and society. Milbank Quarterly 
85(3):533-559. 
Mensink, R. P., P. L. Zock, A. D. Kester, and M. B. Katan. 2003. Effects of dietary fatty acids 
and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and 
apolipoproteins: A meta-analysis of 60 controlled trials. American Journal of Clinical 
Nutrition 77(5):1146-1155. 
Moore, L. V., and A. V. Diez Roux. 2006. Associations of neighborhood characteristics with the 
location and type of food stores. American Journal of Public Health 96(2):325-331. 
Moore, L. V., A. V. Diez Roux, and S. Brines. 2008. Comparing perception-based and 
geographic information system (GIS)-based characterizations of the local food environment. 
Journal of Urban Health 85(2):206-216. 
Morenoff, J. D., J. S. House, B. B. Hansen, D. R. Williams, G. A. Kaplan, and H. E. Hunte. 
2007. Understanding social disparities in hypertension prevalence, awareness, treatment, and 
control: The role of neighborhood context. Social Science and Medicine 65(9):1853-1866. 
Morland, K., S. Wing, A. Diez Roux, and C. Poole. 2002. Neighborhood characteristics 
associated with the location of food stores and food service places. American Journal of 
Preventive Medicine 22(1):23-29. 
Mujahid, M. S., A. V. D. Roux, J. D. Morenoff, T. E. Raghunathan, R. S. Cooper, H. Y. Ni, and 
S. Shea. 2008a. Neighborhood characteristics and hypertension. Epidemiology 19(4):590-
598. 
Mujahid, M. S., A. V. D. Roux, M. W. Shen, D. Gowda, B. Sanchez, S. Shea, D. R. Jacobs, and 
S. A. Jackson. 2008b. Relation between neighborhood environments and obesity in the 
Multi-Ethnic Study of Atherosclerosis. American Journal of Epidemiology 167(11):1349-
1357. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
GENERAL POPULATION INTERVENTIONS 101 
PREPUBLICATION COPY: UNCORRECTED PROOF 
Murray, C. J., J. A. Lauer, R. C. Hutubessy, L. Niessen, N. Tomijima, A. Rodgers, C. M. Lawes, 
and D. B. Evans. 2003. Effectiveness and costs of interventions to lower systolic blood 
pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-
disease risk. Lancet 361(9359):717-725. 
National Urban League. 2009. Health and quality of life. http://www.nul.org/what-we-do/our-
programs/health-and-quality-life (accessed November 9, 2009). 
NCHS. 2003. National Health Interview Survey (NHIS). 
http://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease200309.pdf (accessed February 
12, 2010). 
———. 2006. Prevalence of overweight and obesity among adults: United States, 2003-2004. 
http://www.cdc.gov/nchs/data/hestat/overweight/overwght_adult_03.htm (accessed February 
12, 2010). 
———. 2008. Healthy People 2010 progress review: Focus area 19: Nutrition and overweight 
presentation. National Center for Health Statistics Website, 
http://www.cdc.gov/nchs/about/otheract/hpdata2010/focusareas/fa19_2_ppt/fa19_2_ppt.htm 
(accessed September 14, 2009). 
Ohmori, S., Y. Kiyohara, I. Kato, M. Kubo, Y. Tanizaki, H. Iwamoto, K. Nakayama, I. Abe, and 
M. Fujishima. 2002. Alcohol intake and future incidence of hypertension in a general 
Japanese population: The Hisayama study. Alcoholism, Clinical and Experimental Research 
26(7):1010-1016. 
Osypuk, T. L., A. V. D. Roux, C. Hadley, and N. Kandula. 2009. Are immigrant enclaves 
healthy places to live? American Journal of Epidemiology 169:S71-S71. 
Palar, K., and R. Sturm. 2009. Potential societal savings from reduced sodium consumption in 
the U.S. adult population. American Journal of Health Promotion 24(1):49-57. 
Papas, M. A., A. J. Alberg, R. Ewing, K. J. Helzlsouer, T. L. Gary, and A. C. Klassen. 2007. The 
built environment and obesity. Epidemiologic Reviews 29:129-143. 
Parker, E. D., K. H. Schmitz, D. R. Jacobs, Jr., D. R. Dengel, and P. J. Schreiner. 2007. Physical 
activity in young adults and incident hypertension over 15 years of follow-up: The CARDIA 
study. American Journal of Public Health 97(4):703-709. 
Pereira, M. A., A. R. Folsom, P. G. McGovern, M. Carpenter, D. K. Arnett, D. Liao, M. Szklo, 
and R. G. Hutchinson. 1999. Physical activity and incident hypertension in black and white 
adults: The Atherosclerosis Risk in Communities Study. Preventive Medicine 28(3):304-312. 
Phelan, J. C., and B. G. Link. 2005. Controlling disease and creating disparities: A fundamental 
cause perspective. Journals of Gerontology. Series B, Psychological Sciences and Social 
Sciences 60 Spec No 2:27-33. 
Poulter, N. R., K. T. Khaw, B. E. Hopwood, M. Mugambi, W. S. Peart, G. Rose, and P. S. Sever. 
1990. The Kenyan Luo Migration Study: Observations on the initiation of a rise in blood 
pressure. British Medical Journal 300(6730):967-972. 
Poulter, N. R., K. T. Khaw, M. Mugambi, W. S. Peart, and P. S. Sever. 1985. Migration-induced 
changes in blood pressure: A controlled longitudinal study. Clinical and Experimental 
Pharmacology and Physiology 12(3):211-216. 
Rose, G. 1992. The strategy of preventive medicine: Oxford University Press. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
102 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
Sacks, F. M., and E. H. Kass. 1988. Low blood pressure in vegetarians: Effects of specific foods 
and nutrients. American Journal of Clinical Nutrition 48(3 Suppl):795-800. 
Sacks, F. M., B. Rosner, and E. H. Kass. 1974. Blood pressure in vegetarians. American Journal 
of Epidemiology 100(5):390-398. 
Sacks, F. M., L. P. Svetkey, W. M. Vollmer, L. J. Appel, G. A. Bray, D. Harsha, E. Obarzanek, 
P. R. Conlin, E. R. Miller, 3rd, D. G. Simons-Morton, N. Karanja, and P. H. Lin. 2001. 
Effects on blood pressure of reduced dietary sodium and the dietary approaches to Stop 
Hypertension (DASH) diet. DASH-sodium Collaborative Research Group. New England 
Journal of Medicine 344(1):3-10. 
Saelens, B. E., and S. L. Handy. 2008. Built environment correlates of walking: A review. 
Medicine and Science in Sports and Exercise 40(7 Suppl):S550-566. 
Schulze, M. B., K. Hoffmann, A. Kroke, and H. Boeing. 2003. Risk of hypertension among 
women in the EPIC-Potsdam Study: Comparison of relative risk estimates for exploratory 
and hypothesis-oriented dietary patterns. American Journal of Epidemiology 158(4):365-373. 
Sesso, H. D., N. R. Cook, J. E. Buring, J. E. Manson, and J. M. Gaziano. 2008. Alcohol 
consumption and the risk of hypertension in women and men. Hypertension 51(4):1080-
1087. 
Sever, P. S., D. Gordon, W. S. Peart, and P. Beighton. 1980. Blood-pressure and its correlates in 
urban and tribal Africa. Lancet 2(8185):60-64. 
Sondik, E. 2008. Focus area 19: Nutrition and overweight progress review. PowerPoint 
Presentation at Progress Review Focus Area 19 - Nutrition and Overweight, April 3, 2008, 
Washington, DC. 
Stamler, J. 1997. The INTERSALT Study: Background, methods, findings, and implications. 
American Journal of Clinical Nutrition 65(2 Suppl):626S-642S. 
Stamler, R., J. Stamler, F. C. Gosch, J. Civinelli, J. Fishman, P. McKeever, A. McDonald, and A. 
R. Dyer. 1989. Primary prevention of hypertension by nutritional-hygienic means. Final 
report of a randomized, controlled trial. JAMA: Journal of the American Medical Association 
262(13):1801-1807. 
Stevens, V. J., E. Obarzanek, N. R. Cook, I. M. Lee, L. J. Appel, D. Smith West, N. C. Milas, M. 
Mattfeldt-Beman, L. Belden, C. Bragg, M. Millstone, J. Raczynski, A. Brewer, B. Singh, and 
J. Cohen. 2001. Long-term weight loss and changes in blood pressure: Results of the Trials 
of Hypertension Prevention, Phase II. Annals of Internal Medicine 134(1):1-11. 
Stranges, S., T. Wu, J. M. Dorn, J. L. Freudenheim, P. Muti, E. Farinaro, M. Russell, T. H. 
Nochajski, and M. Trevisan. 2004. Relationship of alcohol drinking pattern to risk of 
hypertension: A population-based study. Hypertension 44(6):813-819. 
Sturm, R., and A. Datar. 2005. Body mass index in elementary school children, metropolitan 
area food prices and food outlet density. Public Health 119(12):1059-1068. 
———. 2008. Food prices and weight gain during elementary school: 5-year update. Public 
Health 122(11):1140-1143. 
Thadhani, R., C. A. Camargo, Jr., M. J. Stampfer, G. C. Curhan, W. C. Willett, and E. B. Rimm. 
2002. Prospective study of moderate alcohol consumption and risk of hypertension in young 
women. Archives of Internal Medicine 162(5):569-574. 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
GENERAL POPULATION INTERVENTIONS 103 
PREPUBLICATION COPY: UNCORRECTED PROOF 
The Trials of Hypertension Prevention Collaborative Research Group. 1992. The effects of 
nonpharmacologic interventions on blood pressure of persons with high normal levels: 
Results of the Trials of Hypertension Prevention, Phase I. JAMA: Journal of the American 
Medical Association 267(9):1213-1220. 
———. 1997. Effects of weight loss and sodium reduction intervention on blood pressure and 
hypertension incidence in overweight people with high-normal blood pressure. The Trials of 
Hypertension Prevention, Phase II. The Trials of Hypertension Prevention Collaborative 
Research Group. Archives of Internal Medicine 157(6):657-667. 
Trogdon, J. G., E. A. Finkelstein, I. A. Nwaise, F. K. Tangka, and D. Orenstein. 2007. The 
economic burden of chronic cardiovascular disease for major insurers. Health Promotion 
Practice 8(3):234-242. 
Wassertheil-Smoller, S., A. Oberman, M. D. Blaufox, B. Davis, and H. Langford. 1992. The 
Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with 
regard to blood pressure, cardiovascular risk, and quality of life. American Journal of 
Hypertension 5(1):37-44. 
Whelton, P. K., J. He, J. A. Cutler, F. L. Brancati, L. J. Appel, D. Follmann, and M. J. Klag. 
1997. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled 
clinical trials. JAMA: Journal of the American Medical Association 277(20):1624-1632. 
Whelton, S. P., A. Chin, X. Xin, and J. He. 2002. Effect of aerobic exercise on blood pressure: A 
meta-analysis of randomized, controlled trials. Annals of Internal Medicine 136(7):493-503. 
Williams, D. R., and C. Collins. 2001. Racial residential segregation: A fundamental cause of 
racial disparities in health. Public Health Rep 116(5):404-416. 
Witteman, J. C., W. C. Willett, M. J. Stampfer, G. A. Colditz, F. J. Kok, F. M. Sacks, F. E. 
Speizer, B. Rosner, and C. H. Hennekens. 1990. Relation of moderate alcohol consumption 
and risk of systemic hypertension in women. American Journal of Cardiology 65(9):633-
637. 
World Cancer Research Fund. 2007. The choices that affect your cancer risk http://www.wcrf-
uk.org/preventing_cancer/diet/choices_that_affect.php (accessed November 9, 2009). 
Xin, X., J. He, M. G. Frontini, L. G. Ogden, O. I. Motsamai, and P. K. Whelton. 2001. Effects of 
alcohol reduction on blood pressure: A meta-analysis of randomized controlled trials. 
Hypertension 38(5):1112-1117. 
Zenk, S. N., A. J. Schulz, B. A. Israel, S. A. James, S. M. Bao, and M. L. Wilson. 2005. 
Neighborhood racial composition, neighborhood poverty, and the spatial accessibility of 
supermarkets in metropolitan detroit. American Journal of Public Health 95(4):660-667. 
 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
Copyright © National Academy of Sciences. All rights reserved.









INTERVENTIONS DIRECTED AT INDIVIDUALS WITH 
HYPERTENSION 
The previous chapter discusses population-based interventions that can be beneficial 
irrespective of hypertension status. This chapter focuses more narrowly on interventions directed 
at individuals who have been diagnosed with hypertension. A wide range of strategies are 
considered to reduce adverse health consequences associated with hypertension through early 
detection, treatment, and control. Strategies range from those that offer access to healthcare 
providers who screen and treat individuals with high blood pressure, reduce the cost of 
medications for those in treatment (insurance coverage, benefit design, cost sharing), support 
hypertension control (e.g., quality control measures), and increase hypertension awareness, 
treatment, and control ( e.g., worksite wellness initiatives). The chapter also considers 
community health workers as a potential strategy to increase treatment adherence among 
individuals with hypertension. 
ACCESS TO CARE AND CONTROL OF HYPERTENSION  
Access to health care, including access to providers, is generally considered important to 
improved health outcomes (IOM, 2003b, 2003d). Data are somewhat mixed, however, about 
whether hypertension control is improved if patients have a regular source of care (Ahluwalia et 
al., 1997; Col et al., 1990; Fihn and Wicher, 1988; He et al., 2002). Studies that have shown 
improvement in care include data from multiple surveys. For example, national survey data (e.g., 
the 1987 Medical Expenditure Panel Survey [MEPS]) have shown that having a regular source of 
care is associated with hypertension screening, follow-up care, and the use of medication (Moy 
et al., 1995). Data from the 1990 National Health Interview Survey (NHIS) showed a strong 
association between seeing a physician in the past year and taking action to control hypertension 
(taking medication, reducing salt, reducing weight) (CDC, 1994). Similarly, in an analysis of 
NHANES (National Health and Nutrition Examination Survey) III, He et al. (2002) found that 
the percentage of persons with controlled hypertension was higher for those who visited the same 
facility (OR = 2.77 [1.88-4.09]) or saw the same provider (OR = 2.29 [1.74-3.02]) for their 
health care. Another study reported that severe, uncontrolled hypertension was more common 
among Medicaid patients who could not identify a source of care (Lurie et al., 1984).  
A few case control studies have reported similar findings. Shea et al. (1992a) found that 
severe, uncontrolled hypertension was more common among those who did not have a primary 
care physician (adjusted OR = 3.5 [1.6-7.7]) and those who did not comply with antihypertensive 
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treatment (adjusted OR = 1.9 [1.4-2.5]). Ahluwalia and colleagues also found that controlled 
hypertension was associated with having a regular place of care (OR = 7.93 [3.86-16.29] 
(Ahluwalia et al., 1997). In a study of medically stable Department of Veterans Affairs (VA) 
patients terminated from regular outpatient care, compared with those retained in care, 41 
percent of discharged patients had blood pressure that was uncontrolled compared to 5 percent at 
the time of discharge; blood pressures were taken 13 months after discharge (p < 0.001) (data for 
the control group were 17 percent at follow-up versus 9 percent, a nonsignificant difference). 
Among discharged patients with diagnosed hypertension, systolic blood pressure rose an average 
of 11.2 mm Hg; diastolic blood pressure rose an average of 5.6 mm Hg (p < 0.001). Of the 
discharged group, 47 percent reduced their prescription medications compared with 25 percent in 
the control group (p = 0.002) (Fihn and Wicher, 1988). 
Another study found that one of the factors associated with a hospitalization due to 
noncompliance with medication (medications included an ACE [angiotensin-converting enzyme] 
inhibitor) was the number of physicians seen regularly (p = 0.007). The adjusted OR for seeing a 
greater number of physicians was 2.0 (p < 0.005) (Col et al., 1990). 
On the other hand, Kotchen and colleagues reported that neither having seen a provider 
within the past three months (p > 0.4) nor receiving care from the same provider at each 
encounter (p > 0.8) was associated with improved hypertension control (Kotchen et al., 1998). 
Similarly, Stockwell and colleagues found that a greater number of physician visits was not 
associated with awareness of hypertension, the number of antihypertensive drug days, or blood 
pressure control (Stockwell et al., 1994).  
One of the reasons for the lack of a consistent association between access to health care 
and hypertension control may be because control of hypertension is inadequate even in those 
with access to health care. NHANES III data have shown that 86 percent of individuals with 
uncontrolled hypertension have a usual source of care and average 4.3 physician visits per year; 
75 percent of those who are unaware of their hypertension had had their blood pressure measured 
in the previous year. Lack of awareness of hypertension (OR = 7.69; p < 0.001) and being aware 
but uncontrolled (OR = 2.08; p < 0.001) were more likely in those 65 or older, a population that 
has access to health care. In fact, most uncontrolled hypertension was mild systolic hypertension 
in older adults with access to health care and frequent physician contact (Hyman and Pavlik, 
2001).  
In a cohort study of a hypertensive VA population examined over a two-year period, less 
than 25 percent had adequate blood pressure control (<140/90 mm Hg), and 40 percent had a 
blood pressure >160/90 mm Hg despite having an average of 6.4 (+3.3) hypertension-related 
physician visits. In addition, the mean systolic blood pressure (SBP) was virtually unchanged at 
the end of two years (146.2 and 145.4 mm Hg, not significant), while the diastolic blood pressure 
(DBP) decreased (from 84.3 to 82.6, p < 0.001) (Berlowitz et al., 1998). In the Stockwell et al. 
(1994) study of a well-insured population, 71 percent of individuals with hypertension were 
aware of their hypertension, only 49 percent were being treated, and only 12 percent of these 
were controlled (<140/90 mm Hg), despite frequent utilization of the healthcare system. Other 
researchers have also reported poor hypertensive control despite access to health care. 
Framingham study participants are highly compliant with follow-up exams, and findings on 
exam are discussed with them and also sent to their primary care providers. Still, in a 
Framingham cohort followed for four years, only 32 percent of untreated individuals with 
hypertension were subsequently on treatment and only 40 percent of those not under control 
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initially (>140 mm Hg SBP or >90 mm Hg DBP) were brought under control. Older age was a 
strong predictor for lack of control overall and among those under treatment (Lloyd-Jones et al., 
2002).  
In a survey of African Americans, 27 percent were unaware of their hypertension, despite 
77 percent of them having had a blood pressure measurement by a physician within the previous 
two years; most had mild systolic hypertension. Those unaware of their hypertension were only 
slightly less likely to have had their blood pressure checked in the past year and were nearly 
equally likely as those who were aware to have had it checked in the prior two years (Pavlik et 
al., 1997). Kotchen et al. (1998) reported that only 70 percent of inner-city individuals with 
hypertension were aware of their hypertension, 55 percent were taking medication, and 26 
percent were under control despite most having seen a physician within the previous six months. 
Hyman and Pavlik calculated the attributable risk of lack of awareness of hypertension 
(Table 5-1): 46 percent of the attributable risk was being age 65 or older; 22 percent was being 
male; 5 percent was being African American; and 9 percent was having no recent visit to a 
physician. They also calculated the attributable risk of being aware, but having uncontrolled 
hypertension: 32 percent of the attributable risk was being age 65 or older; 12 percent was being 
male; and only 8 percent was having had no recent physician visit (Hyman and Pavlik, 2001). 
TABLE 5-1 Proportion of Cases of Uncontrolled Hypertension in Each Population Subgroup Attributable to 
Identified Risk Factors 
  
Lack of Awareness of Condition 
 















       
Age > 65 (vs. <65) 7.69 0.13 + 0.0072 0.46 2.08 0.44 + 0.0153 0.32 




1.45 0.11 + 0.0063 0.05 — — — 
No physician visits 
in past 12 months 
(vs. >1 visit) 
1.40 0.25 + 0.0062 0.09 1.89 0.10 + 0.0099 0.08 
NOTE: Attributable risk is calculated as P(RR – 1) ÷[P(RR – 1) + 1], where P is the prevalence of the risk factor in 
the population and RR is the relative risk associated with the presence of the factor. Dashes indicated that non-
Hispanic black race is not a significant risk factor in the model. SOURCE: Hyman and Pavlik, 2001. Copyright © 
[2001] Massachusetts Medical Society. All rights reserved. 
Consequences of Racial and Ethic Disparities in Awareness, Treatment, and Control  
The above demographic differences in awareness, treatment, and control of hypertension 
directly contribute to the nation’s long-standing racial, ethnic, gender, and age disparities from 
cardiovascular disease (CVD) and kidney disease. For example, using data from the NHANES 
III Mortality Follow-up Study (mean duration = 8.5 years; 143,551 person-years), Gu et al. 
(2008) observed a 3.86 greater risk (hazard ratio = 3.86, 95 percent confidence interval [95 % 
CI]: 1.60-9.32) of CVD deaths among individuals with hypertension under age 65 compared to 
similar-age individuals with normal blood pressure levels. For non-Hispanic whites, the hazard 
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ratio for hypertensives versus normotensives was 1.70 (95% CI: 1.09-2.65); however, when non-
Hispanic white hypertensives with controlled blood pressure were compared to their 
normotensive counterparts, the excess CVD mortality risk was no longer statistically significant 
(hazard ratio = 1.17, 95% CI: 0.72-1.91). For non-Hispanic blacks, a considerably smaller 
reduction in the hazard ratio was observed—4.65 (95% CI: 2.26-9.57) for controlled 
hypertensives versus 3.93 for normotensives (95% CI: 1.78-8.68. The comparable hazard ratios 
for Mexican Americans were 2.09 (95% CI: 0.93-4.65) versus 1.27 (95% CI: 0.46-3.52), a 
reduction slightly greater than that for non-Hispanic whites. Gu et al. (2008) speculated that the 
much smaller reduction in excess CVD mortality for blacks with controlled hypertension was 
probably due to several factors, including an earlier onset and greater severity of hypertension, 
less adequate blood pressure control, and less access to healthcare services. The cumulative 
effects of these factors probably led to more severe hypertensive target organ damage in blacks, 
thereby elevating CVD mortality rates even among those whose hypertension was controlled.  
Lopes et al. (2003) described some of the most promising recent advances in 
nonpharmacologic (e.g., diet, physical activity) as well as pharmacologic approaches to treating 
hypertension in African Americans. First, they noted the acceptability (Vollmer et al., 1998) and 
the effectiveness (Svetkey et al., 1999) of the DASH (Dietary Approaches to Stop Hypertension) 
diet (low-fat dairy food, fruit or vegetables, and foods low in total and saturated fat) among 
African Americans who enrolled in the DASH clinical trial. Bray and colleagues, in an analysis 
of the effects of the DASH diet and three dietary sodium levels on blood pressure, also reported 
that the lower the sodium level, the greater the mean reduction in blood pressure. The effect was 
even more pronounced and beneficial for African Americans (Bray et al., 2004). 
Lopes et al (2003) also highlighted findings from a randomized, controlled clinical trial 
(Kokkinos et al., 1995) wherein African-American men with stage three hypertension were 
assigned, or not, to a regimen of moderately intense, aerobic physical activity for 16 weeks. 
Engaging in aerobic exercise was associated with a significant decrease in blood pressure among 
the men randomized to the exercise arm. In addition, significant reductions in thickness of the 
interventricular septum and left ventricular mass, and in the left ventricular index, were observed 
for men assigned to the exercise arm. Collectively, these findings from well-designed and 
executed clinical trials of nonpharmacologic interventions for hypertension provide encouraging 
evidence that carefully supervised nonpharmacologic interventions focused on African 
Americans will likely reduce their excess risk for serious medical complications known to be 
caused by uncontrolled hypertension. 
In summarizing advances in pharmacologic approaches to treating hypertension in 
African Americans, Lopes et al. (2003) concluded that studies continue to support the use of 
diuretics and β-blockers as first-line antihypertensive therapy for everyone, regardless of race. 
However, they noted that findings from the African-American Study of Kidney Disease and 
Hypertension, or the AASK trial (Wright et al., 2002), also provided some support for the use of 
ACE inhibitors as first-line antihypertensive drugs in African Americans. An ACE inhibitor-
based treatment program, they concluded, was more beneficial than calcium channel blockers 
and β-blockers in reducing the progression of renal failure in blacks with hypertensive 
nephropathy.  
Thus, recent studies indicate that closely supervised administration of nonpharmacologic 
as well as pharmacologic antihypertensive interventions by primary care providers could 
substantially reduce the black-white racial disparities in medical complications due to poorly 
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controlled blood pressure. As is true of much of the extant literature on disparities in U.S. health 
care, the literature on hypertension continues to be disproportionately focused on blacks and 
whites and there is a lack of evidence-based recommendations that address disparities in 
hypertension awareness, treatment, and control for the nation’s other high-risk populations.  
Physician Adherence to Guideline Recommendations and Hypertension Control 
Although patient compliance with treatment is one reason for lack of hypertension 
control, it is also clear that lack of physician adherence to hypertensive guidelines is a major 
problem and a significant reason for the lack of awareness, lack of pharmacologic treatment, and 
lack of hypertension control in the United States (Chiong, 2008; Pavlik et al., 1997). Notably, 
older age and SBP predicted lack of control, even if the blood pressure was being treated (Lloyd-
Jones et al., 2002; Pavlik et al., 1997). NHANES III data show that lack of awareness of 
hypertension (OR = 7.69; p < 0.001) and being aware but uncontrolled (OR = 2.08; p < 0.001) 
were more likely in those 65 or older: persons >65 years of age comprise 45 percent of the 
unaware, 32 percent of the aware but untreated, and 57 percent of the treated but uncontrolled 
hypertensives. Lack of hypertension control was associated with older age: OR = 2.43 (1.79-
3.29) for ages 61-75 and OR = 4.34 (3.10-6.09) for those >75 years of age (Lloyd-Jones et al., 
2002). In fact, most uncontrolled hypertension was mild systolic hypertension in older adults 
with access to health care and frequent physician contact. In addition, 75 percent of the unaware, 
60 percent of the known but untreated, and 75 percent of the treated but not controlled 
hypertensives had a DBP <90 mm Hg (Hyman and Pavlik, 2001). A Framingham study found 
that only 33 percent were controlled to a systolic blood pressure goal, whereas 83 percent were 
controlled to a diastolic blood pressure goal. Of those on medication (61 percent), 49 percent 
were controlled to a systolic blood pressure goal compared with 90 percent to a diastolic blood 
pressure goal (Lloyd-Jones et al., 2000).  
Physician Nonadherence to Recommendations for Treatment of Hypertension 
Systolic hypertension may be more complex to treat than diastolic pressure (SHEP 
Cooperative Research Group, 1991), but multiple studies show that physicians are unlikely to 
treat or intensify treatment for mild to moderate systolic hypertension (<165 mm Hg) if the DBP 
is <90 mm Hg (Figures 5-1 and 5-2) (Berlowitz et al., 1998; Hyman et al., 2000). Berlowitz and 
colleagues (in a VA cohort study) found that if SBP was >155 mm Hg and the DBP >90 mm Hg, 
treatment was intensified 25.6-35 percent of the time (the larger percentage was if the medication 
had been changed during the previous visit); if the SBP was >165 mm Hg and the DBP was <90 
mm Hg, medication was increased 21.6 percent of the time, but if the SBP was <165 mm Hg, 
medication was increased only 3.2 percent of the time when the DBP was <90 mm Hg. Overall, 
treatment was intensified in only 6.7 percent of visits (Berlowitz et al., 1998). Oliveria and 
colleagues also identified patients with uncontrolled hypertension. Pharmacologic therapy was 
initiated or changed at only 38 percent of the visits, despite documented hypertension for at least 
six months prior to the most recent visit (Oliveria et al., 2002).  
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FIGURE 5-1 The proportion of patients over a 24-month period that was not diagnosed with hypertension, 
separated by average diastolic and systolic blood pressure. 
SOURCE: Physician Role in Lack of Awareness and Control of Hypertension, Hyman, D.J., V.N. Pavlik, and C. 
Vallbona, 2000. Copyright © 2000 Journal of Clinical Hypertension. Reproduced with permission of Blackwell 
Publishing Ltd. 
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FIGURE 5-2 The diastolic and systolic blood pressure ranges at which physicians would start drug treatment in 
patients with uncomplicated hypertension.  
SOURCE: Hyman and Pavlik, Archives of Internal Medicine, August 14/28, 2000, 160: 2283. Copyright © (2000) 
American Medical Association. All rights reserved. 
In a study that linked adults’ survey responses to their medical records, Hyman and 
colleagues found that these adults averaged 5.7 physician visits (median 4.0 visits). Of those with 
a 24-month average blood pressure >140/90, 25 percent were not diagnosed with hypertension. 
This proportion of “unaware” is comparable to the national rate reported by NHANES III. Only 
5 percent of those with a DBP greater than 90 mm Hg did not have a diagnosis of hypertension, 
but two-thirds were not diagnosed if the blood pressure was 140-159/<90 mm Hg. Of those on 
medication, the average blood pressure was 147/86, and only 24 percent had a blood pressure 
<140/90. When the DBP was >90 mm Hg, 98 percent had medication prescribed and treatment 
was intensified 24 percent of the time if the blood pressure remained >90 mm Hg. Treatment was 
intensified only 4 percent of the time when the SBP was >140 and the DBP <90 mm Hg. There 
was almost no action taken for persistently high SBP over many consecutive visits (Figure 5-1) 
(Hyman et al., 2000). 
A recent study by Okonofua et al. (2006) assessed the extent of therapeutic inertia, 
defined as providers’ failure to increase therapy when treatment goals are unmet, in 62 diverse 
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clinical sites participating in the Hypertension Initiative medical record audit and feedback 
program conducted in the Southeastern part of the United States. The researchers found that 
antihypertensive therapy was not intensified in 86.9 percent of visits when blood pressure was ≥ 
140/90. They estimated that improvement of 20 percent in the percentage of visits in which 
treatment is intensified, blood pressure control could increase from the study’s observed 46.2 
percent to a projected 65.9 percent in 1 year. The study did not provide information on the 
reasons for therapeutic inertia.  
Physician adherence to guidelines for nonpharmacological strategies to mange 
hypertension is also problematic. Lifestyle modifications (weight management, healthy diet, 
exercise) or non-pharmacologic strategies have been found to be effective in managing 
hypertension as discussed in Chapter 4. Few physicians however, encourage patients to make 
such modifications. Based on data from the National Ambulatory Medical Care Survey 
(NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) for 1999-
2000, only about 35 percent of patients with hypertension received counseling for diet and 26 
percent for exercise (Mellen et al., 2004). Asians and Hispanics received the highest levels of 
counseling and non-Hispanic whites the least. Patients with Medicaid had the highest exercise 
counseling rates compared to patients with other payment providers. Diet counseling did not 
differ by payment provider. Diet counseling rates were also higher for patients with co-occurring 
diabetes, obesity or dyslipidemia. With respect to exercise counseling, patients with obesity had 
significantly higher odds of receiving exercise counseling. Patients with two or more 
cardiovascular morbidities were also more likely to receive diet and exercise counseling 
compared to those with less than one co-occurring morbidity. In NAMCS representing office-
based practices, 36 percent of hypertension patients received diet counseling and 27 percent 
received exercise counseling. In hospital-based clinics (NHAMCS), 25 percent received diet 
counseling and 14 percent counseling for exercise.  
A more recent study found that health care providers fail to counsel patients with 
hypertension to increase physical activity as a measure to lower blood pressure. Halm and 
Amoako (2008), in an analysis of NHANES III data, found that only one third of patients with 
hypertension reported having received a physical activity recommendation from their health care 
provider. However, 70 percent of those counseled followed the recommendation and had on 
average a systolic blood pressure that was 3 to 4 mm Hg lower than those who did not follow the 
recommendation. Given the potential impact of non-pharmacologic strategies on hypertension 
management, there is an area that deserves greater attention. 
Reasons for Poor Physician Adherence with Guidelines 
Survey data shows that U.S. physicians are more likely to report that they adhere to 
diastolic threshold recommendations for initiating or intensifying treatment than for systolic 
thresholds (Chiong, 2008). In a national survey of primary care physicians, Hyman found that 39 
percent would not start treatment for middle-aged patients with uncomplicated hypertension 
unless the DBP was >95 mm Hg; 52 percent of physicians would not start treatment for an SBP 
of 140-160, and 48 percent would not start treatment unless the SBP was greater than 160 mm 
Hg. In patients age 40-60 years without complications who were on drug treatment, 25 percent of 
physicians would not intensify drug therapy for a persistent DBP of 94 mm Hg; 33 percent 
would not intensify drug treatment for an SBP of 158 mm Hg. Providers were even less 
aggressive in older patients: 48 percent would not take action for an elevated DBP of 94 mm Hg 
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and 67 percent would not take action for those 70 or older with an SBP <160 mm Hg (Hyman 
and Pavlik, 2000).  
Similarly, in a survey of primary care clinicians at three VA medical centers compared 
with the clinical database of patients cared for by these providers, clinicians overestimated the 
proportion of patients who were prescribed guideline-concordant medications (75 percent 
perceived versus 67 percent actual, p < 0.001) and the proportion of patients who had blood 
pressures levels <140/90 at their last visit (68 percent perceived versus 43 percent actual, p < 
0.001). Physicians with lowest actual performance were the most likely to overestimate their 
adherence and rates of control (Steinman et al., 2004) 
Oliveria and colleagues (2002) identified patients with uncontrolled hypertension. The 
treating primary care physicians were then asked to complete a survey about the patient visit 
(and given a copy of their office notes). The most frequently cited reason for no initiation or 
intensification of therapy was that there was a need to continue monitoring (35 percent); 
satisfaction with BP level (30 percent); it was not the focus of the visit (29 percent); the presence 
of a satisfactory DBP (16 percent); and the presence of only borderline hypertension (10 
percent). For 93 percent of visits in which the physician reported being satisfied with the BP 
level, SBP was >140 mm Hg; 35 percent had a blood pressure >150 mm Hg; and the DBP was 
>90 mm Hg at 22 percent of these visits. Physicians attributed a higher risk to elevated DBP than 
to elevated SBP, and on average, physicians reported that 150 mm Hg was the lowest SBP at 
which they would recommend pharmacologic treatment for those without comorbidities 
(compared to 91 mm Hg for DBP) (Figure 5-3) (Oliveria et al., 2002). 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
114 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
 
FIGURE 5-3 The systolic (A) and diastolic (B) blood pressures of 72 patients with no initiation or change in 
antihypertensive medication. 
SOURCE: Oliveria et al., Archives of Internal Medicine, February 25, 2002, 162: 417 Copyright © (2002) 
American Medical Association. All rights reserved. 
In an older study in Wales, the reasons given for not starting or intensifying treatment in 
older patients with isolated systolic hypertension were fear that side effects would decrease the 
quality of life (39 percent); isolated systolic hypertension was an inevitable consequence of 
aging (35 percent); systolic hypertension was not as great a problem as diastolic hypertension (32 
percent); isolated systolic hypertension was a compensatory mechanism to force blood through 
arteriosclerotic arteries (28 percent); and there was no beneficial effect of treating hypertension 
in the elderly (14 percent) (Ekpo et al., 1993).  
Despite 1988 guidelines recommending treatment if SBP >140 mm Hg or DBP > 90 mm 
Hg, 41 percent of primary care physicians had not heard of or were not familiar with the Joint 
National Committee (JNC) guidelines. Familiarity with the JNC guidelines was consistently 
associated with having more aggressive blood pressure goals, including statistically significant 
increases in initiating treatment for SBP in older patients and intensifying treatment for mildly 
elevated SBP and DPB in younger patients. However, familiarity with the guidelines was 
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associated with a lower likelihood of intensifying treatment among older patients with mildly 
elevated SBP, particularly if they have isolated systolic hypertension (Hyman and Pavlik, 2000).  
According to NHANES III data, isolated systolic hypertension in the elderly comprises 
the majority of uncontrolled hypertension in the United States (Franklin et al., 2001; Hyman and 
Pavlik, 2001). Isolated systolic hypertension was also the majority subtype of uncontrolled 
hypertension among those >50 years of age. Additionally, only 29 percent of those with an SBP 
>140 mm Hg knew they were hypertensive and 80 percent of both the untreated and the 
inadequately treated older individuals with hypertension had isolated systolic hypertension 
(Figure 5-4) (Franklin et al., 2001; Izzo et al., 2000). Factors that could lead to reduced control of 
hypertension in the elderly include potential biological resistance to therapy because of longer 
duration of hypertension and more target organ damage (Franklin et al., 2001; Izzo et al., 2000; 
Lloyd-Jones et al., 2002). However, it is also clear that physicians are less aggressive in treating 
older patients and less aggressive in treating isolated systolic hypertension (Berlowitz et al., 
1998; Chiong, 2008; Hyman et al., 2000; Izzo et al., 2000; Lloyd-Jones et al., 2002). 
“Undiagnosed hypertension and treated but uncontrolled hypertension occurs largely under the 
watchful eye of the health care system” (Hyman and Pavlik, 2001). Furthermore, physicians are 
not providing treatment consistent with the JNC guidelines, particularly in the treatment of 
isolated systolic hypertension, yet the largest attributable fraction for lack of awareness and lack 
of control of hypertension is being age 65 or older and having isolated systolic hypertension. 
 
FIGURE 5-4 (Left) Frequency and distribution of untreated hypertensive individuals by age and hypertension 
subtype. Numbers at the tops of bars represent the overall percentage distribution of all subtypes of untreated 
hypertension in that age group. (Right) Frequency distribution of hypertensive individuals classified as inadequately 
treated by age and hypertension (HTN) subtype. Numbers at top of bars represent overall percentage distribution of 
all subtypes of inadequately treated hypertension in that age group. ■, Isolated Systolic Hypertension (SBP≥140 mm 
Hg and DBP <90 mm Hg); ░, Systolic-Diastolic Hypertension (SBP ≥ 140 mm Hg and DBP ≥90 mm Hg); □, 
Isolated Diastolic Hypertension (SBP <140 mm Hg and DBP ≥90 mm Hg). 
SOURCE: Franklin et al., Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US 
Hypertensives, Hypertension, 37 (3): 871. 
Patient Nonadherence to Treatment of Hypertension 
Patient noncompliance with prescribed antihypertensive medications is also a problem 
that contributes to suboptimal rates of blood pressure control. It is estimated that 50 percent of 
patients discontinue drug treatment after one year, and only 10 percent continue to follow advice 
concerning lifestyle modifications (Elliott, 2003). This problem can be addressed in part by 
increased attention from providers in identifying barriers to medication adherence and engaging 
patients in treatment decisions (Harmon et al., 2006). One study investigating how providers 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
116 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
assess antihypertensive medication adherence revealed that patients were not asked about 
medication taking in 39 percent of encounters (Bokhour et al., 2005). Effective communication 
strategies and patient centered counseling can be employed as a means to improve treatment 
adherence.  
Krousel-Wood and colleagues (2005) suggest that future research should focus on the 
development of adherence models which consider the influence of social, psychological, and 
biological variables on antihypertensive medication adherence. Some established methods of 
improving adherence to long term therapies include the provision of verbal and written 
instructions and patient education materials, simplification of regimen, once a day dosing (when 
possible), minimizing the number of pills, recommendation of well tolerated therapies, and 
sensitivity concerning cost of pills and attempt to minimize out of pocket costs (Elliott, 2003).  
Quality of Care and Performance Measurement for Hypertension Care 
Shortfalls in the general quality of health care in the United States have been well 
documented (IOM, 2000, 2001b, 2003c). Studies discussed previously also indicate that the 
quality of care for hypertension received by some patients, particularly the elderly, is suboptimal 
(Oliveria et al., 2002). Further, the First National Report Card on Quality of Health Care in 
America published by the RAND Corporation in 2004 documented that patients with 
hypertension received less than 65 percent of recommended care (RAND, 2006). 
Since the release of the Institute of Medicine (IOM) health care quality report series 
(IOM, 2000, 2001b, 2003c), improving quality of care has become of paramount concern for a 
whole host of healthcare system stakeholders (plans, providers, purchasers). In support of 
healthcare quality improvement, organizations such as the National Committee for Quality 
Assurance (NCQA) and the American Medical Association (AMA)-Physician Consortium for 
Performance Improvement (PCPI) have developed performance measure for determining 
benchmarks by which healthcare providers and organizations can assess their progress in 
improving healthcare services, processes, and outcomes. These organizations include specific 
performance measures for care of hypertension (Table 5-2). The Healthcare Effectiveness Data 
and Information Set (HEDIS®) performance measures put forth by NCQA are widely used to 
assess quality of care and service of health plans. Health plans use HEDIS® results to determine 
the need for and focus of quality improvement efforts. In an analysis of the potential effects of 
eight HEDIS® performance measures related to the quality of care for cardiovascular disease 
and diabetes, Eddy et al. (2008) concluded that “[f]rom the perspective of the population as a 
whole, the most important single measure is the hypertension measure, which is very effective in 
reducing the risk of both MIs [myocardial infarctions] and strokes. This is due to the large 
number of people who had diagnosed but uncontrolled hypertension (approximately 14 percent 
of adults in the pre-HEDIS population) and the effectiveness of available treatments in 
preventing CVD events in people who have uncontrolled hypertension.”  
The PCPI is a physician-led initiative to develop tools by physicians for physicians. 
Members of the consortium include clinical experts representing more than 50 national medical 
specialty societies, state medical societies, methodological experts, the Agency for Healthcare 
Research and Quality, and the Centers for Medicare and Medicaid Services. The PCPI develops 
evidence-based clinical performance measures and outcomes reporting tools for physicians. Both 
organizations (the NCQA and the PCPI) envision that routine measurement of hypertensive care 
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quality among provider groups or plans can lead to improved care processes and blood pressure 
control (Table 5-2). 
 
TABLE 5-2 HEDIS® and Physician Consortium for Performance Improvement Hypertension Measures 
Measures 
HEDIS® Measures 
Controlling High Blood Pressure: Percentage of patients 18-85 years of age with a diagnosis of hypertension 
whose blood pressure was adequately controlled (less than 140/90 mm Hg) during the management year 
 
PCPI Measures 
Blood Pressure Screening: Percentage of patient visits for patients aged 18 years and older with a diagnosis 
of hypertension with blood pressure recorded 
 
Plan of Care: Percentage of patient visits for patients aged 18 years and older with a diagnosis of 
hypertension with either systolic blood pressure is greater than or equal to 140 mm Hg or diastolic blood 
pressure is greater than or equal to 90 mm Hg, with documented plan of care for hypertension 
 
SOURCE: AMA, 2006; NCQA, 2009. 
Organizations or providers seeking to improve care processes, services, and outcomes 
can turn to a number of potential strategies. The Agency for Healthcare Research and Quality 
(AHQR, 2004) commissioned a review of the literature related to specific strategies for 
improving the quality of hypertension treatment. Among the quality strategies assessed were 
physician and patient reminder systems, continuing education for physicians, education for 
patients, and electronic transfer of patient data from specialty clinics to primary care physicians, 
among other strategies. The researchers found that most of the quality improvement strategies 
contributed to some improvement in the detection and control of high blood pressure, but it was 
difficult to determine which strategy was superior. The researchers also noted that multiple 
strategies are often used so it is difficult to identify which have the greatest effect on patient 
outcomes. The researchers observed that few of the quality improvement strategies had an 
impact on providers’ adherence to optimal treatment guidelines. In summary, performance 
measurement can catalyze action toward quality improvement, some quality improvement 
strategies can improve hypertension detection and control, but improving physician adherence to 
treatment guidelines poses an elusive problem requiring further attention.  
Cost of Medication and Hypertension  
One reason for patient nonadherence with treatment is out-of-pocket costs for medication 
(Chockalingam et al., 1998). Controlling for health status, financial burden (out-of-pocket costs 
compared to income) has been shown to be significantly greater for persons with chronic 
conditions such as hypertension (Rogowski et al., 1997). Many studies, using a variety of 
methodologies, have documented a relationship between cost to patients, poorer adherence to 
treatment, and poorer control of hypertension (Fihn and Wicher, 1988).  
Several studies have utilized survey data to assess the relationship between cost and 
adherence to treatment (Ahluwalia et al., 1997; Clark, 1991; Col et al., 1990). Generally these 
studies have reported that cost is a significant problem (Mojtabai and Olfson, 2003), particularly 
for ethnic minorities, those with lower incomes, and those with higher out-of-pocket costs (Fihn 
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and Wicher, 1988; Steinman et al., 2001). In a 2002 nationally representative survey of 
chronically ill U.S. adults, 9 percent had cost-related antihypertensive medication underuse in the 
previous year, and 7 percent underused at least monthly. Income and high out-of-pocket costs 
(OR = 4.6; p < 0.001) were each associated with cost-related underuse of antihypertensive 
medications (Piette et al., 2004). In a 1981 survey, a larger proportion of people with 
uncontrolled or moderate to severe hypertension than controlled hypertension reported economic 
barriers to pharmacologic and medical care. Cost was a barrier to getting initial medication (36 
percent among uncontrolled versus 22 percent for those with controlled hypertension); 
medication refills (36 percent versus 16 percent); and office visits 26 percent versus 16 percent 
(Shulman et al., 1986). In an older Gallup survey, 6 percent of respondents reported that they 
stopped their antihypertensive medication because they could not afford the cost (Gallup and 
Cotugno, 1986). A case control study found that control of hypertension was associated with 
reporting that cost was not a deterrent to buying medications (OR = 3.83 [1.59-8.28]) (Ahluwalia 
et al., 1997).  
A few studies have looked at the cost of treatment and linked it to health outcomes. In the 
2000 Health and Retirement Study, cost-related poor medication adherence was related to self-
reported adverse health outcomes: 7 percent versus 4 percent had worsening of hypertension (OR 
= 1.76; p < 0.05), and the odds of BP not being controlled were 1.92 ( p < 0.01) (Mojtabai and 
Olfson, 2003). Noncompliance with antihypertensive medication is associated with increased 
hospital admissions (Maronde et al., 1989). McCombs et al. (1994) found that continuous 
antihypertensive therapy was associated with statistically significant reductions in hospital 
expenditures per patient that were greater than the accompanying drug costs; they estimated that 
an additional day of uninterrupted drug therapy would save $3 per day in total costs. In a study 
of medically stable VA patients discharged from regular care (compared with those retained in 
care), those discharged who reported a financial barrier to receiving care had a mean increase in 
SBP of 14.0 mm Hg and a mean increase in DBP of 6.4 mm Hg; this was significantly greater 
than the 3.2 mm Hg increase in SBP and 0.5 mm Hg increase in DBP among those reporting no 
financial barriers (p = 0.001 and 0.0001, respectively) (Fihn and Wicher, 1988).  
Insurance Coverage and Control of Hypertension 
One way of reducing patient costs of treatment is through insurance coverage. Many 
studies have examined the impact of insurance coverage on hypertension. Many of the data come 
from observational studies.  
Insurance and Screening for Hypertension 
National surveys (1982 NHIS, 1987 MEPS) support the association of insurance 
coverage with hypertension screening, follow-up care, and use of medication (Chiong, 2008; 
Moy et al., 1995; Woolhandler and Himmelstein, 1988). For example, inadequate screening for 
hypertension was 18 percent among the uninsured versus 11 percent for the insured (adjusted OR 
= 1.46 [1.28-1.67]; p < 0.01) (Woolhandler and Himmelstein, 1988). In another survey, the long-
term uninsured (19.5 percent) and short-term uninsured (8.6 percent) were less likely than the 
insured (5.8 percent) to have been screened for hypertension in the previous two years (both 
were statistically significant differences) (Ayanian et al., 2000). In a randomized controlled trial 
that was representative of the U.S. population, the Rand Health Insurance Experiment, 
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hypertensive individuals given free care were more likely to see a physician and to have their 
hypertension detected and a medication prescribed (Keeler et al., 1985; Keeler et al., 1987). 
Studies have assessed the impact of insurance coverage on utilization of antihypertensive 
medications (Adams et al., 2001b; Blustein, 2000). In a state survey among hypertensives, the 
adjusted odds ratio of prescription treatment for those with prescription drug coverage compared 
to those without prescription drug coverage was 1.20 (0.87-1.64) (Stuart and Grana, 1998). Data 
from the 2000 Health and Retirement Study showed that going from full coverage to partial 
coverage and from partial coverage to no coverage reduced compliance with antihypertensive 
medications (adjusted OR = 0.46; p < 0.001). The percentages with poor adherence due to cost 
were 11 percent for those with no coverage, 5 percent for those with partial coverage, and 4 
percent for those with full coverage (Mojtabai and Olfson, 2003). Two studies used the 1995 
Medicare Current Beneficiary Survey: Blustein (2000) reported that hypertensives without drug 
coverage (21.8 percent) were more likely than those with coverage (17.1 percent) to have not 
purchased any antihypertensive medication (p < 0.01); the adjusted percentage was 22.2 percent 
versus 16.9 percent (OR = 1.4; p = 0.002). Insurance coverage was not significantly associated 
with the number of tablets purchased in the unadjusted analysis, but in the multivariate analysis, 
medication coverage increased the number of tablets purchased per year by 37 (p = 0.02) 
(Blustein, 2000). Adams and colleagues reported that the utilization of antihypertensive 
medications was 1.26 (p = 0.043) among Medicare enrollees with coverage compared with those 
who had no coverage. Better insurance coverage led to greater use of antihypertensive 
medications and purchase of a greater number of tablets (Adams et al., 2001b). In a 2002 
nationally representative survey of chronically ill U.S. adults, the OR was 3.3 (p < 0.001) for 
underuse of antihypertensive medication among those with no prescription coverage compared to 
those with such coverage (Piette et al., 2004). 
On the other hand, in a study of low-income black and Hispanic patients diagnosed with 
hypertensive emergency or hypertensive urgency (compared to controls who were hypertensive 
patients hospitalized or seen in the emergency room (ER) for other acute conditions), Shea et al. 
(1992a) found that self-reported nonadherence to medication was not significantly associated 
with insurance coverage (OR = 1.6 [0.84-3.10]). 
Some studies have assessed the relationship between insurance coverage and control of 
hypertension (Ahluwalia et al., 1997). An analysis of NHANES III data showed that the 
percentage of persons with controlled hypertension was higher among those with private 
insurance as compared with uninsured or government insured individuals (OR = 1.59 [1.02-
2.49]) (He et al., 2002). In a survey of low-income African Americans, those having no 
insurance were significantly more likely to have uncontrolled hypertension (Pavlik et al., 1997). 
In a case series of consecutive hospital admissions, lack of insurance coverage for prescription 
drugs was associated with hospitalization due to medication noncompliance (medications 
implicated in hospitalizations due to noncompliance included an ACE inhibitor). The elderly 
(whose medications were not covered by insurance) were most likely to be noncompliant with 
their medication (52 percent versus 31 percent; p = 0.04) (Col et al., 1990). Being switched from 
free care to paying $20-$30 per visit led to a significant worsening of hypertension at six months 
(10 mm Hg higher versus no change in the control group) and one year (6 mm Hg higher than 
baseline [p < 0.001]). At one year, the percentage of people with a diastolic blood pressure <90 
mm Hg was 51 percent, compared with 75 percent at baseline (p < 0.01); the percentage with 
DBP >100 mm Hg was 19 percent, compared with 3 percent at baseline (p < 0.01) (Lurie et al., 
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1986). Another study in two states assessed the relative risk of admission for avoidable hospital 
conditions (AHCs). The uninsured and those on Medicaid were more likely than the insured to 
be hospitalized with AHCs. For malignant hypertension, the odds of AHCs for the uninsured 
versus those with private insurance were 2.38 (1.83-2.93; p < 0.05) in Massachusetts and 1.93 
(1.41-2.44; p < 0.05) in Maryland. For Medicaid recipients, the odds ratios were 1.56 (1.29-1.82; 
p < 0.05) and 1.74 (1.36-2.13; p < 0.05), respectively (Weissman et al., 1992). A study of 
indigent inner-city hypertensive patients showed that hypertension control was associated with 
having insurance (OR = 2.15 [1.02-4.52]) (Ahluwalia et al., 1997). Another study of low-income 
black and Hispanic patients reported that severe, uncontrolled hypertension was more common 
among persons with no health insurance (adjusted OR = 2.2 [1.0-4.6]; p = 0.04) (Shea et al., 
1992b).  
NHANES III data show that 92 percent of persons with uncontrolled hypertension have 
health insurance (Hyman and Pavlik, 2001). Similarly, among a well-insured population in New 
York, only 71 percent were aware of their hypertension, only 49 percent were treated, and only 
12 percent had their blood pressure controlled at recommended levels (Stockwell et al., 1994). 
Hypertension Control and Cost Sharing Among Those with Insurance  
Cost sharing is described by AHRQ as the contribution consumers make towards the cost 
of their healthcare as defined in their health insurance policy. Rising healthcare costs have 
resulted in a shift toward greater cost sharing, particularly for prescription medications. There is 
a substantial body of literature (primarily observational studies) investigating the implications of 
cost sharing on medication utilization. Several studies have examined the impacts and health 
outcomes associated with cost sharing of “essential” medications such as antihypertensives. 
A Cochrane review and other studies have reported that out-of-pocket costs (whether 
imposed as copayments, caps, ceilings, tiered drug categories, and/or restricted formularies) can 
reduce medication utilization, often substantially (Adams et al., 2001a; Artz et al., 2002; 
Austvoll-Dahlgren et al., 2008; Blustein, 2000; Cox et al., 2001; Fairman et al., 2003; Goldman 
et al., 2004; Goldman et al., 2007; Harris et al., 1990; Huskamp et al., 2003; Kamal-Bahl and 
Briesacher, 2004; Landsman et al., 2005; Lexchin and Grootendorst, 2004; Motheral and 
Henderson, 1999a; Nair et al., 2003; Poirier, 1998; Reeder and Nelson, 1985; Schneeweiss et al., 
2002a; Shrank et al., 2006; Solomon et al., 2009; Soumerai et al., 1994; Soumerai et al., 1991; 
Taira et al., 2006; Tamblyn et al., 2001; Tseng et al., 2004). In some cases, patients faced with 
out-of-pocket costs do not start their medication, reduce the amount of medication taken to make 
it last longer, switch medication, discontinue the medication, or take someone else’s medicine 
(Cox et al., 2001; Schulz et al., 1995; Tseng et al., 2004). However, not all studies have shown 
significant impacts associated with cost sharing (Blais et al., 2001; Motheral and Fairman, 2001; 
Motheral and Henderson, 1999b). A review article, after excluding studies with very small cost-
sharing changes and those without an adequate control group, estimated that cost-sharing 
increases of 10 percent would be associated with a 2-6 percent decrease in prescription drug use 
or expenditures (Goldman et al., 2007). 
Most studies assessing the impact of cost sharing on essential drugs such as 
antihypertensives have reported a significant decrease in use (4-28 percent); with smaller impact 
seen for essential medications than nonessential medications ((Adams et al., 2001a; Austvoll-
Dahlgren et al., 2008; Goldman et al., 2007; Harris et al., 1990; Hsu et al., 2006; Landsman et 
al., 2005; Lexchin and Grootendorst, 2004; Motheral and Henderson, 1999a; Nair et al., 2003; 
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Reeder and Nelson, 1985; Schneeweiss et al., 2002a; Shrank et al., 2006; Soumerai et al., 1994; 
Soumerai et al., 1991; Tamblyn et al., 2001). A few studies, however, showed no significant 
difference in the use of essential drugs or between use of essential and nonessential drugs 
(Goldman et al., 2007; Johnson et al., 1997b; Lohr et al., 1986; Motheral and Fairman, 2001; 
Motheral and Henderson, 1999b). For example, Fairman and colleagues (2003) compared an 
intervention group of members switched from a two-tier to a three-tier plan with a comparison 
group retained in the two-tier plan (tiered plans employ formularies with differential copayments 
to encourage the use of generic drugs, or brand drugs that have been made available at a 
discounted rate). Although there was lower use of nonformulary (tier 3) medications in the first 
year, antihypertensive therapy continuation rates were not significantly different during the 
second year. Similarly, Motheral and Fairman (2001) found that moving from a two-tier to a 
three-tier plan resulted in no significant decrease in use of antihypertensive medication.  
A Cochrane review concluded that the impact of cost-sharing was greater for the 
chronically ill and persons on multiple drugs (Austvoll-Dahlgren et al., 2008). Most studies that 
have assessed the differential impact have found a greater impact of cost sharing among low-
income patients (Brook et al., 1983; Goldman et al., 2007; Schneeweiss et al., 2002a; Shrank et 
al., 2006; Tamblyn et al., 2001), but not all (Poirier, 1998). It has also been reported that low-
income patients were more likely than high-income patients to stop all antihypertensive therapy 
(Schneeweiss et al., (2002a).  
Studies Assessing Impact of Cost Sharing on Antihypertensive Medication Utilization 
The impact of cost sharing specifically related to the use of antihypertensive medication 
has been assessed (Adams et al., 2001a; Blais et al., 2001; Blustein, 2000; Brook et al., 1983; 
Fairman et al., 2003; Goldman et al., 2004; Hsu et al., 2006; Huskamp et al., 2003; Johnson et 
al., 1997b; Kamal-Bahl and Briesacher, 2004; Keeler et al., 1985; Landsman et al., 2005; 
Motheral and Fairman, 2001; Motheral and Henderson, 1999a; Poirier, 1998; Schneeweiss et al., 
2002a; Taira et al., 2006). In an analysis of the 1995 Medicare Current Beneficiary Survey, 
Blustein (2000) found that a $1 increase in out-of-pocket per-tablet cost resulted in the purchase 
of 114 fewer hypertension pills per year. In a study by Schneeweiss (2002a), 3 percent of 
individuals subject to cost sharing discontinued all antihypertensive medications; however, 
Johnson (1997b) found that the largest price increase led to fewer days of antihypertensive 
medication use, but not discontinuance of treatment. 
In a cross-sectional study of Medstat’s 1999 MarketScan database, Kamal-Bahl and 
Briesacher (2004) noted that the average annual use of antihypertensive medication was lower in 
the two- or three-tier plans with higher copayments, but not in single-tier plans. The average 
antihypertensive use in two-tier plans dropped from 18.9 prescriptions to 14.5 prescriptions with 
copayment increases of $5-$10 for brand-name products even though less costly generics were 
available. When brand-name copayments were increased to at least $14, the average annual use 
of antihypertensive medication fell to 10.8 prescriptions, despite a large increase in generic 
spending. The effect was greatest for angiotension II receptor blockers (ARBs) and ACE 
inhibitors. 
Claims data have been used as a means to compare the impact of various benefit designs 
on the use of antihypertensive medication. Doubling copayments has been shown to reduce 
antihypertensive use by 26 percent, with less impact among those under regular care (Goldman 
et al., 2004). Higher cost sharing has been associated with delayed initiation of hypertensive 
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therapy. Solomon and colleagues (2009) found that doubling copays led to initiation of therapy 
in 39.9 percent (compared with 54.8 percent) at one year and 66.2 percent (compared with 81.6 
percent) by five years. The authors concluded that the effect of cost sharing is greatest soon after 
diagnosis and then declines over time; however, in those without prior medication experience it 
declines more slowly. Tiara and colleagues (2006) found that medication compliance decreased 
substantially with increasing copayments.  
In a study examining the effect of a preferred drug list restricting 17 antihypertensive 
medications, 21 percent of individuals on antihypertensives were found to discontinue their 
medication (Wilson et al., 2005). Another study found that a 66-100 percent increase in 
copayments led to a significant decrease in use of CCBs (4.1 percent) and ACE inhibitors (4.1 
percent) and a nonsignificant decrease in ARBs (3.2 percent). There were also significantly 
higher discontinuance rates for ACE inhibitors (23.8 percent net increase) and ARBs (25.7 
percent net increase) and a nonsignificant increase in discontinuance rate for CCBs in the three-
tier plans (Landsman et al., 2005). In a prospective cohort study, Hsu et al. (2006) found that 15 
percent of persons on long-term antihypertensive therapy whose drug benefits were capped were 
nonadherent the next year; significantly more that among those who drug benefits were not 
capped. 
Cost sharing is not always consistent with decrease in utilization. In one study, the 
intervention group with the change in benefits was less likely than the control group to stop using 
ACE inhibitors (Huskamp et al., 2003). In another study, the introduction of a new cost-sharing 
led to a significant decrease in antihypertensive medication use at three months, but only a 1.1 
percent decline (not significant) at 13 months (Blais et al., 2001). Fairman and colleagues (2003) 
compared those switched from a two- to a three-tier plan with those retained in the two-tier plan, 
and found that continuation rates for antihypertensive medications did not differ significantly at 
6 through 38 months’ follow-up. The Rand randomized controlled trial found that cost sharing 
had little impact on compliance with medication, but that those under free care were more likely 
to be taking medication (due to improved case finding, prescription of medication, and more 
frequent follow-up) (Keeler et al., 1985; Keeler et al., 1987; Lohr et al., 1986). 
Cost Sharing for Medication and Health Impacts  
Although concerns have been raised about adverse health outcomes from reductions in 
“essential” drugs to treat chronic diseases, only a few studies have examined the impact of cost 
sharing on health outcomes, ER visits, or hospitalization (Adams et al., 2001a; Anis et al., 2005; 
Austvoll-Dahlgren et al., 2008; Brook et al., 1983; Goldman et al., 2007; Hsu et al., 2006; 
Lexchin and Grootendorst, 2004; Soumerai et al., 1994; Soumerai et al., 1991), and very few 
have specifically assessed the impact on hypertensive patients. Studies focusing on chronically 
ill patients have consistently shown greater use of inpatient and ER services with higher cost 
sharing; however, studies across broader ranges of drugs showed mixed results as to whether 
cost sharing leads to adverse health outcomes or increased costs (Goldman et al., 2007).  
In a large study restricted to persons using medication for which a reduction in use might 
be expected to have an adverse affect on health, a 25 percent cost-sharing policy for prescription 
drugs up to an income-dependent deductible was associated with reductions in essential drug use 
and an increase in serious adverse events and emergency room visits among the elderly and 
welfare recipients. In contrast, reductions in use of less essential drugs were not associated with 
an increase in risk of adverse events or ER visits (Tamblyn et al., 2001). In a prospective cohort 
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study, Hsu and colleagues (2006) reported that those whose prescriptions were capped had fewer 
office visits and worse physiologic outcomes (systolic blood pressure >140 mm Hg) than those 
whose prescriptions were not capped. Capped individuals also had an increase in ER visits, 
increase in nonelective hospitalizations, and higher death rates. The rates of elective 
hospitalization were not significantly different between the two groups.  
In an older randomized controlled trial that was representative of the U.S. population (the 
Rand Health Insurance Experiment), those who had only catastrophic coverage had the highest 
blood pressures. Hypertensive individuals given free care were more likely than those under 
cost-sharing plans to be compliant with dietary recommendations, to have a BP <140/90 (43 
percent in free care versus 37 percent for those in a cost-sharing plan), and to have a BP <160/95 
(65 percent versus 56 percent). The impact was greater for those of lower SES. The authors 
estimated a 5-8 percent difference in the probability of death in the next year as a result of poorer 
hypertension control in the cost-sharing plan (Brook et al., 1983; Keeler et al., 1985; Keeler et 
al., 1987). Hypertensive individuals in the cost-sharing plans were less likely to be diagnosed 
with hypertension despite having a blood pressure 4 mm Hg higher than those with free care who 
had also seen a physician This failure to diagnose and treat resulted in most of the overall 
difference in blood pressure control between plans at the end of the study (Keeler et al., 1985; 
Keeler et al., 1987).  
Not all research has demonstrated adverse health outcomes associated with cost sharing. 
For example, Johnson et al. (1997a) reported no consistent changes in office visits, emergency 
room visits, home healthcare visits, or hospitalization with copayment changes over four time 
periods. In comparing members switched from a two-tier to a three-tier plan with those retained 
in the two-tier plan, Fairman and colleagues (2003) found that the two groups did not differ 
significantly with respect to the number of office visits, emergency department visits, or 
inpatient hospitalizations. Another study assessing the impact of moving from a two-tier to a 
three-tier system also found no significant difference in emergency room visits or 
hospitalizations (Motheral and Fairman, 2001). A study comparing patients whose ACE 
inhibitors were put on reference pricing with those switched to an ACE inhibitor that was not 
subject to the price increase found a transient (two-month) increase in physician visits and 
hospitalization through the emergency room for those who were switched to reference pricing, 
but no evidence that reference pricing resulted in increased long term healthcare utilization 
(Schneeweiss et al., 2002b). In a prospective cohort study, Hsu and colleagues (2006) reported 
that those whose prescriptions were capped had lower pharmacy and outpatient visit costs, but 
higher hospitalization costs and higher ER costs than individuals not subject to a cap. Total 
medical costs were comparable in the two groups. In a study of individuals who were switched to 
a no-cost ACE inhibitor compared with those who had cost sharing for ACE inhibitors, overall 
healthcare costs decreased (a slight increase in costs of physician visits but large decreases in 
medication costs) (Schneeweiss et al., 2002b). 
EMPLOYER INITIATIVES TO ADDRESS HYPERTENSION  
Traditional worksite health promotion programs strive to maintain worker health, 
improve work productivity, lower healthcare costs, and enhance organizational image and future 
interests (Goetzel and Ozminkowski, 2008). Increasingly, worksite health promotion programs 
are an element of corporate “health management” programs. Typically these programs provide a 
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number of workforce-based initiatives that may include health promotion services, disease 
management, and other efforts to improve employee productivity by improving employe e health 
(Goetzel et al., 2007).  
Healthy People 2010 further describes workplace health promotion to include not only 
health education that focuses on skill development and lifestyle behavior change but also 
programs that help employees assess health risks and link to health plan benefits to provide 
appropriate medical follow-up and treatment. Key to these programs is their integration within 
the organizational structure and a supportive environment in which organizational values, norms, 
policies, and initiatives reinforce and support a healthy work culture (Partnership for Prevention, 
2001). 
The evidence supporting worksite prevention interventions is addressed in the Guide to 
Community Preventive Services (Guide to Community Preventive Services, 2009). The Task 
Force on Community Preventive Services reviewed the 31 studies to determine if health risks 
assessment with feedback plus health education with or without other interventions could lead to 
changes in employees’ health outcomes; blood pressure was included among these outcomes. Of 
the studies reviewed, significant changes were seen in systolic and diastolic blood pressure. The 
median decrease in systolic blood pressure was 2.6 mm Hg, and the median decrease in diastolic 
blood pressure was 1.8 mm Hg. A decrease of 4.5 percentage points (median) in the proportion 
of employees with a high-risk blood pressure reading was also noted. The Task Force concluded 
that there is strong evidence of effectiveness to support worksite interventions that include the 
assessment of health risks with feedback plus health education with or without other 
interventions.  
Worksite prevention programs may be attractive to employers if they can yield a return 
on investment (ROI). Koffman et al. (2005), for example, found a $3 to $6 ROI for every dollar 
invested over a two- to five-year period to implement a comprehensive worksite health 
promotion program focused on employee cardiovascular health. Aldana (2001) reported an 
average ROI of $3.48 in healthcare savings for every dollar expended on a health promotion 
program. Of the 12 studies reviewed to assess the financial impact of health promotion programs 
on healthcare costs, 7 studies had a positive ROI and 4 studies reported no effects of the 
programs on healthcare costs. Aldana (2001) also reported significant ROI (from $2.50 to $10.00 
saved for every dollar invested) related to reductions in employee absenteeism. 
Some employers have begun to explore benefit-based or value-based interventions as a 
means to address financial barriers that may hinder an employee’s treatment. Benefit- or value-
based insurance design refers to programs that provide a reduction in costs to targeted patients 
for targeted interventions that are deemed from the medical evidence to be highly beneficial. For 
example, a program might provide lower copayments for hypertension patients for blood 
pressure medications that are known to be effective (Chernew et al., 2007) Pitney Bowes, a 
Fortune 500 company, reduced or removed coinsurance on maintenance drugs for diabetes, 
hypertension, and asthma. Data available on diabetes care indicated that ER use decreased by 26 
percent and pharmacy costs decreased by 7 percent. Total direct healthcare costs per plan 
participant with diabetes decreased by 6 percent. The hotel chain Marriott also began waiving 
employee copayments on generic drugs and reducing copayments by half for brand name drugs 
for diabetes, asthma, and heart disease (Capozza, 2008); health outcomes and other results are 
still pending.  
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To promote worksite wellness, the Centers for Disease Control and Prevention (CDC) 
Division of Heart Disease and Stroke Prevention (DHDSP) has partnered with the National 
Business Coalition on Health, the National Business Group on Health (NBGH), and other private 
entities. In 2006, NBGH released A Purchaser’s Guide to Clinical Preventive Services: Moving 
Science into Coverage developed in cooperation with the CDC and the AHRQ. The guide 
provides advice to employers to assist them in purchasing health services that have the greatest 
impact on health improvement and are cost-effective. Hypertension screening, counseling, and 
treatment are identified among the top 25 high-value preventive services identified in the guide. 
The document ranked hypertension screening, counseling, and treatment with the highest score 
of clinical preventive burden of disease (on a scale of 1 to 5 where 5 is the highest score) and a 
medium score of 3 for cost-effectiveness (on the 5 point scale). Overall, hypertension screening, 
counseling, and treatment was ranked sixth out of the top 25 high-value preventive services 
(CDC, 2009; Maciosek et al., 2006; Partnership for Prevention, 2006). 
Other products useful for employers include the CDC’s Successful Business Strategies to 
Prevent Heart Disease and Stroke Toolkit, which provides guidance and resources to be used by 
state heart disease and stroke prevention programs to engage the business community (CDC, 
2008b). The toolkit includes a check list to help employers choose and negotiate health benefit 
packages that fit the needs of their employees. The American College of Sport Medicine’s 
Worksite Health Handbook is another resource for employers. It provides a compilation of 
research, evidence, and practice information that supports worksite health promotion as a means 
to enhance productivity management, health promotion, and chronic disease management 
(American College of Sports Medicine, 2009) 
COMMUNITY HEALTH WORKERS AND HYPERTENSION  
Previous sections have addressed a number of system factors that influence the control of 
hypertension. Individual factors such as motivation to take prescribed medication and healthy 
lifestyle choices also play a role. Community health workers (CHWs) have been studied as a 
strategy to help improve hypertension control (Brownstein et al., 2005). Community health 
workers are broadly defined as “community members who work almost exclusively in 
community settings and who serve as connectors between healthcare consumers and providers to 
promote health among groups that have traditionally lacked access to care (Witmer et al., 1995). 
They serve as lay educators, coaches, navigators, advocates, and liaisons to the healthcare system 
(Brownstein et al., 2005). 
Brownstein et al. (2005) reviewed randomized controlled trials (RCTs) and other studies 
to examine the effectiveness of CHWs in supporting the care of individuals with hypertension. 
Highlights from the review include: positive behavioral changes in nine of ten studies 
improvements in appointment keeping, improved adherence to medications and improved blood 
pressure control. Among the five studies that addressed adherence to medications, two RCTs saw 
significant improvement in the intervention groups that included CHWs compared to the control 
group. Another RCT found 26 percent greater compliance among patients receiving intense 
CHW interventions. A time-series study and a before-and-after study also noted improvement 
with CHW interventions. With respect to blood pressure control, nine of ten studies reported 
positive improvements. Improvement in blood pressure control ranged from 4 to 46 percent over 
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different time periods (6 to 24 months). One study did not find differences between CHW and 
control groups. 
The roles and duties of CHWs tend to be similar across studies and reflect the common 
objective of improving blood pressure control through a range of physician- or nurse-supervised 
behavioral and social support interventions. The latter typically include measuring and 
monitoring blood pressure; providing health education to patients and families about behavioral 
risk factors for hypertension; recommending changes in diet and physical activity; explaining 
treatment protocols, health insurance matters, and the importance of adhering to medication 
regimens; providing help with obtaining transportation to medical appointments; serving as 
mediators between patients and healthcare and social service systems; arranging for translation 
services; and finally, listening to patients and their family members, motivating them, reducing 
their isolation, and leading self-help groups.  
Some of the roles and the successes achieved appear to be similar to those of nurses who 
have provided educational interventions aimed at hypertension control and suggest an efficient 
strategy for bringing about enhanced treatment and sustained blood pressure control for targeted 
racially or ethnically diverse, high-risk populations. Although trained laypeople cannot perform 
in the same capacity as professional nurses and health educators, with appropriate training and 
supervision they can successfully contribute to the care of community members with 
hypertension (Bosworth et al., 2005).  
Community health workers may also play an important role in linking diverse 
communities to the healthcare system (HRSA, 2007; IOM, 2003e). The IOM committee that 
produced the report Unequal Treatment: Confronting Racial and Ethnic Disparities in Health 
Care, found that “community health workers offer promise as a community-based resource to 
increase racial and ethnic minorities’ access to healthcare and to serve as a liaison between 
healthcare providers and the communities they serve.” Based on this finding, the committee 
recommended supporting the use of community health workers. “Programs to support the use of 
community health workers (e.g., as healthcare navigators), especially among medically 
underserved and racial and ethnic minority populations, should be expanded, evaluated, and 
replicated” (IOM, 2003e, 195). 
Federal agencies, including the CDC and the National, Heart, Lung, and Blood Institute, 
recognize the potential contributions of CHWs in the prevention and control of cardiovascular 
disease, including hypertension. Training manuals for community health workers and lay health 
educators have been developed and disseminated by these agencies (CDC, 2008a). 
CONCLUSIONS 
Access to health care and the quality of health care have been areas of serious review and 
analysis at the Institute of Medicine. In the early 2000s, the IOM produced a series of reports on 
the general benefits of having health insurance and the adverse health consequences when 
insurance is lacking (IOM, 2001a, 2002a, 2002b, 2003b, 2003d, 2004). The Institute of Medicine 
also published landmark reports on the poor state of quality in the healthcare delivery system and 
on a comprehensive vision for how the healthcare system might be transformed to be safe, 
effective, patient-centered, timely, efficient, and equitable (IOM, 2001b, 2003c). These reports 
do not specifically address access to hypertension care or providers. One report, Priority Areas 
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for National Action: Transforming Health Care Quality (IOM, 2003c), however, identified 
hypertension (with a focus on appropriate management of early disease) as one of 20 priority 
areas for improvement in healthcare quality.  
The committee, in its review of the evidence related to hypertension control and access to 
care and providers, found that although lack of health insurance is associated with poorer 
screening rates, poorer compliance with medication, and poorer blood pressure control; the vast 
majority of individuals with uncontrolled hypertension in the United States are insured. In fact, 
the committee found that lack of health insurance or lack of access to health care accounts for a 
relatively low proportion of poor awareness or poor control of hypertension. Within the context 
of the current healthcare reform debate, the committee supports the recommendations by a 
former IOM committee for “comprehensive and affordable health care to every person residing 
in the United States” and that "all public and privately funded insurance include appropriate 
preventive services as recommended by the U.S. Preventive Services Task Force" (IOM, 2003a). 
The committee encourages the Division of Heart Disease and Stroke Prevention to be supportive 
of such efforts but directs the division's attention to addressing the quality of care for 
hypertension, especially as it relates to healthcare providers’ capacity to deliver quality 
hypertensive care. 
Based on the review of the literature, there is strong evidence that physicians are not 
paying adequate attention to treating and controlling systolic hypertension. The goal of 
improving the education and training of healthcare providers in the prevention of cardiovascular 
disease is central to the Public Health Action Plan to Prevent Heart Disease and Stroke, the 
DHDSP Strategic Plan, and the National Heart Disease and Stroke Prevention Program (as 
described in Chapter 3). For example, under the National Heart Disease and Stroke Prevention 
Program, Virginia, Georgia, and South Carolina have programs to support professional education 
and training to promote quality health care.1 The committee believes that understanding the 
reasons behind nonadherence and increasing physician awareness, understanding and 
implementation of JNC treatment guidelines is essential to increasing the number of individuals 
with controlled hypertension, especially systolic hypertension. This is especially salient among 
the elderly, given the aging of the U.S. population. The committee is concerned that undiagnosed 
hypertension, and treated but uncontrolled hypertension, is occurring under “the watchful eye of 
the healthcare system” and that physicians are not adhering to JNC guidelines. While a number 
of studies have documented the problem, little information is available to understand clearly why 
providers do not adhere to JNC guidelines related to screening and treating or intensifying 
treatment for mild to moderate systolic hypertension. As one study reported, some physicians 
were satisfied with blood pressure levels above 140 mm Hg and 90 mm Hg, and some physicians 
attributed higher risk to elevated diastolic pressure than to elevated systolic pressure, especially 
in the elderly (Oliveria et al., 2002). Numerous questions remain regarding whether the lack of 
adherence is related to a lack of physician agreement with the new treatment guidelines, 
                                                 
1 Virginia's program primarily focuses on educating, training, and certifying healthcare professionals in the proper 
procedures in measuring blood pressure. The Georgia Cardiovascular Health Initiative, along with its partner the 
International Society on Hypertension in Blacks, conducts a series of continuing medical education for community-
based health center staff and other providers. Similarly, South Carolina and its partner, the American Society of 
Hypertension, Inc., provide continuing medical education to health professionals on evidence-based treatment of 
hypertension. The training leads to certification as a “hypertension expert.”  
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physician lack of knowledge regarding the guidelines, inertia due to treating at the previous 
guideline of 160 mm Hg/95 mm Hg, or other barriers.  
5.1 The committee recommends that the Division of Heart Disease and Stroke 
Prevention give high priority to conducting research to better understand the 
reasons behind poor physician adherence to current JNC guidelines. Once these 
factors are better understood, strategies should be developed to increase the 
likelihood that primary providers will screen for and treat hypertension 
appropriately, especially in elderly patients.  
Educating clinicians about the importance of treating and controlling systolic 
hypertension may be one important strategy but is not expected to be the only one.  
Furthermore, high levels of uncontrolled hypertension are indicative of poor-quality care. 
The committee agrees with the IOM recommendation that identified hypertension (with a special 
focus on appropriate management of early disease) as one of the top 20 priorities for 
improvement in healthcare quality (IOM, 2003c). The evidence reviewed indicates that although 
physicians screen for blood pressure, screening does not always lead to treatment or to 
intensified treatment when appropriate.  
5.2 The committee recommends that Division of Heart Disease and Stroke 
Prevention work with the Joint Commission and the healthcare quality community 
to improve provider performance on measures focused on assessing adherence to 
guidelines for screening for hypertension, the development of a hypertension 
disease management plan that is consistent with JNC guidelines, and achievement 
of blood pressure control. 
Out-of-pocket cost of medication has been identified in the literature as a significant 
barrier to patient adherence with hypertension treatment. It is estimated that for every 10 percent 
increase in cost sharing, overall prescription drug spending decreases by 2-6 percent (Goldman et 
al., 2007) Goldman and colleagues compared the impact of reducing cost-barriers with other 
interventions designed to improve adherence with medications for chronic conditions and noted 
that even the most successful interventions designed to increase patient adherence to medication 
did not result in larger improvements in adherence than reducing the costs, and generally relied 
on complicated, labor-intensive regimens (Goldman et al., 2007).  
The committee finds the evidence convincing that reducing costs of antihypertensive 
medication is an important and efficient way to increase medication adherence.  
5.3 The committee recommends that the Division of Heart Disease and Stroke 
Prevention should encourage the Centers for Medicare and Medicaid Services to 
recommend the elimination or reduction of deductibles for antihypertensive 
medications among plans participating under Medicare Part D, and work with 
state Medicaid programs and encourage them to eliminate deductibles and 
copayment for antihypertensive medications. The committee also recommends that 
the DHDSP work with the pharmaceutical industry and its trade organizations to 
standardize and simplify applications for patient assistance programs that provide 
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reduced-cost or free antihypertensive medications for low-income, underinsured 
or uninsured individuals.  
The committee notes that the DHDSP is also well positioned to educate the private sector 
that eliminating or reducing the costs of antihypertensive medications is an important and 
efficient way to increase medication adherence. Through collaborations with the National Forum 
for Heart Disease and Stroke Prevention (Chapter 3) and cooperative agreements and 
partnerships with the private sector, the division provides support and guidance to the employer 
community on hypertension and cardiovascular disease prevention and control. The division’s 
product, The Business of Heart Disease and Stroke Prevention Toolkit, for example, although 
extremely informative and useful, does not address benefit or value-based benefit purchasing that 
can help reduced costs of essential antihypertensive medications. The private sector is already 
experimenting with reducing the copayments associated with drugs commonly prescribed for 
diabetes, asthma, and hypertension (Pitney Bowes, Marriott, others). The results of these 
experiments should be shared broadly with the business community.  
5.4 The committee recommends that the Division of Heart Disease and Stroke 
Prevention collaborate with leaders in the business community to educate them 
about the impact of reduced patient costs on antihypertensive medication 
adherence and work with them to encourage employers to leverage their 
healthcare purchasing power to advocate for reduced deductibles and copayments 
for antihypertensive medications in their health insurance benefits packages. 
The DHDSP might also consider working with the business community to evaluate and 
disseminate broadly the research on the health impacts of efforts to reduce financial burdens 
associated with the treatment of hypertension.  
The use of community health workers to support the care of individuals with 
hypertension has been identified as a promising strategy. Community health workers have 
contributed to greater medication adherence among individuals with hypertension and have been 
shown to play an important role in linking diverse communities to the healthcare system and 
navigating that system. 
5.5 The committee recommends that the Division of Heart Disease and Stroke 
Prevention work with state partners to leverage opportunities to ensure that 
existing community health worker programs include a focus on the prevention and 
control of hypertension. In the absence of such programs, the Division should work 
with state partners to develop programs of community health workers who would 
be deployed in high-risk communities to help support healthy living strategies that 
include a focus on hypertension.  
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IMPLEMENTING A POPULATION-BASED POLICY AND SYSTEMS 
APPROACH TO THE PREVENTION AND CONTROL OF 
HYPERTENSION 
Hypertension is highly prevalent in adults, endemic in the elderly, a major contributor to 
cardiovascular mortality and disability, costly to our society and contributes substantially to 
health disparities in the United States. Hypertension is also simple to diagnose, relatively 
inexpensive to treat, and more importantly, is highly preventable through lifestyle interventions.  
Despite these facts, surprisingly and unfortunately, hypertension does not receive a level 
of attention and funding commensurate with its associated health burden and consequences and 
the public health approach to addressing hypertension in this decade has suffered. The early 
national attention to hypertension of the 1970’s (National High Blood Pressure Education 
Program) has diminished and the focus on prevention and early detection has shifted toward 
pharmacologic treatment. This lack of attention is exacerbated, in part, because hypertension as a 
condition sits between more primary risk factors such as diet and physical activity and medical 
disease states such as cardiovascular and cerebrovascular disease with consequent ambiguity in 
leadership and diffusion of responsibility between public health and medical care. From the 
perspective of those affected, hypertension is easy to neglect. It is not an apparent risk factor like 
smoking or obesity, and for the majority of individuals, it causes no symptoms. Thus there has 
been little “ownership” for the prevention of hypertension.  
The CDC, through the Division of Heart Disease and Stroke Prevention, has leveraged its 
broader cardiovascular disease prevention and control programmatic efforts to address 
hypertension primarily through its state heart disease and stoke prevention programs. Many of 
these efforts are described in Chapter 3 and throughout other chapters. Objectively however, 
there are two significant problems with the current status and direction of hypertension 
prevention and control activities: 
• Hypertension is only one component of a larger cardiovascular disease prevention 
program that has more of a medical care rather than a population-based prevention focus. 
• The CDC’s cardiovascular disease program in general, and the hypertension program in 
particular, are dramatically under funded relative to the preventable burden of disease and 
the strategy and action plan that has been developed. Despite the magnitude of 
hypertension-associated morbidity and mortality and costs to the health care system ($73 
billion annually), the current resources available for hypertension prevention and control 
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at CDC are surprisingly limited ($54 million for all cardiovascular and stroke activities in 
2009). 
This current economic reality limiting the absolute amount of resources available to CDC 
must drive short term programmatic priorities towards approaches that are not only cost effective 
but also low in absolute cost. Compared with interventions directed towards individuals, 
interventions directed towards policy, systems, and environmental changes in populations are 
more likely to be realistic and effective in the current resource-constrained environment. The 
committee believes that DHDSP should focus its priorities on approaches that cater to the 
strength of the public health system – population-based policy and systems approaches rather 
than individual health care-based approaches. Any investments in the health care sector should 
be policy and systems-based and should leverage health care system resources.  
The committee has recommended a number of high priority strategies to prevent and 
control hypertension to the DHDSP throughout chapters 4 and 5. The recommendations embody 
a population-based policy and systems approach grounded in the principles of measurement, 
system change, and accountability. In brief, the recommendations seek to:  
• Shift the balance of the Division’s hypertension strategies from individual-based 
strategies to population-based strategies to:  
• strengthen collaboration among CDC units (and their partners) to ensure that 
prevention of hypertension is a major consideration in the implementation of 
population-based activities around healthy lifestyle improvement, particularly 
healthy eating and increased physical activity. 
• strengthen CDC’s leadership in monitoring and reducing sodium intake in the 
American diet to meet current dietary guidelines 
• improve the surveillance and reporting of hypertension to better characterize 
overall trends and trends among subgroups of the population 
• Promote policy and system approaches to: 
• Improve the quality of care provided to individuals by assuring that 
individuals who should be in treatment are in treatment and receive care that 
is consistent with current treatment guidelines  
 Increase the importance of treating systolic hypertension, especially 
among the elderly 
• Remove economic barriers to effective antihypertensive medications  
• Provide community-based support for individuals with hypertension through 
community health workers who are trained in dietary and physical activity 
counseling. 
The committee, through these recommendations, underscores the importance of policy, 
systems and environmental change interventions as fundamental to preventing and controlling 
hypertension. Clearly, this approach cannot be limited to the CDC DHDSP but must also extend 
to state and local health departments and other partners responsible for implementing these 
interventions. Successfully implementing a population-based policy and systems approach at all 
levels will depend on the resources available and systems of accountability to ensure that 
resources are appropriately aligned and outcomes are achieved. In the next section the committee 
makes recommendations for state and local health jurisdictions, including necessary resources 
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and accountability measures to support the recommended population-based policy and systems 
approach to preventing and controlling hypertension. 
Recommendations for State and Local Health Jurisdictions  
State and local level governments have specific roles and responsibilities for protecting, 
preserving, and promoting the public’s health. They fulfill their responsibility through many 
activities including monitoring injury and disease in the population through surveillance systems; 
providing a broad array of population-wide prevention services; and helping to assure access to 
high-quality health care services for poor and vulnerable populations. They also engage in a 
broad array of regulatory activities, and they oversee the quality of health care provided in the 
public and private sectors (IOM, 2002). State and local public health agencies can act on the 
most upstream level of determinants of health. Action at this level may help to shift norms and 
values and lead to policies that promote health (for example state and local tobacco policies). 
Thus, as with federal public health agencies, state and local public health agencies are uniquely 
skilled in population-based interventions and in general have more experience in these 
interventions than in interventions that directly provide health care to individuals.  
The committee views population-based approaches to prevent and control hypertension at 
the state and local level to be consistent with the broad mandates of state and local public health 
jurisdictions (SLHJs).  
6.1 The Committee recommends that state and local public health jurisdictions 
give priority to population-based approaches over individual-based approaches to 
prevent and control hypertension. 
Population-based policy and systems interventions for hypertension prevention and 
control are arguably the most important and relevant component of hypertension programming 
for SLHJs. By their nature, many elements of hypertension prevention fit neatly into current 
SLHJs programs for healthy eating, active living, and obesity prevention (IOM, 2007, 2009). As 
such, population approaches to hypertension should be integrated into these existing efforts 
rather than recreated as separate, stand alone programs. At the same time, these existing 
programs may need adjustment and expansion. For example, the high prevalence of hypertension 
in older populations and other population subgroups (African Americans) should lead SLHJs to 
assess, and if necessary modify these programs to assure they are relevant and accessible to older 
and higher risk populations.  
6.2 The committee recommends that state and local public health jurisdictions 
integrate hypertension prevention and control in programmatic efforts to effect 
system, environmental, and policy changes that will support healthy eating, active 
living, and obesity prevention. Existing and new programmatic efforts should be 
assessed to ensure they are aligned with populations most likely to be affected by 
hypertension such as older populations which are often not the target of these 
programs.  
A major risk factor for hypertension – excess sodium consumption in the diet – currently 
is not targeted by most SLHJs and is a new, important target for public health action. Strategies 
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for sodium reduction will be further refined in an upcoming IOM report by the Committee on 
Strategies to Reduce Sodium Intake (slated to be released in early 2010) but may include: 
public education to increase awareness of the importance of reduced sodium in the diet and the 
salt content of foods; modifying sodium policies in food programs under SLHJs jurisdiction; 
voluntary or regulatory measures to reduce sodium levels in processed foods and foods prepared 
in institutions such as schools and worksites.  
Actions to reduce sodium levels in food products have been initiated by other countries 
including the United Kingdom (UK) and are showing some impact. The UK Food Standards 
Agency published voluntary salt reduction targets in March 2006 to lower population salt intake 
from 9.5g (baseline in 2000-2001) to 6 g. Since that time, the Agency has been working with 
health departments, directorates and stakeholders, and industry to reduce salt consumption in the 
UK. A recent progress review indicated that many companies that produce processed foods have 
programs in place to reduce salt and have met targets for specific categories. Urinary analysis 
results taken in January and May of 2008 indicate that overall salt reduction initiatives (public 
awareness, industry activities and others) has decreased average salt intake to 8.6 g based on 
dietary sodium in 24 hour urine samples (National Centre for Social Research, 2008). 
In the United States, cities, states, and national health organizations are taking steps to 
reduce population salt intake; the National Salt Reduction Initiative (NSRI), coordinated by the 
New York City Health Department, has led the way. The NSRI’s strategy includes working with 
the food industry to set sodium reduction targets for their products that are substantive, 
achievable, gradual, measurable, and voluntary, with the goal of reducing population sodium 
intake by 20 percent over five years. The process for implementing the strategy includes meeting 
with food industry leaders to discuss sodium reduction, working with packaged food 
manufacturers and restaurants to set voluntary sodium targets by food category, implementing 
targets and timelines to reduce salt, and monitoring the salt reduction process through the 
creation of restaurant and packaged food nutrition databases. Across the country 26 state and 
local public health agencies and 17 professional associations and organizations have coalesced 
into the NSRI. (The City of New York, 2009)  
6.3 The committee recommends that all state and local public health jurisdictions 
immediately begin to consider developing a portfolio of dietary sodium reduction 
strategies that make the most sense for early action in their jurisdiction. 
Reliable, ongoing measurement of a public health problem is essential to its effective 
control. Blood pressure is relatively simple to measure, however, access to and use of 
hypertension measures at the SLHJs level has proven difficult. The primary national data source 
for population estimates of hypertension – NHANES – is not designed to produce accurate state 
or local estimates. This shortcoming is a major one, as there is likely substantial variation across 
regions not only in prevalence but in the proportions of the hypertensive population not 
diagnosed, diagnosed but not under treatment, and under treatment but not controlled. The 
primary risk factor surveillance system used by SLHJs, the Behavioral Risk Factor Surveillance 
System, is limited because it relies on self report rather than objective measurement, and 
provides no information on the extent and characteristics of undiagnosed hypertension. In short, 
SLHJs do not have the basic data that would be most useful in assessing need and driving local 
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policy interventions; this lack of data may contribute to the relative inattention to hypertension 
by SLHJs to date. 
Hypertension provides one of the most compelling conditions justifying the creation of a 
state and local NHANES-like survey providing representative population-based objective 
clinical information. Some states and localities are moving in this direction. Currently four states 
receive funding from the DHDSP through the State Cardiovascular Health Examination Survey 
program to initiate state HANES-like surveys but data are not yet available. New York City 
currently conducts a local version of the HANES that is a population-based, cross-sectional 
survey of noninstitutionalized NYC adult residents 20 years of age and older (Angell et al., 
2008). The survey has allowed the NYC Department of Health and Mental Hygiene to monitor 
the health of NYC residents including the prevalence, awareness, treatment, and control of 
hypertension. SLHJs without the resources to implement a state-level HANES, may need to 
identify other reliable population-based data sets, for example health care quality reporting data, 
that could be used to monitor local hypertension trends.  
6.4 The committee recommends that state and local public health jurisdictions 
assess their capacity to develop local HANES as a means to obtain local estimates 
of the prevalence, awareness, treatment and control of hypertension. Further, if a 
program to reduce hypertension is a national goal, funding should be made 
available to assure that localities have relevant data that will assist them in 
addressing hypertension in their communities.  
The committee recognizes that local financial constraints may not allow many SLHJs to 
move forward in this regard in the short-term; thus, SLHJs may want to actively seek other 
reliable and available population-based data sets as a way to monitor local hypertension trends. 
As a primary strategy, interventions in which public health dollars are used to directly 
deliver high quality hypertension detection and treatment services are unlikely because of the 
cost of these interventions. Furthermore, direct interventions providing direct health care to 
individuals are most distant from the unique skills and value-added of state and local health 
agencies. But, because hypertension is treatable, SLHJs should consider how to use their limited 
resources to best leverage health care dollars for improved treatment and control of hypertension.  
Public health agencies vary widely in their working relations and links with the health 
care providers in their jurisdictions. In some areas, linkages are strong and the SLHJ could play a 
valuable role in convening and advocating for improved treatment and care for persons with 
hypertension. But such activity will not be equally productive everywhere and will require a 
case-by-case assessment. Alternatively, SLHJs may be able to play an effective leadership and 
convening and brokering role in influencing community-wide health care practices, for example 
through advocacy for incorporating measures of hypertension control in local or regional 
measures of health care quality. Assuring complementary life-style interventions (physical 
activity, weight management, healthy diet) in health care treatment protocols and linking these 
activities to community-based strategies through community health workers may be another 
important element of a local hypertension control program.  
Systolic hypertension in the elderly is the most common form of uncontrolled 
hypertension in the United States. One area of special SLHJs activity relative to the hypertension 
health care delivery system may be to increase provider awareness of both prevalence and 
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evidence of treatment effectiveness for moderate systolic hypertension in older patients and 
monitoring of provider performance in meeting JNC treatment guidelines.  
6.5 The committee recommends that state and local public health jurisdictions 
serve as conveners of health care system representatives, physician groups, 
purchasers of health care services, quality improvement organizations, and 
employers (and others) to develop a plan to engage, and leverage skills and 
resources for improving the medical treatment of hypertension. 
6.6 State and local public health jurisdictions should work with business coalitions 
and purchasing coalitions to remove economic barriers to effective 
antihypertensive medications for individuals who have difficulty accessing them.  
6.7 State and local public health jurisdictions should promote and work with 
community health worker initiatives to ensure that prevention and control of 
hypertension is included in the array of services they provide and are 
appropriately linked to primary care services. 
Resources for Hypertension Prevention and Control 
The DHDSP has developed a comprehensive strategic plan that is not implementable in 
full with the current resources available. Considering the limited available resources, the 
committee has provided recommendations on priorities among the many possible activities laid 
out by the DHDSP. These recommendations have centered on population-based policy and 
system interventions in which funding can leverage other public health, health care, and private 
sector funding for improved prevention, treatment, and control of hypertension. The committee 
notes, in fact, there are fewer public health resources for hypertension prevention than for any 
other preventable risk factor underlying a disease burden of comparable magnitude. As an 
example, CDC funding for the Office of Smoking and Health is $106.2 million while funding for 
the Division of Heart Disease and Stroke Prevention is $54.1 million; this funding supports 
activities related to not only hypertension but also stroke, and cardiovascular disease in general. 
Federal underfunding and under attention of hypertension relative to the preventable burden of 
disease has played out at the state and local level as well. In general, states and localities have 
not invested in public health chronic disease prevention programs to the extent to which they 
have invested in communicable diseases (Frieden, 2004; Georgeson et al., 2005; Porterfield et 
al., 2009; Prentice and Flores, 2007). The evidence presented in Chapter 4 indicates there is 
potential for a substantial preventive, non-pharmacologic, non-health care, population-based 
policy and system strategy to be implemented at the federal, state and local level. There is also 
room for substantial improvement in health care diagnosis and treatment as discussed in Chapter 
5. Implementation of the strategy, however, will be hampered by limited resources. With the 
nation’s attention now focused on health care reform in general and specifically on the potential 
role of prevention, there is also the opportunity to advocate for increased financing for 
hypertension prevention and control.  
In an era of declining resources and conflicting priorities for public health, taking on any 
new challenges needs careful consideration. But given the disease and economic burden 
associated with hypertension, and in this climate of health care reform and increasing attention to 
prevention, there is great public health opportunity and no better time to rise to the challenge.  
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6.8 The committee recommends that the Congress give priority to assuring 
adequate resources for implementing a broad suite of population-based policy and 
system approaches at the federal, state and local levels that have the greatest 
promise to prevent, treat, and control hypertension.  
The committee notes that it was hampered in fully understanding how DHDSP funds 
were used for hypertension prevention and control activities at the State level insomuch as many 
of these activities were embedded in larger stroke or cardiovascular prevention and control 
activities and reporting was not sufficiently detailed to ascertain the degree of funding that was 
specifically related to hypertension prevention, treatment and control. A vital component of 
DHDSP prioritization of activities must be budget allocation. Rational decisions about where in a 
portfolio the next dollar should be spent can only be made with good information about where 
current dollars are being spent. A gap analysis comparing current resource use against priorities 
is critical to assure adequate resources are devoted to the highest priority areas.  
Attendant to current funding and potential future funding for hypertension prevention, 
treatment, and control, systems need to be in place to track and measure current and new 
programs activities at the federal, state, and local level. Such a system would help ensure that 
resources are appropriately aligned and outcomes are achieved. 
6.9 The committee recommends that Division of Heart Disease and Stroke 
Prevention develop resource accountability systems to track and measure all 
current and new State programs for the prevention, treatment and control of 
hypertension that would allow for resources to be assessed for alignment with the 
population-based policy and systems strategy and for measuring the outcomes 
achieved. 
The committee acknowledges that the recommendations proffered, if adopted, would 
result in a significant programmatic change for the DHDSP. To effectively support the change 
and maintain a population-based focus, new expertise and guidance may be required beyond that 
which may be available through the DHDSP’s partnership with the National Forum for Heart 
Disease and Stroke Prevention.  
6.10 The committee recommends that the Division of Heart Disease and Stroke 
Prevention identify and work with experts grounded in population-based 
approaches to provide guidance and assistance in designing and executing 
hypertension prevention and control efforts that focus on population-based policy 
and system change. These experts could augment an existing advisory body or be 
drawn from an existing body with this expertise. 
Ensuring System Accountability  
The committee considered the results that could be expected if the population-based 
policy and systems approach to prevent and control hypertension were implemented, including 
the potential effect on the overall prevalence of hypertension in the population and on racial and 
ethnic disparities. This section outlines the committee’s consideration of those issues and 
identifies potential outcomes and indicators. The committee’s consideration of potential indictors 
was informed by the Division’s draft document on “Policy and System Outcome Indicators for 
Copyright © National Academy of Sciences. All rights reserved.
A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 
http://www.nap.edu/catalog/12819.html
146 A POPULATION-BASED APPROACH TO PREVENT AND CONTROL HYPERTENSION 
PREPUBLICATION COPY: UNCORRECTED PROOF 
State Heart Disease and Stroke Prevention, Priority Area: High Blood Pressure Control (DHDSP, 
2008).”  
The committee believes that attention to the high priority areas it has identified would 
lead to a reduction in the prevalence of hypertension, improve the quality of care provided to 
individuals with hypertension and in the long term, and ultimately, would reduce mortality and 
morbidity due to heart disease and stroke. In the short term, one visible impact would be strong 
federal, state, and local public health agency leadership that gives priority to reducing the 
prevalence of hypertension through population-based approaches integrated throughout agency 
activities, particularly those that target hypertension risk factors by reducing obesity, promoting 
health diets, increasing physical activity. Active engagement and efforts by federal, state, and 
local jurisdiction to reduce sodium consumption, an area not typically addressed by parts of the 
governmental public health system, would be another short-term visible impact. Improved 
estimates of hypertension prevalence, awareness, and treatment and control for the population as 
a whole and subgroups of the population at the national and state and local level would be 
important results of efforts to improve surveillance and monitoring of hypertension trends. 
Similarly, through improved data collection, public health officials would have better estimates 
to monitor their progress in reducing dietary sodium consumption and the sodium content in 
food. 
Improved blood pressure control, especially systolic blood pressure among the elderly, 
would be the result of strategies designed to address the factors contributing to poor physician 
adherence to JNC treatment guidelines. The effect of removing economic barriers to effective 
antihypertensive medications and employing the use of community health workers to provide 
community-based support for individuals with hypertension would be improved access to 
medications and supportive hypertension care for vulnerable populations. Finally, essentially all 
of the proposed interventions have the potential to reduce health disparities if they are 
implemented with this goal in mind, however, this goal may not be in the forefront by all, thus, 
continued monitoring of health disparities will be necessary.  
Table 6-1 summarizes the committee’s recommendations for high priority areas and 
related short-term, intermediate outcomes, and potential indicators to measure the progress made 
in advancing the committee’s high priority areas. Decreased mortality and morbidity from heart 
disease and stroke are understood as the ultimate long-term indicators as such, they are not 
included in the table due to space consideration. The table is divided into broad sections (e.g. 
Population-based Recommendations to CDC’s Division of Heart Disease and Stroke Prevention 
(DHDSP) and State and Local Jurisdictions (SLHJ), System Approaches Targeting Individuals 
with Hypertension Directed to CDC and State and Local Health Jurisdictions, etc…) and include 
subgroups of recommendations under those headings. Outcomes and indicators found in adjacent 
columns do not tract directly across but correspond to the subgroup of recommendations. 
Recommendations for resources and accountability (6.8-6.10) are not included in the table. 
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Hypertension as a Sentinel for Success of the Public Health System in Reducing Health 
Disparities 
Hypertension may provide an opportunity unique in public health chronic disease 
prevention for program evaluation through outcome measurement. In contrast to most chronic 
disease outcomes, measurement of hypertension has a combination of key ideal characteristics, 
including: 1) objectivity, 2) low cost, 3) ease and reproducibility, and 4) rapid response to 
intervention. In this context, it provides a single, reliable outcome measure that can be linked to 
intervention process measures to rapidly inform program interventions. It is also an early 
objective outcome measure of multiple public health and medical interventions to increase 
healthy eating and physical exercise. 
Hypertension is prevalent, preventable, and treatable, easily measured and rapidly 
changeable. As such, it is a potential sentinel indicator for assessing and testing broader 
approaches to reduce health disparities. Hypertension is a condition strongly influenced by 
underlying individual and community risk factors related to healthy eating and active living – 
risk factors driven by race and class in most communities today. The prevalence of hypertension 
may provide a relatively quick and objective measure of programs directed at these risk factors 
as well as underlying social determinants of health. Hypertension, while treatable, requires 
ongoing access to primary care for maximum effectiveness. Thus, it is also a potentially very 
good marker for access to and continuity of health care in a community. The combination of 
these two elements or drivers of hypertension potentially increases the likelihood that standard 
public health interventions may increase rather than decrease disparities, as has often been the 
case in tobacco reduction interventions. SLHJ should consider hypertension as a sentinel 
measure for evaluation of the effectiveness of a range of disparity reducing activities, including 
importantly, place-based strategies tackling conditions through community policy interventions.  
Hypertension is also a disease of aging, becoming increasingly prevalent as individuals 
grow older. From a proportion affected perspective, attention must be directed towards groups 
with the highest prevalence. But from the perspective of the individual, hypertension in younger 
age groups has a greater potential for causing premature morbidity and mortality and so special 
attention needs to be paid to this risk population. 
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HEALTH PRIORITIES TO REDUCE AND CONTROL HYPERTENSION 
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Centers for Disease Control and Prevention 
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Eduardo Ortiz, M.D., M.P.H.  
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National Heart, Lung and Blood Institute (NHLBI) 
National Institutes of Health 
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New York City Department of Health and Mental Hygiene 
American Heart Association 
Daniel Jones, M.D., F.A.H.A.  
Director 
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Howard Koh, M.D.  
Committee Chair 
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David Goff, M.D., Ph.D. 
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Wake Forest University 
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Frank Sacks, M.D.  
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Department of Nutrition 
Harvard School of Public Health 
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March 30, 2009 
Welcome 
David Fleming, M.D. 
Committee Chair 
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Director 
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Heart Disease & Stroke Prevention Program 
Wisconsin Department of Health Services
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A PUBLIC HEALTH ACTION PLAN TO PREVENT HEART DISEASE AND STROKE 
RECOMMENDATIONS 
To help the public health community implement the Action Plan, specific 
recommendations were developed by five Expert Panels. These panels addressed the five 
essential components of the plan—taking action, strengthening capacity, evaluating impact, 
advancing policy, and engaging in regional and global partnerships. Their work was synthesized 
by a Working Group into 22 recommendations, which are presented here according to the Expert 
Panel that produced them.  
Taking Action: Putting Present Knowledge to Work  
1. Initiate policy development in CVH promotion and CVD prevention at national, state, and 
local levels to assure effective public health action against heart disease and stroke. In 
addition, evaluate policies in non-health sectors (e.g., education, agriculture, transportation, 
community planning) for their potential impact on health, especially with respect to CVD.  
2. Act now to implement the most promising public health programs and practices for 
achieving the four goals for preventing heart disease and stroke, as distinguished by the 
Healthy People 2010 Heart and Stroke Partnership based on the different intervention 
approaches that apply. These goals are prevention of risk factors, detection and treatment 
of risk factors, early identification and treatment of heart attacks and strokes, and 
prevention of recurrent cardiovascular events. Public health agencies and their partners 
must provide continuous leadership to identify and recommend new and effective 
interventions that are based on advances in program evaluation and prevention research 
and a growing inventory of “best practices.”  
3. Address all opportunities for prevention to achieve the full potential of preventive 
strategies. Such opportunities include major settings (schools, work sites, health care 
settings, communities, and families), all age groups (from conception through the life 
span), and whole populations, particularly priority populations (based on race/ethnicity, 
sex, disability, economic condition, or place of residence).  
4. Emphasize promotion of desirable social and environmental conditions and favorable 
behavioral patterns in order to prevent the major CVD risk factors and assure the fullest 
attainable accessibility and use of quality health services for people with risk factors or 
who develop subclinical or overt CVD. These actions are integral to a comprehensive 
public health strategy for CVH promotion and CVD prevention. 
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Strengthening Capacity: Transforming the Organization and Structure of Public Health 
Agencies and Partnerships  
5. Maintain or establish definable entities with responsibility and accountability for CVH 
programs within federal, state, and local public health agencies, including laboratory 
components.  
6. Create a training system to develop and maintain appropriately trained public health 
workforces at national, state, and local levels. These workforces should have all necessary 
competencies to bring about policy change and implement programs to improve CVH 
promotion and decrease the CVD burden, including laboratory requirements.  
7. Develop and disseminate model performance standards and core competencies in CVD 
prevention and CVH promotion for national, state, and local public health agencies, 
including their laboratories.  
8. Provide ongoing access to technical assistance and consultation to state and local health 
agencies and partners for CVD prevention.  
Evaluating Impact: Monitoring the Burden, Measuring Progress, and Communicating 
Urgency 
9. Expand and standardize population-wide evaluation and surveillance data sources and 
activities to assure adequate assessment of CVD indicators and change in the nation’s 
CVD burden. Examples include mortality, incidence, prevalence, disability, selected 
biomarkers, risk factors and risk behaviors, economic burden, community and 
environmental characteristics, current policies and programs, and sociodemographic 
factors (e.g., age, race/ethnicity, sex, and ZIP code).  
10. Establish a network of data systems for evaluation of policy and program interventions 
that can track the progress of evolving best practices and signal the need for changes in 
policies and programs over time. This network would support the full development, 
collection, and analysis of the data needed to examine program effectiveness.  
11. Develop the public health infrastructure, build personnel competencies, and enhance 
communication systems so that federal, state, and local public health agencies can 
communicate surveillance and evaluation results in a timely and effective manner.  
Advancing Policy: Defining the Issues and Finding the Needed Solutions  
12. Conduct and facilitate research by means of collaboration among interested parties to 
identify new policy, environmental, and sociocultural priorities for CVH promotion. Once 
the priorities are identified, determine the best methods for translating, disseminating, and 
sustaining them. Fund research to identify barriers and effective interventions in order to 
translate science into practice and thereby improve access to and use of quality health care 
and improve outcomes for patients with or at risk for CVD. Conduct economics research, 
including cost-effectiveness studies and comprehensive economic models that assess the 
return on investment for CVH promotion as well as primary and secondary CVD 
prevention.  
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13. Design, plan, implement, and evaluate a comprehensive intervention for children and 
youth in school, family, and community settings. This intervention must address dietary 
imbalances, physical inactivity, tobacco use, and other determinants in order to prevent 
development of risk factors and progression of atherosclerosis and high blood pressure.  
14. Conduct and facilitate research on improvements in surveillance methods and data 
collection and management methods for policy development, environmental change, 
performance monitoring, identification of key indicators, and capacity development. 
Address population subgroups in various settings (schools, work sites, health care, and 
communities) at local, state, and national levels. Additionally, assess the impact of new 
technologies and regulations on surveillance systems and the potential benefit of 
alternative methods.  
15. Conduct and support research to determine the most effective marketing messages and 
educational campaigns to create demand for heart-healthy options, change behavior, and 
prevent heart disease and stroke for specific target groups and settings. Create and evaluate 
economically viable CVD prevention ventures (e.g., in food production, manufacturing, 
marketing).  
16. Initiate and strengthen training grants and other approaches, such as training workshops 
and supervised research opportunities, to build the competencies needed to implement the 
CVD prevention research agenda. .  
Engaging in Regional and Global Partnerships: Multiplying Resources and Capitalizing on 
Shared Experience  
17. Engage with regional and global partners to mobilize resources in CVH promotion and CVD 
prevention, develop and implement global CVH policies, and establish or strengthen liaison 
with the partners identified in these recommendations.  
18. Address inequalities in CVH among developed and developing countries, rich and poor 
people within countries, and men and women of all ages. Work with national and global 
partners to assess the impact of globalization and trade policies on global CVH.  
19. Develop a strategy to promote use of the media to support  
20. Strengthen global capacity to develop, implement, and evaluate policy and program 
interventions to prevent and control heart disease and stroke. Involve all relevant parties—
governmental and nongovernmental, public and private, and traditional and nontraditional 
partners—in a systematic and strategic approach.  
21. Strengthen the global focus of public health agencies in the United States and their partners 
on CVH and increase their participation in partnerships intended to a) develop and implement 
standards for adequate monitoring of health, social, and economic indicators and b) develop 
the ability to effectively disseminate and translate information into policy and action. 22. 
Promote and support research on implementing and evaluating CVH policy interventions in 
diverse settings where different social and economic development and health transition 
experiences offer contrasting conditions for testing new intervention approaches.  
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22 Promote and support research on implementing and evaluating CVH policy interventions in 
diverse settings where different social and economic development and health transition 
experiences offer contrasting conditions for testing new intervention approaches.
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